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General Introduction & Outline
General introduction to the gastrointestinal tract
The mouse gastrointestinal tract is an organ of mainly endodermal origin consisting 
of oral cavity, esophagus, stomach, small intestine, coecum, large intestine, rectum 
and anus. Its function lies in the digestion of ingested food and the absorption of all 
substances, which are necessary for maintenance and growth of the body. 
The gastrointestinal tract is a hollow tube that is lined by four layers: mucosa, 
submucosa, muscularis and serosa1. The inner epithelial lining, together with a 
lamina propria (loose connective tissue, blood and lymph vessels) and the muscularis 
mucosae form the mucosa. The submucosa is composed of dense connective tissue 
containing blood and lymph vessels as well as the submucosal (Meissner’s) nerve 
plexus. The muscularis forms the third layer of the tube and contains next to smooth 
muscle cells also the myenteric (Auerbach’s) nerve plexus. The serosa consists of a 
thin layer of connective tissue and a covering squamous epithelium1.
In the mouse, the oral cavity, the esophagus and the proximal part of the stomach 
(forestomach) have mainly a transport function and are thus lined by a strong, 
stratified squamous epithelium. 
The distal part of the stomach is lined by glandular epithelium and subdivided into 
corpus and pyloric antrum. The corpus contains mucous secreting neck cells, acid 
secreting parietal cells and pepsinogen secreting chief cells. After being released 
into the acid environment of the stomach, inactive pepsinogen is rapidly converted 
into pepsin, which is responsible for the initial digestion of proteins1. The pyloric 
antrum contains mainly surface pit cells and mucous producing neck cells. The 
insoluble and bicarbonate-rich mucous is protecting the epithelial surface against 
the corroding activity of the acid environment. The pylorus, a circular muscle, is 
separating the stomach from the small intestine. 
The small intestine is subdivided into three segments (duodenum, jejunum, ileum) 
and is lined by a continuously regenerating epithelium composed of invaginations, 
the crypts of Lieberkühn, and extrusions, the villi. Adult stem cells reside in the base 
of the crypts from where they give rise to a highly proliferative population of transit-
amplifying cells. Transit amplifying cells are proliferative uncommitted progenitors, 
which eventually differentiate into the four main intestinal cell lineages, namely 
absorptive enterocytes, secretory goblet cells, hormone-producing enteroendocrine 
cells and Paneth cells2. Enterocytes, the main cell lineage of the small intestine, are 
columnar cells that have little protrusions (microvilli) on the apical cell end. Enzymes 
bound to this so-called brush border facilitate the hydrolysis of disaccharides and 
dipeptides. Through these microvilli the surface of the intestinal lining is tremendously 
increased, which enables enterocytes to efficiently absorb the nutrients that are 
released after digestion of the ingested food. Goblet cells are increasing in number 
towards the ileum. They produce acid glycoproteins of the mucin type, which protect 
and lubricate the intestinal surface1. Enteroendocrine cells secrete hormones, which 
have either paracrine or endocrine effects. Motilin is for example a hormone produced 
by enteroendocrine cells –it increases the motility of the gut1. Somatostatin is another 
enteroendocrine hormone, which functions in a paracrine fashion to locally inhibit 
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other endocrine cells1. While enterocytes, goblet and enteroendocrine cells form the 
epithelial lining of the villus, Paneth cells are the only terminally differentiated cell 
type which reside within the crypt stem cell zone of the upper intestinal tract, though 
they are absent in the colon2. Paneth cells harbor secretory granules, which contain 
lysozyme, an enzyme that is able to digest the cell walls of bacteria. Therewith 
Paneth cells fulfill an antibacterial and protective function within the gastrointestinal 
epithelium. Recently it has been shown, that Paneth cells are closely associated 
with and form the niche of crypt base columnar cells, the cycling stem cell population 
of the small intestine (for more details see Introduction)3. The overall structure is 
partially conserved in the large intestine (proximal and distal colon) where, however, 
only crypts (and no villi) are present2.
The gastrointestinal tract is amongst the fastest self-renewing organs in our body. 
The esophagus and the stomach renew completely within 7-10 days, while the 
small intestine has a turnover time of 3-5 days. This high turnover rate in the small 
intestine is fueled by a population of fast cycling crypt base columnar cells, which 
are intermingled between Paneth cells in the base of the crypts of Lieberkühn. For 
many tissues, such as the hematopoietic system and the skin, a dichotomy of stem 
cell states has been described. While fast cycling tissue stem cells are responsible 
for daily tissue turnover, their more slowly cycling quiescent counterpart is only 
activated in situations of tissue injury and is responsible for tissue regeneration and 
repair. Is this dichotomy also present within the gastrointestinal stem cell niche? A 
similar dichotomy of (cancer) stem cell states has been described in tumors. Do 
gastrointestinal tumors contain a population of quiescent (slowly cycling) cells, which 
are possibly reminiscent of cancer stem cells?
The main topic addressed in this PhD thesis is the presence and functional role of 
quiescent, label-retaining cells in the mouse gastrointestinal tract during homeostasis, 
tissue injury and in cancer. 
Outline of the thesis
The Introduction summarizes the current literature on quiescence in adult stem cell 
niches and the various methods for the isolation of quiescent stem cells, outlines 
the complexity of the intestinal stem cell niche, and formulates the hypothesis that 
quiescent stem cells are involved in inflammation-associated tumours. Moreover, 
quiescent cancer stem cells and their clinical relevance are reviewed.
In Chapter 1 and 2 we describe the generation of tightly regulated doxycycline-
inducible models for studying mouse intestinal and esophageal biology respectively. 
The mouse model developed and characterized in Chapter 1 was employed in 
Chapter 3 to isolate and characterize a quiescent label-retaining cell population 
present within the intestinal epithelium. 
Chapters 4 to 6 describe the role of quiescent cells during tissue injury and their 
presence in full-blown tumors. In Chapter 4, we describe the induction of colonic 
inflammation in tumor-prone Apc1638N/+/villin-KRASG12V animals. These mice develop 
colon cancer characterized by the presence of Paneth-like cells. In Chapter 5, a rare 
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villin-expressing, quiescent population of tumor cells is shown to be present in stomach 
tumors of the intestinal type from Apc1638N/+ animals. Moreover, we characterized 
quiescent, label-retaining tumor cells in small intestinal adenocarcinomas of 
Apc1638N/+/villin-KRASG12V animals, as outlined in Chapter 6. 
Finally, the Discussion summarizes the main finding of this thesis and gives 
directions for future research.
1 Luiz Carlos Junqueira, J. C. Basic Histology Text and Atlas.  (2003).
2 Roth, S. & Fodde, R. Quiescent stem cells in intestinal homeostasis and cancer. Cell 
Commun Adhes 18, 33-44, doi:10.3109/15419061.2011.615422 (2011).
3 Sato, T. et al. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 
469, 415-418, doi:nature09637 [pii] 10.1038/nature09637 (2011).
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ABSTRACT
Adult stem cell niches are characterized by a dichotomy of cycling and quiescent 
stem cells: while the former are responsible for tissue turnover, their quiescent 
counterparts are thought to become active upon tissue injury thus underlying 
the regenerative response. Moreover, quiescence prevents adult stem cells from 
accumulating mutations thus ensuring a reservoir of unaltered stem cells. In the 
intestine, while cycling stem cells were shown to give rise to the main differentiated 
lineages, the identity of their quiescent equivalents remains to date elusive. This 
is of relevance for conditions such as Crohn’s disease and ulcerative colitis where 
quiescent stem cells may underlie metaplasia and the increased cancer risk 
associated with chronic inflammation. Tumours are thought to share a comparable 
hierarchical structure of adult tissues with pluripotent and self-renewing cancer stem 
cells (CSCs) giving rise to more differentiated cellular types. As such, neoplastic 
lesions may encompass both cycling and quiescent CSCs. Because of their 
infrequent cycling, quiescent CSCs are refractory to chemo- and radiotherapy and 
are likely to play a role in tumour dissemination, dormancy and recurrence. 
17
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Quiescence in adult stem cell niches
Adult stem cells constitute a population of long-lived cells that have the capacity to 
self-renew and differentiate not only while fuelling daily turnover in homeostasis but 
also to underlie the regenerative response upon tissue injury. Given the importance 
of these tasks, it was originally proposed that adult stem cells must be of slow-
cycling nature to preserve their DNA integrity by preventing the accumulation of 
errors during DNA replication. It has only been in the last few years that the existence 
of a dichotomy within the adult stem cell population has been acknowledged, i.e. the 
coexistence of frequently cycling and quiescent adult stem cells each with distinct 
functions: while frequently cycling adult stem cells are responsible for the daily tissue 
turnover, their quiescent counterparts are mainly responsible for tissue regeneration 
in response to damage 1. This dichotomy of rapidly cycling and quiescent adult stem 
cells appears to be conserved throughout evolution and was assessed in a broad 
spectrum of tissues and organisms. 
Table 1. Overview of quiescent stem cells characterized to date.
Tissue type Markers Reference
cornea 3H-thymidine label retention Cotsarelis et al., 1989
hair follicle Label retention Cotsarelis et al., 1990
Cytokeratin 15 Lyle et al., 1998
Cytokeratin 15 Lyle et al., 1999
H2B-GFP label retention Tumbar et al., 2004
hematopoietic system H2B-GFP label retention Wilson et al., 2008
H2B-GFP label retention Foudi et al., 2009
mammary gland BrdU label retention, Sca-1 Welm et al., 2002
CD29hi CD24+ Shackleton et al., 2006
PKH26 label retention Pece et al., 2010
forebrain 3H-thymidine label retention Morshead et al., 1994
pancreas label retention Teng et al., 2007
prostate BrdU label retention Tsuijmura et al., 2002
small intestine BrdU label retention Potten et al., 1998
Msi-1 Potten et al., 2003
Msi-1 Nishimura et al., 2003
Dcamkl-1 May et al., 2008 and 2009
Bmi-1 Sangiorgi et al., 2008
mTert Breault et al., 2008
mTert Montgomery et al., 2011
H2B-GFP label retention Roth et al., 2011
stomach Villin Qiao et al., 2007
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In the mouse, the presence of quiescent stem cells next to more actively cycling 
ones has been observed in a variety of tissues (Table 1), including cornea 2, hair 
follicle 3-7, the hematopoietic system 8,9, mammary gland 10-12, forebrain 13, pancreas 
14, prostate 15, small intestine 16-20 and the stomach 21,22. The presence of quiescent 
stem cells in the intestinal tract will be discussed below.
The methods of choice to identify and isolate quiescent stem cells are mainly 
based on their intrinsic label-retaining capacity, a consequence of their infrequent 
cell cycle rates. In general, different cell types within a given tissue can be marked 
by different dyes, which are either incorporated into the cell membrane, DNA or 
chromatin. Frequently dividing cells will quickly and progressively loose the label 
while slow cycling ones will retain it thus allowing their selective isolation. These 
cells are referred to as label-retaining cells (LRCs). Early studies on LRCs isolation 
employed tritiated thymidine (3HTdR) or the thymidine analog Bromodeoxyuridine 
(5-bromo-2-deoxyuridine, BrdU) 16,23. Both are mutagenic agents which become 
incorporated into the DNA of replicating cells. Thus, 3HTdR- and BrdU-labelling 
occur in a cell division-dependent fashion. To increase labelling efficiency, a division 
stimulus such as tissue injury by means of radiation was often applied. From this 
perspective, the 3HTdR/BrdU labelling itself represents a mutagenic insult to the 
cells and may thus activate quiescent stem cells to cycle as part of their regenerative 
response 9. At present, the impact of this labelling procedure on the dynamics of 
quiescent stem cells is not entirely clear 8. Nevertheless, non-mutagenic labelling 
procedures, which are possibly also independent of cell cycle status, should be 
preferred. 
Figure 1. Tet-inducible strategies in pulse-chase experiments to selectively label and pro-
spectively isolate quiescent (stem) cells by H2B-GFP retention.
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Labelling of quiescent cells using histone 2B (H2B)-green fluorescent protein 
(GFP) fusion protein represents an attractive alternative for label retention studies 
aimed at the identification of quiescent stem cells 5 (Figure 1). In short, the H2B-GFP 
fusion gene is regulated by tetracycline-regulatable promoter (tet operator or TetO) in 
combination with a tissue-specific promoter driving the expression of the transcriptional 
transactivator (tTA; Tet-Off) version. In the absence of tetracycline or of its more 
frequently employed analogue doxycycline, production of H2B-GFP is constitutive 
as the tTA binds to the tet operator and activates H2B-GFP transcription. In the 
presence of doxycycline however, the tTA is released from the operator, thus turning 
off H2B-GFP expression. Vice versa in the Tet-On system, H2B-GFP is normally 
silenced by constitutive expression of the reverse transcriptional transactivator 
(rtTA). In this case, doxycycline treatment will inactivate rtTA thus inducing H2B-GFP 
expression. Notably, in both cases H2B-GFP histone protein will incorporate into 
chromatin in a replication-independent manner 9. Furthermore H2B-GFP chromatin 
labelling is not mutagenic 9. H2B-GFP labelling has been employed for the isolation 
and characterization of quiescent or infrequently dividing cells in a broad spectrum of 
adult stem cell niches, among others in the skin 5,24 and the hematopoietic system8,9. 
However, promiscuous expression of the H2B-GFP transgene has been reported in 
hematopoietic stem cells 25. Therefore, negative controls are extremely important 
while using the H2B-GFP transgene. 
Nonetheless, the isolation and characterization of label retaining cells does not 
yet prove the existence of quiescent stem cells. Next to quiescent stem cells, any 
other long-lived, terminally differentiated cells will retain the (H2B-GFP) label for 
extended periods of time. Stemness of LRCs must be further demonstrated either by 
transplantation assays or by lineage tracing. The latter technique allows permanent 
(genetic) marking of the suspected stem cell population and its offspring. To this 
aim, a gene uniquely expressed in these cells must be identified to allow specific 
earmarking of the lineages arising from them. Transgenic and “knock-in” approaches 
where an inducible variant of the C-recombinase (Cre) is placed under the promoter 
of the marker gene are often employed for this purposes. Cre-expression in the 
alleged stem cells will recombine Lox target sequences (e.g. Rosa Lox-stop-Lox), 
thus allowing visualization and tracing of their offspring 19. 
A third method for the selective labelling of infrequently dividing or quiescent 
cells relies on the use of fluorescent lipophilic carbocyanines, including the DiI, 
DiO, PKH2 and PKH26 dyes, which are integrated into the phospholipid bilayer of 
the cell membrane 26,27. These membrane dyes can be used to label cells grown in 
vitro and study their proliferation both in vitro and in vivo. Cell division will result in 
the progressive dilution of the membrane label thus allowing LRC visualization and 
prospective isolation by means of immunofluorescence microscopy and fluorescence 
activated cell sorting (FACS). Membrane labelling dyes are easy to use though their 
main application is limited to the study of primary ex vivo cells or to established cell 
lines grown in vitro. As for 3HTdR, BrdU and H2B-GFP, label retention of membrane 
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dyes is not per se indicative of stemness but only of the slow cycling characteristics 
of a specific subset of cells. Transplantation assays and/or lineage tracing studies 
need to be performed on the LRCs to assess their self-renewal and differentiation 
capacities. 
Overall, use of H2B-GFP or of fluorescent membrane dyes should be preferred 
to 3HTdR- and BrdU-based labelling methods to identify potential quiescent 
stem cells because of their non-mutagenic and cell-cycle independent features, 
and of the possibility to visualize and prospectively isolate the labelled cells by 
immunofluorescence and FACS thus allowing subsequent in vitro and in vivo 
assessment of their stem-like characteristics.
  
The intestinal stem cell niche
The intestine has served as an ideal model of adult stem cell niches from 
flies to mammals mainly because of its high turnover rates and its architectural 
organization. The mouse small intestine is lined by a continuously regenerating 
epithelium composed of invaginations, the crypts of Lieberkühn, and extrusions, the 
villi. This structure is partially conserved in the large intestine (proximal and distal 
colon) where, however, only crypts (and no villi) are present. Adult stem cells reside 
in the base of the crypts from where they give rise to a highly proliferative population 
of transit-amplifying (TA) cells. TA cells eventually differentiate into the four main 
intestinal cell lineages, namely absorptive enterocytes, secretory goblet cells, 
hormone-producing enteroendocrine cells and Paneth cells. While enterocytes, 
goblet and enteroendocrine cells form the epithelial lining of the villus, Paneth cells 
are the only terminally differentiated cell type which reside within the crypt stem cell 
zone of the upper intestinal tract, though they are absent in the colon. 
Early lineage tracing studies carried out by Cheng and Leblond showed that 
mitotically active, multipotent stem cells reside in the crypt base and are able to 
give rise to all four differentiated cell types of the small intestine 28. Further studies 
defined the crypt stem cell zone between positions +1 and +4 from the base of the 
crypt 29. This groundbreaking work was not followed up until Barker and colleagues 
identified the Wnt target gene Lgr5 as a marker for the crypt base columnar cells19. 
Lgr5+ cells cycle on average once every 24 hours and can generate all epithelial 
lineages, as shown by lineage tracing. Moreover, single sorted Lgr5+ stem cells can 
form crypt-villus organoids in vitro without a supporting mesenchymal niche, though 
with a rather low clonogenicity 30. Subsequently, the same laboratory found that the 
niche’s physical support and signals are provided by the terminally differentiated 
Paneth cells which reside in close proximity to crypt base columnar cells and can 
greatly enhance the in vitro capacity of Lgr5+ cells to form crypt-villus organoids 31. 
Notably, cell division of this highly proliferative stem cell population seems to occur 
symmetrically rather than asymmetrically, following a pattern of neutral drift 32,33. 
Notwithstanding the strong and elegant experimental evidence supporting the 
central role of Lgr5+ stem cells in the hierarchical structure of the intestinal epithelium, 
additional studies pointed out the existence of further stem cell types within the 
21
Quiescent stem cells in intestinal homeostasis and cancer
crypt of Lieberkühn. Based on the assumption that some stem cells are slow cycling 
in order to protect their genome from accumulating errors during DNA replication, 
Potten and colleagues developed a BrdU-based method to label infrequently dividing 
LRCs both in intestinal homeostasis and following radiation-induced injury. The BrdU 
pulse is followed by a period of chase in which the label is progressively diluted out 
of proliferating but retained in slow cycling cells (see above). Through this analysis, 
a long-term label-retaining cell population was described that resides at position +4 
from the base of the crypt and undergoes cell division approximately once a week16. 
Upon irradiation, these cells become activated and as such possibly underlie the 
clonogenic regenerative response of the crypt 16,34. However, these pivotal studies 
were limited by the absence of specific markers to allow isolation and lineage tracing 
of the +4 LRCs.
Multiple proteins have been identified to mark the allegedly quiescent +4 cell. The 
RNA-binding protein Musashi (encoded by the Msi-1 gene) represents a promising 
candidate though it also marks progeny cells 17. The +4 marker Dcamkl1 (doublecortin-
like kinase 1 or Dckl1) is predominantly expressed in BrdU label retaining cells in 
the lower two thirds of the crypt and, occasionally, in crypt base columnar cells. In 
support of their stem-like features, Dcamkl1+ cells were shown to form spheroids 
in suspension culture. When injected subcutaneously, these spheroids give rise to 
glandular epithelial structures of the intestinal lineage 35,36. Yet, these studies fall 
short of direct lineage tracing of the Dcamkl1+ cells to definitely draw conclusions on 
their stem cell identity. 
The polycomb complex gene Bmi1 was also shown to mark cells at position 
+4 from the base of the crypt, though by in situ hybridization (ISH) only 37. In the 
same study, lineage-tracing experiments were conducted in Rosa-lacZ reporter 
mice expressing an inducible variant of the C-recombinase (Cre) under control of 
the Bmi1 promoter. Five days after tamoxifen induction, only 1-2 LacZ-labelled cells 
could be observed in the duodenum, which is suggestive of their slow-cycling nature. 
Nonetheless, the Bmi1+ cells give rise to all differentiated lineages and their progeny 
could be detected even one year after tamoxifen induction 37. However, it is not 
clear whether Bmi1 expression is restricted to the +4 position or is more widespread 
throughout the crypt. In fact, quantitative RT-PCR analysis of Lgr5+ cells revealed 
that Bmi1 is also expressed in crypt base columnar cells 20,38. Most likely, the cells 
marked by Bmi1-CreERT2 and by ISH are those expressing Bmi1 at highest levels. 
Relative resistance to senescence also represents a common feature of stem 
cells, though not specifically of their quiescence. As loss of telomeric DNA beyond 
a critical threshold induces senescence, it is thought that telomerase activity may 
earmark stem cell compartments. Indeed, It was shown that adult stem cell niches 
harbour the longest telomeres 39. Following this line of reasoning, expression of 
mouse telomerase reverse transcriptase (mTert) correlates with telomerase activity, 
is down-regulated upon differentiation in most somatic cells, and is thought to play a 
central role in adult stem cells. Accordingly, mTert-GFP reporter mice were developed 
which show GFP-expression in long-term BrdU-retaining single cells located in the 
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lower portion of the intestinal crypts 40. More recently, lineage tracing analysis of 
mTert+ quiescent cells confirmed their identity as slow-cycling, intestinal stem cells41. 
Our laboratory has applied the in vivo H2B-GFP pulse chase approach (Figure 
1) to label and prospectively isolate infrequently dividing cells from the mouse upper 
GI tract 20,42. Notably, a specific subset of cells were identified which 1. localize within 
the lower third of the crypt, 2. can retain the label for more than 80-90 days, 3. have 
morphological and gene expression features reminiscent of the Paneth lineage, and 
4. can respond to tissue insults by cell cycle activation and Bmi1 expression 20.  Also 
in this case, progressive dilution of the H2B-GFP label upon multiple rounds of cell 
divisions does not allow in vivo lineage tracing. Nevertheless, although it is not yet 
clear what the exact relationship is among Bmi1+, mTert+, Dcamkl1+ and the H2B-
GFP-retaining cells, and whether the latter encompass a true stem cell population, 
the above data suggest that the intestinal stem cell niche encompasses a rather 
heterogeneous population in terms of marker expression, position along the crypt-
villus axis, and cycling rates. The dichotomy between the fast cycling crypt base 
columnar cells (Lgr5+) and a more, yet poorly defined, quiescent stem cell population 
suggests parallels to other stem cell niches where cycling SCs are responsible for 
daily tissue turnover while their quiescent counterparts are only activated to underlie 
the regenerative response in situations of tissue injury. 
Notably, the existence of the quiescent and cycling stem cell dichotomy has also 
been a matter of controversy in the fruit fly Drosphila melanogaster. In particular, 
whereas a constantly cycling stem cell population was shown to control homeostasis 
in the adult Drosophila midgut, i.e. the equivalent of the mammalian upper GI 
tract 43,44, the identity and cycling rate of stem cells within the Drosophila hindgut 
(equivalent to the mammalian large intestine) have been debated 45. According to 
the original observation, the hindgut is maintained by a population of actively cycling 
stem cells confined within the HPZ (hindgut proliferation zone) 46. Subsequently, this 
model was argued against by the results by Fox and Spradling who convincingly 
showed that hindgut stem cells are generally quiescent whereas their more active 
counterparts are virtually absent in the hindgut of adult flies 47. By means of BrdU 
labelling assays, it was shown that LRCs are distributed sporadically along the 
proximal part of the hindgut (pylorus and ileum) during larval development whereas 
in adult flies only few BrdU-retaining cells are restricted to the pylorus.  However, the 
hindgut quiescent stem cells are able to become cycling and move in response to 
tissue injury to underlie the regenerative response and repair the damaged tissue 47.
Overall, although the published data are still partially controversial and incomplete, 
it appears that the intestinal stem cell niche does not represent an exception to 
the “tortoise and hair” model where slow-cycling stem cells coexist with their more 
actively dividing counterparts in homeostasis and tissue injury 1.   
Chronic inflammation, metaplasia and cancers of the digestive tract
Chronic inflammation along the digestive tract is invariably accompanied by 
metaplasia, i.e. the abnormal transformation of an adult, fully differentiated cell type 
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into a distinct, differentiated cell type that does not normally occur in the tissue in 
question 48. Pathologists have reported metaplastic changes already for a long time 
in a broad spectrum of tissues and organs, especially in response to chronic stress, 
inflammation, and/or tissue damage, often in association with dysplastic changes 
and cancer 48,49. Along the digestive tract, intestinal metaplasia has been observed 
in the oesophagus in association with gastric oesophageal reflux disease (GERD) 
and Barrett’s oesophagus 50; in the stomach upon Helicobacter pyloris infection 51; 
and even in inflammatory bowel diseases (IBD) in the form of Paneth cell metaplasia 
(see below)52,53.
IBD include conditions such as Crohn’s disease and colitis ulcerosa characterized 
by chronic inflammation of the distal ileum and the colorectum 54. In these pathologies, 
mucosal tissue is constantly ulcerated, crypt architecture is lost and extensive 
lymphocyte infiltration can be observed. Loss of integrity of the mucosal barrier 
leads to a deregulated immune response against the normal commensal microflora. 
Chronic inflammation is thus characterized by continuous tissue destruction followed 
by repair, and by a persistent activation of immune cells. A striking morphologic 
observation in IBD is represented by Paneth cell metaplasia, i.e. the presence 
of Paneth cells in the non-neoplastic colonic tissue adjacent to these tumours 52. 
While Paneth cells form an essential part of the small intestinal stem cell niche, they 
are rarely observed in the colon, especially in young, healthy individuals. Paneth 
cell metaplasia is of interest in view of the observations according to which these 
terminally differentiated cells were shown to function as niche for Lgr5+ stem cells 31, 
and, allegedly, as quiescent stem-like cells 20.
Apart from the morbidity associated with chronic inflammation of the intestinal 
mucosa, both Crohn’s disease and colitis ulcerosa are strongly associated with 
increased risk of small bowel and colorectal carcinoma. In ulcerative colitis patients, 
the duration and severity of inflammation correlate with the cumulative probability of 
colorectal cancer, namely from 2% at 10 years to 18% after 30 years 55. Even more 
strikingly, Crohn’s patients with an inflammation restricted to the small intestine have 
a 12 to 60-fold increased risk of developing adenocarcinoma of the small intestine 
compared to healthy individuals 56. However, the molecular and cellular mechanisms 
underlying the causal relationship between inflammation and bowel cancer are still 
poorly understood. 
Mouse models represent valuable tools for studying the connection between 
intestinal inflammation and cancer. IBD can be induced both genetically as 
well as chemically 57. Colitis and colitis-associated cancers can be triggered by 
the administration of dextran sodium sulfate (DSS), a non-genotoxic sulfated 
polysaccharide, in the drinking water. Chronic DSS treatment induces an ulcerative 
colitis pathology, including inflammation of the colorectum, epithelial cell erosions, 
crypt distortions, epithelial proliferation and dysplasia 58. Administering DSS to 
tumour-prone animals such as ApcMin/+ leads to a strong increase of colorectal 
carcinogenesis due to the chronic inflammation 59. This is thought to occur in a 
stepwise progression from epithelial hyperplasia to dysplasia, adenoma, and 
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adenocarcinoma. Over time, cells acquire DNA damage caused by inflammation-
associated high levels of reactive oxygen and nitrogen species 60,61. 
A role for quiescent stem cells in inflammation-associated tumorigenesis?
Although frequently interpreted as a form of trans-differentiation, the metaplastic 
changes often observed in the context of chronic inflammatory conditions are most 
likely the result of reprogramming of the differentiation pattern of resident stem cells 48. 
The connection between stem cell reprogramming and metaplasia is best illustrated 
in embryonic development where different tissues arise through the combinatorial 
expression levels of specific morphogens (code). In general, adult tissue stem cells 
are thought to retain this morphogen code. However, environmental changes and/or 
(epi-)genetic modifications may alter their code and trigger aberrant differentiation 
into different tissue types. If the metaplastic tissue entails a growth advantage 
within the altered environment, it will persist and possibly overgrow the endogenous 
tissue 48. Likewise, Paneth cell metaplasia in the colorectum of IBD patients is most 
likely the result of reprogramming of the resident colonic tissue stem cell caused by 
chronic inflammation and continuous tissue repair. Morphologically, the metaplastic 
Paneth cells do not differ from the ones present in the small intestine. However, 
mutation and loss of heterozygosity (LOH) analysis of human Paneth cell metaplasia 
revealed both KRAS mutations and aneuploidy 62. Neoplastic Paneth cells can also 
be observed within inflammation-related colorectal adenocarcinomas63. These 
observations led to the development of a new hypothesis on the sequence of events 
underlying colorectal carcinogenesis in IBD, i.e. epithelial inflammation, followed by 
colorectal Paneth cell metaplasia and neoplasia 64. 
Judging from their early presence during metaplasia and tumorigenesis, 
Paneth cells are seemingly of functional relevance and represent one of the first 
differentiation lineages resulting from the alleged reprogramming of the resident 
colonic stem cell. In view of the above mentioned data pointing at the existence of 
intestinal quiescent stem-like cells closely related to the Paneth lineage and capable 
of cycling upon tissue injury 20, and to the supporting role of mature Paneth cells as 
niche of Lgr5+ crypt base columnar cells 31, it is likely that their early appearance in 
IBD plays a functional role in the regenerative response to inflammation-induced 
tissue damage and in cancer onset. We thus hypothesize a mechanism in which 
chronic inflammation triggers the activation of quiescent stem cells of the gut that 
increase their turnover rate in order to facilitate tissue repair. This increase in 
division rate, together with a constant exposure to mutagenic inflammatory agents, 
predisposes the quiescent stem cell population to acquire somatic mutations and/or 
epigenetic alterations. Alterations within the quiescent stem cells will eventually lead 
to transformation and thus tumour development. In this scenario, quiescent stem 
cells of the colon could be the cell of origin of inflammation-related malignancies 
(Figure 2). 
Barker and colleagues provided evidence for the cycling stem cell as the cell 
of origin of intestinal tumourigenesis by showing that Apc mutations lead to the 
formation of multiple adenomas in the small intestine and colon exclusively when 
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induced in Lgr5+ crypt base columnar cells 65. When the same Apc mutation was 
induced in the transit amplifying cell compartment, microadenomas were observed 
which do not progress into bona fide tumours. In a second study, the endogenous 
promoter of the cancer stem cell marker CD133 (prominin, Prom1) was used to 
drive inducible Cre-expression 66 and to demonstrate that Prom1 expression largely 
overlap with that of Lgr5 at the base of the small intestinal crypt, albeit absent in the 
colon. Accordingly, Wnt signalling activation within the Prom1+ cells leads to massive 
dysplasia in the small intestine but not in the colon 66.
Thus, alterations in tissue stem cells are the origin of some types of cancer, 
amongst others colon cancer. In the specific case of the digestive tract, a scenario 
can be envisaged where cycling stem cells represent the cell of origin of sporadic 
cancers (i.e. not associated with chronic inflammation) whereas their more quiescent 
equivalents are likely to play a similar role in cancers arising in individuals affected 
by inflammatory conditions.
Cancer stem cell quiescence
The cancer stem cell (CSC) model postulates that multipotent, self-renewing 
cancer stem cells co-exist with more differentiated and mature cells within the tumour 
mass. In this scenario, the tumour recapitulates the hierarchical structure of normal, 
self-renewing tissues. By further extending this parallel between self-renewing 
tissues and tumour masses, the dichotomy of cycling versus quiescent stem cells 
may also apply for the CSC niche. Do quiescent cancer stem cells (qCSCs) co-
exist together with their more actively cycling and tumour-propagating counterparts? 
Figure 2. Hypothetical model for the quiescent stem cell origin of inflammation associated
cancers.
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If validated, the very existence of qCSCs may have profound clinical implications 
as malignant cells with quiescent characteristics are more likely to be resistant 
to conventional cytotoxic therapeutic agents whose mode of action relies on the 
introduction of DNA damage into dividing cells. Moreover, qCSCs may represent 
the elusive dormant cancer cells, which underlie metastasis in cancer patients even 
decades after removal of the primary tumour 67,68. 
The existence of quiescent CSCs has now been demonstrated in several tumour 
types (Table 2). Using the membrane labelling dyes PKH26 and PKH67, ovarian 
adenocarcinoma cell lines were studied for their label retention properties when 
injected subcutaneously into NOD-SCID mice 69. Notably, LRCs encompassed a 
population of stem-like cells, which were shown to be reversibly quiescent and 
refractory to therapy. Following chemotherapy, a fraction of these cells acquires the 
potential to proliferate in a drug-refractory manner 69. 
Similarly, slow cycling stem-like cells were isolated from pancreas adeno-
carcinoma cell lines by using the long term lipophilic tracer dye similar to PKH26, 
DiI (C59H97ClN2O4) 
70. Notwithstanding the only partial overlap between the DiI+ 
slow-cycling cells (DiI+/SCCs) and other CD markers commonly employed to enrich 
CSCs from pancreatic adenocarcinomas (CD133+, CD24+/CD44+), they were shown 
to have increased in vivo tumorigenic potential and a fibroblast-like morphology 
suggestive of an epithelial-mesenchymal transition (EMT). Indeed, several EMT 
markers were found to be increased among DiI+/SCCs 70. 
A subpopulation of slow cycling, PKH26 label retaining melanoma cells was also 
identified in primary melanoma cell lines 71. These cells express the H3K4 methylase 
JARID1B whose knockdown results in tumour exhaustion, thus suggesting that the 
JARID1B-positive cells are essential for continuous tumour growth. Notably, both 
the melanoma and pancreas cancer studies revealed a dynamic process affecting 
the qCSCs and their progenies as indicated by the capacity of LRCs to generate 
non-LRCs and, more surprisingly, of non-LRCs to give rise to LRCs 70,71. This 
dynamic regulation of tumour cells is in apparent contradiction with the hierarchical 
CSC model 72 and could be explained by cancer cells undergoing EMT and MET in 
response to environmental cues 73.   
Cancer type Method used Reference
Ovarian adenocarcinoma PKH26, PKH67 Kusumbe and Bapat, 2009
proliferation rate Gao et al., 2010
Pancreas adenocarcinoma DiI (C59H97ClN2O4) Dembinski et al., 2009
Melanoma PKH26 Roesch et al., 2010
Breast cancer PKH26 Pece et al., 2010
Hepatocellular carcinoma Hoechst 33342, PY Haraguchi et al., 2010
AML (acute myelogenous
leukaemia)
cell cycle analysis Saito et al., 2010
Table 2. Overview of quiescent cancer stem cells characterized to date.
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PKH26 label retention was also employed to define a molecular signature of human 
normal mammary stem cells (hNMSC) more commonly represented in high vs. 
low-grade breast cancers. Accordingly, mammospheres derived from high grade 
tumours displayed a higher percentage of PKH26 label retaining cells and, vice 
versa, hNMSC+ breast cancer cells more efficiently formed mammospheres in vitro 
and tumours in vivo when compared with hNMSC cells 12.
In hepatocellular carcinoma (HCC), a side population fraction of cells was 
identified that is partly marked by the surface marker CD13 74. CD13-positive cells 
are semiquiescent as shown by Hoechst 33342 and by the RNA-binding dye Pyronin 
Y, and typically formed cell clusters within the tumour. In mouse xenograft models, 
the combination of the CD13-inhibitor ubenimex and a  genotoxic agent such as 
5-fluorouracil proved to be most efficient in reducing tumor size than either agent 
alone 74. CD13+ cells resist chemotherapy because of reduced reactive oxygen 
species (ROS) and, accordingly, acquire chemosensitivity upon ubenimex treatment 
and increase of ROS levels 74. 
Possibly the most clinically relevant example of quiescent cancer stem cells 
comes from a mouse model of acute myelogenous leukaemia (AML), where 
patient-derived CSCs have been identified that engraft within the bone marrow 
endosteal region where they are protected from chemotherapy-induced apoptosis75. 
Subsequent characterization of these leukaemia stem cells showed that they are 
partly quiescent and can be induced to enter cell cycle through a pre-treatment with 
granulocyte colony-stimulating factor (G-CSF). Accordingly, a combined G-CSF and 
chemotherapy treatment enhances the induction of apoptosis and elimination of AML 
stem cells thus significantly increasing survival when compared to chemotherapy 
alone 76. 
Lastly, in human ovarian cancers, the surface molecule CD24 marks a 
subpopulation of cancer cells that is enriched for CSCs characterized by a lower 
proliferation rate than the bulk of the tumour 77. The CD24+ qCSCs were able to form 
tumour xenografts in nude mice at low multiplicities, whereas equal number of CD24- 
cells remained non-tumorigenic. Notably, a number of ‘stemness’ genes, including 
Nestin, b-catenin, Bmi1, and Oct3/4 were found to be expressed in CD24+ cells at 
higher level than bulk tumour cells 77. 
These results are of interest as CD24 is up-regulated in the regenerating intestinal 
mucosa from patients affected by inflammatory bowel disease 78 and could represent 
a marker of quiescent stem-like cells activated by tissue insults. Notably, CD24 also 
earmarks cells of the Paneth lineage in the mouse 31, previously shown to have label-
retaining capacities and to undergo specific changes upon inflammation, irradiation 
and chemotherapy including hyperplasia and metaplasia 79. These observations, 
together with our own preliminary data showing that quiescent cells of the upper GI 
tract share features of the Paneth cell lineage 20, point to a potentially relevant role of 
Paneth cells in the regeneration of intestinal mucosa.
Overall, quiescent cancer stem cells seem to be common to a broad spectrum of 
malignancies and are likely to be of clinical relevance both because of their intrinsic 
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resistance to chemo- and radiotherapy and due to their alleged identity as dormant 
tumour cells causing relapses and distant metastases in cancer patients.   
 
Quiescent CSCs: clinical relevance 
Cancer treatments have become more efficient and successful over the last 
decades. However, metastases occurring from tumour cell dissemination after a 
period of dormancy still represent the main cause of morbidity and mortality among 
individual cancer patients. Tumour dormancy is a widely used term to describe the 
state in which tumour cells exist for long periods of time following treatment and/
or surgical removal of the primary tumour. From their dormant state, quiescent 
cancer cells can subsequently switch to a state of active cycling and underlie tumour 
relapse. In the clinic, tumours are considered dormant if they recur after at least 
5 years from surgical treatment. Whereas 85% of recurrences of colon tumours 
already occur within the first three years, patients with breast cancer are at risk for 
up to 12 years after surgery 80,81. The notion that (quiescent) cancer stem cells may 
be resistant to therapy implies that many cytotoxic regimens would result in an initial 
shrinkage of the tumour mass but also in the relative enrichment in the CSCs82. Apart 
from their slow cycling rates, additional mechanisms are likely to underlie CSCs’ 
innate resistance to therapy: up-regulation of cellular efflux pumps e.g. the multidrug 
resistance transporter MDR-1 83,84, activation of DNA damage response85, and lower 
concentrations of critical mediators of ionizing-radiation-induced cell killing such 
as ROS 86. Understanding the biology of tumour dormancy and the molecular and 
cellular mechanisms underlying both its maintenance and the triggers of cell cycle 
activation leading to metastatic growth will be crucial for the future development of 
targeted therapies. 
Metastasis can be viewed as a rather inefficient process 87 where tumour cells 
need to undergo epithelial to mesenchymal transitions in order to detach from the 
primary tumour, enter the blood stream to be spread throughout the body, extravasate 
from the blood vessels, and eventually home in a distant organ and establish a 
metastatic outgrowth by mesenchymal to epithelial transition 88. In various types 
of cancer, disseminated and circulating tumour cells (DTCs, CTCs) are commonly 
observed in the bone marrow and blood of cancer patients, respectively. Notably, 
dissemination can occur even at very early stages as shown both for colorectal 
adenoma and breast cancer patients 89,90. DTCs are mainly detected by means of 
immunocytochemical staining or PCR-based analyses of bone marrow samples 
collected from the iliac crest 91,92. On the other hand, peripheral blood represents 
a more easily accessible site of sampling for monitoring circulating tumour cells 
(CTCs). Overall, DTCs and, to a lesser extent, CTCs were shown to have prognostic 
significance and predict unfavourable clinical outcome especially in breast 
cancer92,93. However, the relationship between DTCs/CTCs and (quiescent) cancer 
stem cells is still correlative in nature 68. DTCs and CTCs are viable tumour cells 
of epithelial origin that exist in a non-proliferating, quiescent state and have been 
shown to resist to systemic chemotherapy 94,95. Moreover, DTCs from early stage 
29
Quiescent stem cells in intestinal homeostasis and cancer
breast cancer patients encompass considerable numbers of cells expressing the 
CD44+CD24-/low markers characteristic of CSCs 96. Also, breast DTCs show increased 
angiogenic capacity and the expression of the CXCR4 receptors likely to facilitate 
their dissemination to distant organs 96.
The expression of receptors such as CXCR4 and even HER2 previously found in 
CSCs 97 is of good auspices for the future development of antibodies-based targeted 
therapies and may explain the positive results obtained by trastuzumab in preventing 
metastasis in breast cancer patients 98. Likewise, the inefficacy of conventional 
cytotoxic chemotherapy (doxorubicin) on the number of dormant breast CTCs 99 
highlights the need for tailor-made intervention strategies aimed at quiescent cancer 
cells. 
Conclusions and future directions
The intestine, like many other adult stem cell niches, is a hierarchically organized, 
self-renewing tissue characterised by a dichotomy of cycling and quiescent stem 
cells. While the actively cycling stem cells are responsible for daily tissue turnover, 
their quiescent counterparts are likely to become activated upon tissue injury in 
the regenerative response underlying tissue repair. In conditions such as IBD, the 
chronic inflammation continuously stimulates the quiescent stem cell population to 
cycle. We here propose that, because of the presence of mutagenic substances in 
the inflammatory tissue and of their high turnover rate, quiescent tissue stem cells 
accumulate somatic mutations. In parallel, constant exposure to inflammation leads to 
stem cell reprogramming resulting in metaplastic changes. In the colon, the presence 
of Paneth cells within the inflamed epithelium indicates a pre-cancerous condition 
characterized by the activation of otherwise quiescent stem cells and the presence 
of metaplastic and dysplastic lesions. Prolonged exposure to chronic inflammation 
will eventually result in the accumulation of additional somatic mutations and further 
progression towards invasive colorectal carcinomas. 
Apart from their putative role as cell of origin of inflammation-associated tumours, 
quiescent stem cells are also likely to play a highly relevant role within tumours. 
Analogous to the normal stem cell niches, malignancies encompass both cycling and 
quiescent cancer stem cells. While the former fuel the tumour mass and underlie its 
growth, quiescent cancer stem cells are likely to play a central role in dissemination 
and metastasis formation at distant organ sites. In view of their intrinsic resistance 
to radio- and chemotherapy future therapeutic strategies will need to tackle 
disseminated dormant cancer cells to prevent recurrence in cancer patients.  
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ABSTRACT
In order to develop a sensitive and inducible system to study intestinal biology, 
we generated a transgenic mouse model expressing the reverse tetracycline 
transactivator rtTA2-M2 under control of the 12.4 kb murine Villin promoter. The 
newly generated Villin-rtTA2-M2 mice were then bred with the previously developed 
tetO-HIST1H2BJ/GFP model to assess inducibility and tissue-specificity. Expression 
of the histone H2B-GFP fusion protein was observed exclusively upon doxycycline 
induction and was uniformly distributed throughout the intestinal epithelium. The 
Villin-rtTA2-M2 was also found to drive transgene expression in the developing 
mouse intestine. Furthermore, we could detect transgene expression in the proximal 
tubules of the kidney and in a population of alleged gastric progenitor cells. By 
administering different concentrations of doxycycline, we show that the Villin-
rtTA2-M2 system drives transgene expression in a dosage-dependent fashion. 
Thus, we have generated a novel doxycycline-inducible mouse model, providing a 
valuable tool to study the effect of different gene dosages on intestinal physiology 
and pathology.
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INTRODUCTION
The intestinal epithelium consists of distinct crypt-villus units, which undergo renewal 
through a tightly regulated sequence of proliferation, differentiation, migration 
and cell death. Distinct gene expression levels are necessary to maintain tissue 
homeostasis. Alterations of these levels will lead to disruption of the equilibrium 
between proliferation and cell death, and loss of tissue architecture 1. Many genes 
have been implicated in intestinal development and carcinogenesis. The temporal 
and spatial control over expression of specific genes at distinct dosage levels 
represents a powerful approach to evaluate their role during development as well 
as in tumor initiation and progression to malignancy. To address these questions, a 
model system is needed where tight regulation of intestine-specific gene expression 
at different dosages and at various time-points during development and adulthood 
is feasible. 
 Different promoters have been described which are able to drive intestine-specific 
expression. While activity of the Fabpl596 promoter is restricted to the small intestine 
and cecum, its derivative Fabpl4x promoter has been shown to drive expression in 
more distal intestinal segments including ileum, cecum and colon. Both promoters 
reveal patchy transgene expression patterns 2,3. More recently, the Villin promoter 
has become the promoter of choice for intestine-specific gene expression. Using a 
9 kb promoter fragment, Pinto et al. demonstrated transgene expression throughout 
the cephalocaudal axis of the gut 4. Both this promoter construct and a 12.4 kb 
variant thereof have been used successfully to generate various transgenic models 
for intestinal specific expression 5-8. The Villin promoter is also active in the putative 
stem cells of the intestinal epithelium, as demonstrated by long-term labeling of 
crypt-villus units using a tamoxifen-dependent and Villin-driven Cre recombinase 8.
Inducible transgenic mouse models represent unique experimental tools to study 
transgene expression in a tightly regulated fashion. Ideally, such an inducible mouse 
model should drive homogeneous transgene expression in the tissue of interest 
exclusively upon induction and in a dosage-dependent manner. Furthermore, 
induction of gene expression should be reversible 9. Such a model is currently not 
available for the intestinal tract. Therefore, we set out to generate a mouse model 
allowing robust induction of intestine-specific gene expression.
RESULTS AND DISCUSSION
Transgenic Villin-rtTA2-M2 founder lines were generated with a construct consisting 
of 12.4 kb murine Villin promoter sequence in front of the reverse tetracycline 
transactivator rtTA2-M2, previously described as an improved rtTA variant (‘Tet-
On’) with strongly reduced background activity and a 10-fold increased sensitivity 
for doxycycline-driven induction 10. Southern blot analysis identified two transgenic 
founders. Functionality of the transgene was tested by breeding the transgenic 
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animals with tetO-HIST1H2BJ/GFP mice. These mice express histone H2B-green 
fluorescent protein (H2B-GFP) controlled by a tetracycline-responsive regulatory 
element 11. Compound transgenic animals and wild type littermates were given 
drinking water supplemented with 5% sucrose, either with or without 2 mg/ml 
doxycycline. Induction of H2B-GFP gene expression was analyzed by fluorescence 
microscopy and immunohistochemistry. One transgenic line was identified that 
showed homogeneous and high H2B-GFP expression levels throughout the entire 
length of the intestinal tract, from the pyloric area to the distal colon and rectum 
(Fig.1). The H2B-GFP fusion protein was expressed in all epithelial cells of the small 
and large intestine, with slightly reduced expression levels in small intestinal crypts 
and the lower half of the colonic crypts (Fig. 1e,f,g,j,k). In agreement with previous 
reports 4,5, a very limited number of crypt-villus structures did not show H2B-GFP 
induction. No nuclear background fluorescence could be observed in the epithelial 
cells of all control animals, i.e. induced and un-induced wild type or single transgenic 
littermates, whereas a low level of auto-fluorescence was present in the cytoplasm, 
only detectable with long exposure times (Fig. 1a,c,h). Closer examination of the un-
induced double-transgenic animals occasionally revealed a small number of positive 
epithelial nuclei barely detectable above background levels (data not shown). This 
very low level of leakiness in un-induced animals was not detectable by FACS (see 
below) or by western analysis for the H2B-GFP protein, whereas a strong induction 
of transgene expression was observed in the doxycycline-treated animals (Fig. 2).
Notably, transgene expression was also observed in two additional organs outside 
the intestinal tract, namely kidney and stomach (Fig. 3). In line with what has been 
reported for the 9 kb Villin promoter 8,  the 12.4 kb variant employed for the generation 
of the Villin-rtTA2-M2 transgenic model revealed expression in the proximal tubules 
of the kidney (Fig. 3c). The same was found to be true for a limited number of 
stomach cells located in the antrum, at or below the isthmus of the glands (Fig.3d). 
Their position along the crypt axis is reminiscent of the gastric progenitor cells with 
multi-lineage potential recently reported to express a b-galactosidase reporter 
cassette driven by the same Villin 12.4 kb promoter employed here 12. Hence, the 
Villin-rtTA2-M2 model fully recapitulates the expression pattern previously reported 
for other Villin transgenic models.
The Villin promoter has previously been shown to be expressed already from early 
phases of mouse embryonic development 8,13. From 6.5 dpc onwards, the Villin 
promoter is active in the extra-embryonic visceral endoderm and from 9.5 dpc a clear 
activity has been shown in the hindgut. In the developing intestine, expression could 
be observed from 10.5 dpc onwards 8,13. Furthermore, parts of the urogenital tissue 
and the developing auditory system show Villin promoter activity during embryonic 
development 13. In order to demonstrate the utility of the Villin-rtTA2-M2 model for 
developmental studies, we bred transgenic animals with TetO-Myc-Sox2 mice 14 
and analyzed the resulting embryos upon doxycycline induction. Administration of 
doxycycline to pregnant females from gestational age 10.5 days onwards in the 
drinking water resulted in intestine-specific expression of Myc-Sox2 in the embryos 
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Figure 1. “Tet On” regulated expression of the H2B-GFP fusion protein in the adult 
mouse intestine. Immunofluorescence (a, c, e, h, j; original magnification 100x) and immuno-
histochemistry (b, d, f, g, i, k) analysis for H2B-GFP expression. Intestines from doxycycline-
induced wild-type mice (a, b) have a similar GFP-background as un-induced Villin-rtTA;H2B-
GFP littermates (c, d). After 7 days of doxycycline treatment, double transgenic mice show 
strong expression of nuclear H2B-GFP throughout the epithelial cells of the intestine (e,f,g,j,k). 
Expression reaches higher levels in the small intestinal villi than in the crypts (e, f, g).  
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Figure 2 (left). Induction of H2B-GFP expression after doxycycline treatment. West-
ern Blot analysis revealed no detectable levels of transgene expression in induced wild type 
animals and un-induced compound transgenic littermates. Doxycycline treatment of double 
transgenic animals resulted in high expression levels of H2B-GFP fusion protein throughout 
the intestinal tract. “TUB” is tubulin used as loading control; “GFP” is the doxycycline-induced 
H2B-GFP protein.
Figure 3 (right). Transgene expression in kidney proximal tubules and stomach pro-
genitor cells. a,b: Kidney and stomach of un-induced double transgenic animals do not show 
detectable levels of H2B-GFP. c: In the kidney of doxycycline-induced double transgenic ani-
mals, nuclear GFP staining (brown) is clearly observed in the proximal tubules as identified 
by PAS staining of the brush border (pink). d: Using fluorescence analysis (original magnifica-
tion 250x), doxycycline-induced H2B-GFP was detected in a small population of cells of the 
stomach.
Figure 4 (left). Transgene expression in the developing intestine. Cross section through 
embryonal intestine at 18 dpc after 8 days of doxycycline induction. Immunostaining with an 
antibody against the myc epitope present within the Sox2 transgene reveals strong positive 
nuclear staining in intestinal epithelial cells (b). In wild type or single transgenic littermates 
only background staining is observed, mainly in the cytoplasm (a).
Figure 5 (right). Assessment of transgene integration site and copy number. a: FISH 
analysis indicates that the Villin-rtTA2-M2 transgene integration maps on chromosome 2. The 
probe for the Villin-rtTA2-M2 transgene is labelled in green; the telomeric probe for chromo-
some 2 is labelled in red. b: Southern blot analysis of HincII digested DNA from a Villin-rtTA2-
M2 transgenic and wild-type animal. The endogenous Villin band (6.5 kb) was used as a 
reference in PhosphorImager analysis to estimate the number of transgenic integrations to 
approximately 35.
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(Fig. 4). This shows that the Villin-rtTA2-M2 mouse model is also able to drive 
transgene expression in the mouse embryo and can be used to study the effect of 
induced gene expression during development. 
Dual-color FISH (fluorescent in situ hybridization) analysis of metaphase 
chromosome spreads was performed with chromosome-specific probes to determine 
the chromosomal integration site of the Villin-rtTA2-M2 transgene 15. As shown in 
Figure 5a, use of a chromosome 2 specific telomeric probe revealed that the Villin 
transgene has a single integration site at chromosomal position 2A5. An additional, 
though considerably weaker signal was observed for the endogenous Vil1 gene on 
chromosome 1. The strong intensity of the transgenic signal indicates that multiple 
copies are likely to be integrated. Accordingly, Southern analysis revealed that 
approximately 35 copies of the transgene are present (Fig. 5b).
The inducible Villin-rtTA2-M2 system allows the titration of levels of transgene 
expression. Therewith it is possible to investigate the impact of gene dosages 
on differentiation processes in the intestine. To this aim, double transgenic Villin-
rtTA2-M2/H2B-GFP mice were administered different doxycycline dosages (between 
2 ng/ml and 2 mg/ml) via their drinking water for 7 days before being sacrificed. Frozen 
sections of these mice were analyzed and revealed that not only the expression 
level of H2B-GFP fusion protein but also that the relative number of crypt-villus 
units actively expressing the transgene decreased with lower doxycycline dosages. 
The overall pattern became patchier, clearly visible at a doxycycline concentration 
of 4 μg/ml (data not shown). H2B-GFP expression of duodenum, jejunum, ileum 
Figure 6. The inducible Villin-rtTA2-M2 system allows titration of levels of transgene 
expression. Transgenic Villin-rtTA2-M2/H2B-GFP mice were administered different dosages 
of doxycycline between 2 ng/ml and 2 mg/ml in the drinking water for 7 days. Intestinal tissue 
specimens of duodenum, jejunum, ileum and colon were then analyzed by flow cytometry. 
Background GFP (FITC) levels of intestinal cells from un-induced Villin-rtTA2-M2/H2B-GFP 
double transgenic mice are indistinguishable from wild type controls. In contrast, we detected 
doxycycline-dosage dependent levels of GFP with a maximum induction of approximately 
1000-fold in intestinal cells from doxycycline-induced double-transgenic mice.
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and colon of these animals were assessed separately using flow cytometry. To 
that aim, mouse intestinal specimens were digested and dissociated into single 
cell suspensions. Moreover, single cell gating was applied to exclude doublets. 
Voltages of the FACS were also adjusted so that the background levels are around 
102 relative units. Background GFP (FITC) levels of epithelial cells from un-induced 
Villin-rtTA2-M2/H2B-GFP mice are indistinguishable from those derived from wild 
type controls (Fig.6). In contrast, among intestinal cells from doxycycline-induced 
compound transgenic mice, high GFP levels were observed, compatible with up to 
an approximately 1000-fold induction. Stepwise reduction of doxycycline dosages 
led to a similar reduction of the average signal intensity per cell (Fig. 6). Thus, 
treating transgenic animals with lower dosages of doxycycline can help to circumvent 
potential toxicity associated with the over-expression of certain transgenes. 
In conclusion, we have generated an inducible mouse model that upon doxycycline 
administration shows homogeneous transgene expression throughout the intestinal 
tract. Notably, expression levels can be tightly regulated without any significant 
leakiness. Therewith, this mouse model offers new opportunities for studying the 
impact of distinct gene dosages on intestinal homeostasis in the adult as well as 
during development of the mouse intestine, and will be a valuable tool for studying 
intestinal biology and pathology in vivo. This mouse model can furthermore be used 
for the identification of putative intestinal stem cells using a chase for several weeks 
after a pulse of doxycycline-induced H2B-GFP expression. These experiments have 
been performed and have resulted in the identification of a low number of H2B-GFP-
label retaining cells at the bottom of the crypt (Roth et al., manuscript in preparation).
MATERIALS AND METHODS
Transgenic mice
The Villin-rtTA2-M2 construct was generated as follows. The rtTA2-M2 sequence 
was PCR-amplified from the pUHrT62-1 vector 10 (gift from W. Hillen, Erlangen) 
using the forward primer 
5’-ATTCTCGAGGCCGCCACCATGTCTAGACTG-3’ and the reverse primer 
5’-TAGATCGATTATCCTGGGAGCATGTCAAGG-3’. The PCR product was 
inserted into the vector containing the 12.4 kb Villin promoter 5 (a gift from D. 
Gumucio, Michigan) by digesting PCR product and vector using restriction 
enzymes XhoI and ClaI, and ligating both fragments. The final vector was sequence 
verified using the sequencing primers 5’-CTTTTCGGCCTGGAACTAATC-3’ and 
5’-CTGTCCAGCATCTCGATTG-3’. The 14.7 kb expression cassette was cut out of 
the plasmid backbone by PmeI digest, gel-purified and prepared for injection into 
fertilized FVB/N oocytes.  Founders were identified by PCR amplification of tail DNA 
using transgene specific primers (5’-CAAGACTTTCTGCGGAACAAC-3’ and 5’- 
GTGTCTCTCTTTCCTCTTTTG-3’). 
Transgenic Villin-rtTA2-M2 animals were bred with tetO-HIST1H2BJ/GFP (H2BGFP) 
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animals 11 (kindly provided by E. Fuchs, New York). Transgene expression was 
induced in compound heterozygous animals and their littermates by replacing 
normal drinking water with 5% sucrose water containing 2 mg/ml doxycycline (Sigma, 
D9891). Dox-treated water was changed every 2 days. After 7 days of doxycycline 
treatment, mice were sacrificed and tissues were analysed for H2B-GFP-expression. 
Transgenic Villin-rtTA2-M2 animals were also bred with tetO-myc-Sox2 transgenic 
mice 14. Doxycycline was administered to dams from gestational age 10.5 onwards 
in the drinking water (2 mg/ml doxycycline, 5% sucrose) and embryos were analysed 
at day 18.5. 
Cryosectioning 
The intestinal tract was removed, cut open and washed in PBS. Next, sections of 
~10 cm were spread out flat on paper and fixed in 4% PFA for 60 min and washed 
in PBS for 30 min. Swiss-rolls were placed in KP-CryoBlock (Klinipath, Duiven, NL) 
and frozen on dry ice. The left kidney was dissected, washed in PBS and frozen on 
dry ice using KP-CryoBlock. Five μm sections were cut and placed on SuperFrost 
Plus slides. The sections were stained with DAPI and analysed by fluorescence 
microscopy. 
Immunohistochemistry
Dissected tissues were fixed in 4% PFA overnight, processed and embedded in 
paraffin. Immunohistochemistry for GFP and Myc-tag was done using citrate antigen 
retrieval followed by overnight incubation in 5% non-fat dry milk/PBS with, respectively, 
2.5 μg/ml rabbit anti-GFP antibody (Molecular Probes) and 12.5 μg/ml anti-C-myc 
clone 9E10 (Roche). The Rabbit ChemMateTM EnVisionTM kit (DakoCytomation) was 
employed as a secondary antibody, according to manufacturer’s instructions. 
FACS analysis
Duodenum, jejunum, ileum and colon were dissected, cut-open, washed in PBS and 
chopped into small pieces using a razor blade. Tissue pieces were left at 37˚C in 
digest medium (RPMI + p/s, 10%FCS, 5 ng/ml EGF, 0.03 ng/ml Hydrocortisone, 1x 
Insulin/Transferrin, 4 mg/ml Collagenase, 0.1 mg/ml Dispase, 50 μg/ml DNAse) for 
2.5h until 90% were single cells. The cell suspension was passed through a 40μm 
cell strainer, washed by doubling the volume using 2% FCS/PBS, and spun down for 
8 min at 1200 rpm at 4˚C. To exclude non-epithelial cells from analysis, 1x106 cells 
were stained 30min in 100μl of lineage staining solution consisting of 2% FCS/PBS, 5 
μg/ml Biotin anti-mouse CD31, 2.5 μg/ml Biotin anti-mouse CD45 and 5 μg/ml Biotin 
anti-mouse TER-119 (all BD Pharmingen) at 4˚C. After a washing step, staining with 
the secondary antibody (0.2 μg/ml Strepavidin-PerCP-Cy5.5; BD Pharmingen) was 
performed in the dark at 4˚C. Cells were then washed and re-suspended in 0.2 μg/
ml Hoechst in 2%FCS/PBS in order to facilitate discrimination of live from dead cells. 
Fluorescent activated cell sorting analysis was performed on samples from each part 
of the intestine separately using a BD FACSAria. 
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Western Blotting
Intestinal tissue specimens (~2 mm) were snap-frozen in liquid nitrogen and 
subsequently lysed in 200 μl Laemmli sample buffer for 30 minutes using a 
thermoshaker set at 1000 rpm and 75°C. Twenty μl of each sample was loaded 
on a 10% SDS-PAGE gel. Western blotting was performed according to standard 
procedures. Immunoreactive bands were detected using 4 μg/ml rabbit polyclonal 
anti-GFP primary antibody (Molecular Probes) in 5% non-fat dry milk/PBS, 
followed by HRP-conjugated goat anti-rabbit antibody (Jackson ImmunoResearch 
Laboratories), and ECL-based chemiluminescence. As loading control, tubulin 
expression was assessed using 0.1 ug/ml rabbit polyclonal anti-tubulin (Abcam).
Fluorescence in situ hybridisation (FISH)
Femur bone marrow cultures were treated with 100 ng/ml colcemid (GIBCO-
BRL, KaryoMAX Colcemid solution) for 15 min to arrest cells at metaphase, and 
subsequently treated with 75 mM KCl, and fixed with methanol/acetic acid (3:1). 
FISH was carried out to determine the chromosomal site of transgene integration, 
basically as previously described 15. As a specific probe a Biotin-16-dUTP-labeled 
Villin-rtTA construct was used. Slides were embedded in DABCO/Vectashield 
containing 4′,6-diamidino-2-phenylindole (DAPI) as counterstain. Initial determination 
of chromosomal location of the wild-type and the transgene integration signal was 
established by inverted DAPI band analysis. To confirm the specific localization of 
the integration site, we performed dual-colour FISH using a Digoxigenin-11-dUTP-
labeled probe specific for the telomeric region of mouse chromosome 2 (P1 clone 
5309 16). Fluorescence signals were visualized with a Leica DM 6000B fluorescence 
microscope (Leica, Rijswijk, The Netherlands) using Mac Probe Software (version 
4.3, Applied Imaging, Newcastle upon tyne, United Kingdom).  
Southern blot analysis of transgene copy number
Transgene copy number for the Villin-rtTA2-M2 line was determined from the 
intensity of fragments obtained after hybridizing HincII digested liver DNA with 
a 225 bp probe prepared by PCR amplification of a region within intron 1 of the 
endogenous Vil1 gene using specific primers: 5’-GAGGGAGGGGTATGTTTTAAG-
3’and 5’-GTGGACGAGCCTAGAGGAG-3’. The probe was designed so that no 
repetitive sequences were present using repeatmasker software (http://www.
repeatmasker.org/). This probe recognizes a 6.5 kb endogenous Vil1 band and a 3.1 
kb transgenic band. PhosphorImager analysis was performed using Image-Quant 
software (Molecular Dynamics, Sunnyvale, CA).
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ABSTRACT
To facilitate the in vivo study of esophageal (stem) cell biology in homeostasis 
and cancer, novel mouse models are necessary to elicit expression of candidate 
genes in a tissue-specific and inducible fashion. To this aim, we developed and 
studied mouse models to allow specific labeling and tracing of esophageal cells 
with the histone 2B green fluorescent protein (H2B-GFP) fusion protein. First, 
we generated a transgenic mouse model expressing the reverse tetracycline 
transactivator rtTA2-M2 under control of the promoter (EDL-2) of the Epstein-Barr 
virus (EBV) gene encoding the latent membrane protein-1 (LMP-1). The newly 
generated ED-L2-rtTA2-M2 mice were then bred with the previously developed tetO-
HIST1H2BJ/GFP model to assess inducibility and tissue-specificity. Expression of 
the H2B-GFP fusion protein was observed exclusively upon doxycycline induction 
but was restricted to the suprabasal compartment of terminally differentiated cells. 
To achieve expression in the basal compartment of the esophagus, we subsequently 
employed a different transgenic model expressing the reverse transactivator 
rtTA2S-M2 under the control of the ubiquitous, methylation-free CpG island of the 
human hnRNPA2B1-CBX3 gene. Upon doxycycline administration to the compound 
hnRNPA2B1-CBX3-rtTA2S-M2//tetO-H2B-GFP mice, near-complete labeling of all 
esophageal cells was achieved. Pulse-chase experiments confirmed that complete 
turnover of the esophageal epithelium in the adult mouse is achieved within 7-10 
days. We show that the esophagus-specific promoter ED-L2 is expressed only in 
the suprabasal layer of differentiated cells. Moreover, we confirmed that esophageal 
turn-over in the adult mouse does not exceed 7-10 days. Notably, no quiescent cells 
were detected, possibly suggesting the cycling nature of the resident stem cells of 
the mouse esophagus. 
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INTRODUCTION
The luminal surface of the mouse esophagus is lined by a stratified squamous 
epithelium, which consists of distinct zones of cell proliferation and differentiation. 
Tissue turnover is fueled by a population of stem cells which are thought to reside 
within the basal layer adjacent to the basement membrane 1. The basal cell layer 
of the human esophagus is characterized by a bimodal distribution of rarely and 
more frequently proliferating cells 2. The slow cycling cells appear to preferentially 
cluster in the interpapillary zone and were proposed, though never formally proven, 
to represent stem cells 2. Recently, a subpopulation of mouse esophageal basal 
cells has been described as having stem-like properties such as the capacity for 
self-renewal and lineage-specification 3. These cells also have the ability to extrude 
Hoechst dye (also referred to as ‘side population’ or SP) and are earmarked by 
expression of the marker CD34 3. The proliferating cells within the basal cell layer 
and the adjacent epibasal layer may represent the analogous of transit amplifying 
cells in the intestinal crypt 2,4. Proliferating basal cells can be visualized by staining 
for cytokeratin 14 3. Thus, progenitor cells arise from rare stem cell divisions, which 
then give rise to a population of transit amplifying cells located in the basal and 
epibasal cell layers. Cell proliferation is followed by progressive cell commitment 
within the differentiated zone. This zone consists of multiple layers of progressively 
flattened and differentiated squamous cells which function as a protective barrier 4. 
Differentiated suprabasal cells can be visualized by cytokeratins 4 and 13 (CK4 and 
CK13)3. 
Because of their rapid and alarming increase during the last 30-40 years, 
esophageal malignancies have become the 6th leading cause of cancer death 
worldwide 5. Two major forms of esophageal cancer are known: squamous cell 
carcinoma and esophageal adenocarcinoma (EA). EA is typically developing in 
patients affected by Barrett’s esophagus, a premalignant condition characterized by 
the progressive replacement of the normal stratified squamous epithelium of the lower 
esophagus with columnar cells of the intestinal type 6. Barrett’s esophagus is thought 
to arise as a consequence of gastro-esophageal reflux disease and the exposure 
of the esophageal epithelium to gastro-duodenal juices causing tissue damage 
and inflammation. However, the molecular and cellular mechanisms underlying 
adenocarcinoma and squamous cell carcinoma in the esophageal epithelium are 
yet largely unknown. In part, this is due to the lack of in vivo experimental tools to 
study the esophageal stem cell niche during homeostasis and its role in the genesis 
of malignancies of the squamous and adenocarcinoma type. 
Many genes have been implicated in esophageal tumorigenesis. The temporal 
and spatial control over expression of specific genes can be achieved through the 
use of tissue-specific and inducible transgenic mouse models 7. To date, the only 
promoter described in the literature to be expressed at high levels in the esophagus 
is encompassed within a 0.6kb ED-L2 fragment from the 3’ non-coding sequence of 
the gene encoding the latent membrane protein-1 (LMP-1) of the Epstein-Bar virus 
52
Chapter 2
(EBV)8,9. Hence, we first employed the ED-L2 promoter to generate a tetracycline-
inducible mouse model allowing esophagus-specific gene expression. 
RESULTS
Generation of transgenic ED-L2-rtTA mice
Transgenic ED-L2-rtTA founder lines were generated with a construct consisting 
of the ED-L2 promoter cloned in front of the reverse tetracycline transactivator 
rtTA2-M2, previously described as an improved rtTA variant (‘Tet-On’) with strongly 
reduced background activity and a 10-fold increased sensitivity for doxycycline-driven 
induction 10(Figure 1A). PCR-analysis identified six founder lines 5 of which showed 
transmission to the germline. Functionality of the transgene was tested by breeding 
the transgenic animals with tetO-HIST1H2BJ/GFP mice expressing the histone H2B-
green fluorescent protein (H2B-GFP) under the control of a tetracycline-responsive 
regulatory element 11. Compound ED-L2-rtTA/tetO-HIST1H2BJ-GFP transgenic 
animals were administered drinking water supplemented with 5% sucrose and 2 mg/
ml doxycycline (Figure 1B). Induction of H2B-GFP gene expression was analyzed 
by immunohistochemistry (Figure 1C-E) and fluorescence microscopy (Figure 3). 
Three transgenic lines were identified that showed homogeneous and high H2B-
GFP expression levels throughout the entire length of the esophagus. H2B-GFP 
expression in all three independent founder lines appeared to be restricted to the 
suprabasal compartment of differentiated cells though not in the basal layer (Figure 
1C-E). 
Figure 1. “Tet On” regulated expression of the H2B-GFP fusion protein in the adult 
mouse esohagus. (A) Schematic map of the ED-L2-rtTA fragment here developed and em-
ployed for transgenic mouse generation. (B) Following doxycycline pulse, compound het-
erozygous ED-L2-rtTA/tetO-HIST1H2BJ-GFP transgenic animals express H2B-GFP. (C-E) 
IHC analysis of H2B-GFP expression. After 7 days of doxycycline treatment (pulse), com-
pound ED-L2-rtTA/tetO-HIST1H2BJ-GFP transgenic mice from all three founder lines (C. line 
1; D. line 5, E. line 6, all 40x magnification) show strong nuclear H2B-GFP expression.
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Figure 2. Squamous epithelium of the esophagus. Immunohistochemistry for cytokeratin 
14 marks the basal layer (A), while cytokeratin 4 and 13 are expressed in the differentiated 
suprabasal layers (B, C). The proliferation marker ki-67 is expressed in distinct basal cells (D). 
All images were taken at 40x magnification.
Figure 3. H2B-GFP expressing cells are located exclusively within the differentiated 
suprabasal cell layers. Immunofluorescence double staining for GFP (green, nuclear) and 
(A,D,G) CK14 (red, basal cell layer), (B,E,H) CK4 and (C,F,I) CK13 (both red, suprabasal cell 
layers) in all three founder lines (A-C line 1; D-F line 5, G-I line 6, all 40x magnification).
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Compound hnRNPA2B1-CBX3-rtTA2S-M2 mice allow complete labeling of 
esophageal cells
To achieve a broader expression pattern in the various cell layers of the 
esophagus, we subsequently employed a different transgenic model expressing 
the reverse transactivator rtTA2S-M2 under the control of the ubiquitous and 
methylation-free CpG island of the human hnRNPA2B1-CBX3 gene 12. Upon 
doxycycline administration to the compound hnRNPA2B1-CBX3-rtTA2S-M2//tetO-
H2B-GFP mice, near-complete labeling of esophageal cells was achieved (Figure 
4A-B). Notably, even in these conditions, rare GFP-negative cells are observed 
which apparently derive from asymmetric distribution of the H2B/GFP fused protein 
upon cell division at the basal layer (Figure 4B, arrow). Nonetheless, the observation 
that the vast majority of cells are labeled upon doxycycline administration allowed 
Detailed Analysis of ED-L2-rtTA transgene expression
To analyze in more detail which cell layers showed expression of H2B-GFP upon 
doxycycline-induction, we performed double staining for GFP and basal as well as 
suprabasal cytokeratins and the proliferation marker ki-67. While CK14 is a marker 
of proliferating basal cells (Figure 2A), CK4 and CK13 mark differentiated suprabasal 
cells (Figure 2B-C), whereas ki-67 expression is observed in a subset of the basal 
cells (Figure 2D)3. Double staining of H2B-GFP and the basal markers CK14 (Figure 
3A,D,G) and ki-67 (Figure 3C,F,I) could not be observed. However, GFP and CK4 
(Figure 3B,E,H) expression patterns do overlap. Thus, H2B-GFP expressing cells are 
located within the differentiated suprabasal cell layers. Cells within the proliferating 
basal cell compartment are devoid of H2B-GFP expression.
Figure 4. IHC analysis of H2B-GFP expression in pulse-chase experiments with com-
pound hnRNPA2B1-CBX3-rtTA2S-M2//tetO-H2B-GFP mice. (A-B) After 7 days of doxycy-
cline treatment in the drinking water (pulse) the vast majority of esophageal cells are positive 
for nuclear GFP expression (A: 40x, B: 60x magnification). (B) Asymmetric distribution of the 
H2B/GFP fused protein upon cell division is observed at the basal layer (arrow). After the 
doxyxycline pulse, mice were chased (no dox in drinking water) and analyzed at 5 (C-D), 7 
(E-F) and 10 (G-H) days. Images were taken at 20x (C,E,G), 40x (A,D,F,H) and 60x (B) mag-
nification.
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us to perform pulse-chase experiments to study the dynamics of cell turnover in the 
esophagus and the alleged presence of infrequently dividing, label-retaining cells 
(LRCs). To this aim, we withdrew doxycycline from the drinking water of previously 
pulsed hnRNPA2B1-CBX3-rtTA2S-M2//tetO-H2B-GFP mice and analyzed their 
esophagi by GFP IHC at different time points. As shown in Figure 4, progressive 
dilution of GFP+ cells was observed, with suprabasal and more differentiated 
squamous cells persisting up to 7 days (Figure 4C-H). This is in agreement with 
previous studies showing a complete turnover of the human esophageal epithelium 
within 4-8 days 13. Notably, under these experimental conditions, no LRCs were 
observed in the basal and suprabasal esophageal layers. 
DISCUSSION
This study shows that the ED-L2 promoter is not active in the basal cell layer 
of the mouse esophagus where stem cells are thought to reside. For the purpose 
of studying the mechanisms of esophageal cancer onset and progression, it is of 
utmost importance to drive expression of candidate genes to distinct cell types 
located within the basal cell layer. Overexpression of the human cyclin D1 oncogene 
under control of the ED-L2 promoter resulted in the development of dysplasia with 
late onset (16 months)9. Similarly, Klf5-overexpression gated by the same ED-L2 
promoter results in a two-fold increase in the proliferation of basal cells 14. The 
mild hyper- and dysplastic phenotypes observed in these models suggest that ED-
L2-driven oncogene (over)expression is insufficient to promote full-blown tumor 
formation in the esophagus. This is likely to be due to the suprabasal-specific 
expression pattern of the viral promoter, i.e. in a compartment where progenitor but 
not stem cells are thought to reside 2,4. In the intestine, loss of function mutations 
at the Apc tumor suppressor gene have been shown to trigger tumor formation 
exclusively from cycling stem cells though not from progenitor, transient amplifying 
cells 15. Likewise, it is plausible that the same holds true for the esophagus where 
oncogene expression under the suprabasal ED-L2 promoter is insufficient for tumor 
formation. Alternatively, cancer-related genes other than cyclin D1 and Klf5 need to 
be mutated for efficient malignant transformation in the esophagus. 
Novel esophageal-specific promoters are needed to study the role played 
by resident stem cells in homeostasis and cancer. As shown here, the use of a 
more ubiquitous promoter to drive expression of the H2B-GFP marker protein has 
confirmed that esophageal turn-over in the adult mouse does not exceed 7-10 days. 
Notably, no quiescent LRCs were detected, possibly suggesting the cycling nature of 
the resident stem cells of the mouse esophagus. Future studies should be directed 
to the identification of esophageal stem cell-specific genes and their promoters to 
allow lineage tracing and the introduction of specific gene mutations to assess their 
potential as cell of origin of esophageal cancer.  
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MATERIALS AND METHODS
Transgenic mice
The ED-L2-rtTA2-M2 construct was generated as follows. The rtTA2-M2 sequence, 
was PCR-amplified from the pUHrT62-1 vector 10 (gift from W. Hillen, Erlangen) 
using the cloning forward (5’-ATTCTCGAGGCCGCCACCATGTCTAGACTG-3’) and 
the cloning reverse (5’-TAGACGCGTTTATCCTGGGAGCATGTCAAGG-3’) primers 
(Figure 1A). The PCR product was then subcloned downstream of the ED-L2 
promoter 8(ED-L2 vector kind gift from Joanna B. Wilson, Glasgow) by digesting both 
PCR product and vector with the restriction enzymes XhoI and MluI, and ligating both 
fragments. The final vector was sequence verified using the sequencing primers 
5’-CTTTTCGGCCTGGAACTAATC-3’ and 5’-CTGTCCAGCATCTCGATTG-3’ 
(Figure 1A). The  2.1 kb expression cassette was cut out of the plasmid backbone 
by BamHI and ClaI digest, gel-purified and prepared for injection into fertilized 
C57BL6/J oocytes.  Founders were identified by PCR amplification of tail DNA using 
transgene specific genotyping primers (5’-CAAGACTTTCTGCGGAACAAC-3’ and 5’- 
GTGTCTCTCTTTCCTCTTTTG-3’, Figure 1A). Transgenic ED-L2-rtTA2-M2 animals 
were bred with tetO-HIST1H2BJ/GFP (H2BGFP) animals 11 (kindly provided by E. 
Fuchs, New York). Transgene expression was induced in compound heterozygous 
animals and their littermates by replacing normal drinking water with 5% sucrose 
water containing 2 mg/ml doxycycline (Sigma, D9891, Figure 1B). Dox-treated 
water was changed every 2 days. After 7 days of doxycycline treatment, mice were 
sacrificed and tissues were analysed for H2B-GFP-expression. 
The same pulse scheme was also applied to the compound hnRNPA2B1-CBX3-
rtTA2S-M2//tetO-H2B-GFP mice. After one week, pulsed mice were withdrawn 
doxycycline from the drinking water and sacrificed at 0, 5, 7 and 10 days (chase).
Cryosectioning 
The esophagus was removed, cut open and washed in PBS. Next, sections of 
~10 cm were spread out flat on paper and fixed in 4% PFA for 60 min and washed in 
PBS for 30 min. Swiss-rolls were placed in KP-CryoBlock (Klinipath, Duiven, NL) and 
frozen on dry ice. Five μm sections were cut and placed on SuperFrost Plus slides. 
The sections were stained with DAPI and analysed by fluorescence microscopy. 
Immunohistochemistry 
Tissues were fixed in 4% PFA and embedded in paraffin. Four μm sections were 
mounted on slides and stained by HE for routine histology. Immunohistochemistry 
was performed according to standard procedures using the following antibodies: 
GFP (1:800, A11222, Invitrogen), CK4 (1:100, ab11215, Abcam), CK13 (1:100, 
ab16112, Abcam), CK14 (1:10000, PRB-155B, Covance) and Ki67 (1:50, M7249, 
DAKO). Signal detection was performed using Rabbit EnVision+ System-HRP 
(K4011, Dako) for GFP. CK4 and CK13 were detected using Goat-anti-Mouse-HRP, 
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CK14 using Goat-anti-Rabbit-HRP. 
Immunofluorescence
GFP (1:50, A11222, Invitrogen), Ki67 (1:50, M7249, Dako), CK4 (1:100, BD 
Pharmingen) ab11215, Abcam), CK13 (1:100, ab16112, Abcam) and CK14 (1:1000, 
PRB-155B, Covance) were employed for Immunofluorescence analysis. Ki67 was 
detected using rabbit-anti-rat-A594 (Invitrogen), CK4 and CK13 were detected using 
goat-anti-mouse-A594 (Invitrogen) and goat-anti-rabbit-A488 (Invitrogen) was used 
for signal detection of GFP.
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ABSTRACT
To facilitate the in vivo study of esophageal (stem) cell biology in homeostasis 
and cancer, novel mouse models are necessary to elicit expression of candidate 
genes in a tissue-specific and inducible fashion. To this aim, we developed and 
studied mouse models to allow specific labeling and tracing of esophageal cells 
with the histone 2B green fluorescent protein (H2B-GFP) fusion protein. First, 
we generated a transgenic mouse model expressing the reverse tetracycline 
transactivator rtTA2-M2 under control of the promoter (EDL-2) of the Epstein-Barr 
virus (EBV) gene encoding the latent membrane protein-1 (LMP-1). The newly 
generated ED-L2-rtTA2-M2 mice were then bred with the previously developed tetO-
HIST1H2BJ/GFP model to assess inducibility and tissue-specificity. Expression of 
the H2B-GFP fusion protein was observed exclusively upon doxycycline induction 
but was restricted to the suprabasal compartment of terminally differentiated cells. 
To achieve expression in the basal compartment of the esophagus, we subsequently 
employed a different transgenic model expressing the reverse transactivator 
rtTA2S-M2 under the control of the ubiquitous, methylation-free CpG island of the 
human hnRNPA2B1-CBX3 gene. Upon doxycycline administration to the compound 
hnRNPA2B1-CBX3-rtTA2S-M2//tetO-H2B-GFP mice, near-complete labeling of all 
esophageal cells was achieved. Pulse-chase experiments confirmed that complete 
turnover of the esophageal epithelium in the adult mouse is achieved within 7-10 
days. We show that the esophagus-specific promoter ED-L2 is expressed only in 
the suprabasal layer of differentiated cells. Moreover, we confirmed that esophageal 
turn-over in the adult mouse does not exceed 7-10 days. Notably, no quiescent cells 
were detected, possibly suggesting the cycling nature of the resident stem cells of 
the mouse esophagus. 
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INTRODUCTION
The luminal surface of the mouse esophagus is lined by a stratified squamous 
epithelium, which consists of distinct zones of cell proliferation and differentiation. 
Tissue turnover is fueled by a population of stem cells which are thought to reside 
within the basal layer adjacent to the basement membrane 1. The basal cell layer 
of the human esophagus is characterized by a bimodal distribution of rarely and 
more frequently proliferating cells 2. The slow cycling cells appear to preferentially 
cluster in the interpapillary zone and were proposed, though never formally proven, 
to represent stem cells 2. Recently, a subpopulation of mouse esophageal basal 
cells has been described as having stem-like properties such as the capacity for 
self-renewal and lineage-specification 3. These cells also have the ability to extrude 
Hoechst dye (also referred to as ‘side population’ or SP) and are earmarked by 
expression of the marker CD34 3. The proliferating cells within the basal cell layer 
and the adjacent epibasal layer may represent the analogous of transit amplifying 
cells in the intestinal crypt 2,4. Proliferating basal cells can be visualized by staining 
for cytokeratin 14 3. Thus, progenitor cells arise from rare stem cell divisions, which 
then give rise to a population of transit amplifying cells located in the basal and 
epibasal cell layers. Cell proliferation is followed by progressive cell commitment 
within the differentiated zone. This zone consists of multiple layers of progressively 
flattened and differentiated squamous cells which function as a protective barrier 4. 
Differentiated suprabasal cells can be visualized by cytokeratins 4 and 13 (CK4 and 
CK13)3. 
Because of their rapid and alarming increase during the last 30-40 years, 
esophageal malignancies have become the 6th leading cause of cancer death 
worldwide 5. Two major forms of esophageal cancer are known: squamous cell 
carcinoma and esophageal adenocarcinoma (EA). EA is typically developing in 
patients affected by Barrett’s esophagus, a premalignant condition characterized by 
the progressive replacement of the normal stratified squamous epithelium of the lower 
esophagus with columnar cells of the intestinal type 6. Barrett’s esophagus is thought 
to arise as a consequence of gastro-esophageal reflux disease and the exposure 
of the esophageal epithelium to gastro-duodenal juices causing tissue damage 
and inflammation. However, the molecular and cellular mechanisms underlying 
adenocarcinoma and squamous cell carcinoma in the esophageal epithelium are 
yet largely unknown. In part, this is due to the lack of in vivo experimental tools to 
study the esophageal stem cell niche during homeostasis and its role in the genesis 
of malignancies of the squamous and adenocarcinoma type. 
Many genes have been implicated in esophageal tumorigenesis. The temporal 
and spatial control over expression of specific genes can be achieved through the 
use of tissue-specific and inducible transgenic mouse models 7. To date, the only 
promoter described in the literature to be expressed at high levels in the esophagus 
is encompassed within a 0.6kb ED-L2 fragment from the 3’ non-coding sequence of 
the gene encoding the latent membrane protein-1 (LMP-1) of the Epstein-Bar virus 
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(EBV)8,9. Hence, we first employed the ED-L2 promoter to generate a tetracycline-
inducible mouse model allowing esophagus-specific gene expression. 
RESULTS
Generation of transgenic ED-L2-rtTA mice
Transgenic ED-L2-rtTA founder lines were generated with a construct consisting 
of the ED-L2 promoter cloned in front of the reverse tetracycline transactivator 
rtTA2-M2, previously described as an improved rtTA variant (‘Tet-On’) with strongly 
reduced background activity and a 10-fold increased sensitivity for doxycycline-driven 
induction 10(Figure 1A). PCR-analysis identified six founder lines 5 of which showed 
transmission to the germline. Functionality of the transgene was tested by breeding 
the transgenic animals with tetO-HIST1H2BJ/GFP mice expressing the histone H2B-
green fluorescent protein (H2B-GFP) under the control of a tetracycline-responsive 
regulatory element 11. Compound ED-L2-rtTA/tetO-HIST1H2BJ-GFP transgenic 
animals were administered drinking water supplemented with 5% sucrose and 2 mg/
ml doxycycline (Figure 1B). Induction of H2B-GFP gene expression was analyzed 
by immunohistochemistry (Figure 1C-E) and fluorescence microscopy (Figure 3). 
Three transgenic lines were identified that showed homogeneous and high H2B-
GFP expression levels throughout the entire length of the esophagus. H2B-GFP 
expression in all three independent founder lines appeared to be restricted to the 
suprabasal compartment of differentiated cells though not in the basal layer (Figure 
1C-E). 
Figure 1. “Tet On” regulated expression of the H2B-GFP fusion protein in the adult 
mouse esohagus. (A) Schematic map of the ED-L2-rtTA fragment here developed and em-
ployed for transgenic mouse generation. (B) Following doxycycline pulse, compound het-
erozygous ED-L2-rtTA/tetO-HIST1H2BJ-GFP transgenic animals express H2B-GFP. (C-E) 
IHC analysis of H2B-GFP expression. After 7 days of doxycycline treatment (pulse), com-
pound ED-L2-rtTA/tetO-HIST1H2BJ-GFP transgenic mice from all three founder lines (C. line 
1; D. line 5, E. line 6, all 40x magnification) show strong nuclear H2B-GFP expression.
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Figure 2. Squamous epithelium of the esophagus. Immunohistochemistry for cytokeratin 
14 marks the basal layer (A), while cytokeratin 4 and 13 are expressed in the differentiated 
suprabasal layers (B, C). The proliferation marker ki-67 is expressed in distinct basal cells (D). 
All images were taken at 40x magnification.
Figure 3. H2B-GFP expressing cells are located exclusively within the differentiated 
suprabasal cell layers. Immunofluorescence double staining for GFP (green, nuclear) and 
(A,D,G) CK14 (red, basal cell layer), (B,E,H) CK4 and (C,F,I) CK13 (both red, suprabasal cell 
layers) in all three founder lines (A-C line 1; D-F line 5, G-I line 6, all 40x magnification).
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Compound hnRNPA2B1-CBX3-rtTA2S-M2 mice allow complete labeling of 
esophageal cells
To achieve a broader expression pattern in the various cell layers of the 
esophagus, we subsequently employed a different transgenic model expressing 
the reverse transactivator rtTA2S-M2 under the control of the ubiquitous and 
methylation-free CpG island of the human hnRNPA2B1-CBX3 gene 12. Upon 
doxycycline administration to the compound hnRNPA2B1-CBX3-rtTA2S-M2//tetO-
H2B-GFP mice, near-complete labeling of esophageal cells was achieved (Figure 
4A-B). Notably, even in these conditions, rare GFP-negative cells are observed 
which apparently derive from asymmetric distribution of the H2B/GFP fused protein 
upon cell division at the basal layer (Figure 4B, arrow). Nonetheless, the observation 
that the vast majority of cells are labeled upon doxycycline administration allowed 
Detailed Analysis of ED-L2-rtTA transgene expression
To analyze in more detail which cell layers showed expression of H2B-GFP upon 
doxycycline-induction, we performed double staining for GFP and basal as well as 
suprabasal cytokeratins and the proliferation marker ki-67. While CK14 is a marker 
of proliferating basal cells (Figure 2A), CK4 and CK13 mark differentiated suprabasal 
cells (Figure 2B-C), whereas ki-67 expression is observed in a subset of the basal 
cells (Figure 2D)3. Double staining of H2B-GFP and the basal markers CK14 (Figure 
3A,D,G) and ki-67 (Figure 3C,F,I) could not be observed. However, GFP and CK4 
(Figure 3B,E,H) expression patterns do overlap. Thus, H2B-GFP expressing cells are 
located within the differentiated suprabasal cell layers. Cells within the proliferating 
basal cell compartment are devoid of H2B-GFP expression.
Figure 4. IHC analysis of H2B-GFP expression in pulse-chase experiments with com-
pound hnRNPA2B1-CBX3-rtTA2S-M2//tetO-H2B-GFP mice. (A-B) After 7 days of doxycy-
cline treatment in the drinking water (pulse) the vast majority of esophageal cells are positive 
for nuclear GFP expression (A: 40x, B: 60x magnification). (B) Asymmetric distribution of the 
H2B/GFP fused protein upon cell division is observed at the basal layer (arrow). After the 
doxyxycline pulse, mice were chased (no dox in drinking water) and analyzed at 5 (C-D), 7 
(E-F) and 10 (G-H) days. Images were taken at 20x (C,E,G), 40x (A,D,F,H) and 60x (B) mag-
nification.
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us to perform pulse-chase experiments to study the dynamics of cell turnover in the 
esophagus and the alleged presence of infrequently dividing, label-retaining cells 
(LRCs). To this aim, we withdrew doxycycline from the drinking water of previously 
pulsed hnRNPA2B1-CBX3-rtTA2S-M2//tetO-H2B-GFP mice and analyzed their 
esophagi by GFP IHC at different time points. As shown in Figure 4, progressive 
dilution of GFP+ cells was observed, with suprabasal and more differentiated 
squamous cells persisting up to 7 days (Figure 4C-H). This is in agreement with 
previous studies showing a complete turnover of the human esophageal epithelium 
within 4-8 days 13. Notably, under these experimental conditions, no LRCs were 
observed in the basal and suprabasal esophageal layers. 
DISCUSSION
This study shows that the ED-L2 promoter is not active in the basal cell layer 
of the mouse esophagus where stem cells are thought to reside. For the purpose 
of studying the mechanisms of esophageal cancer onset and progression, it is of 
utmost importance to drive expression of candidate genes to distinct cell types 
located within the basal cell layer. Overexpression of the human cyclin D1 oncogene 
under control of the ED-L2 promoter resulted in the development of dysplasia with 
late onset (16 months)9. Similarly, Klf5-overexpression gated by the same ED-L2 
promoter results in a two-fold increase in the proliferation of basal cells 14. The 
mild hyper- and dysplastic phenotypes observed in these models suggest that ED-
L2-driven oncogene (over)expression is insufficient to promote full-blown tumor 
formation in the esophagus. This is likely to be due to the suprabasal-specific 
expression pattern of the viral promoter, i.e. in a compartment where progenitor but 
not stem cells are thought to reside 2,4. In the intestine, loss of function mutations 
at the Apc tumor suppressor gene have been shown to trigger tumor formation 
exclusively from cycling stem cells though not from progenitor, transient amplifying 
cells 15. Likewise, it is plausible that the same holds true for the esophagus where 
oncogene expression under the suprabasal ED-L2 promoter is insufficient for tumor 
formation. Alternatively, cancer-related genes other than cyclin D1 and Klf5 need to 
be mutated for efficient malignant transformation in the esophagus. 
Novel esophageal-specific promoters are needed to study the role played 
by resident stem cells in homeostasis and cancer. As shown here, the use of a 
more ubiquitous promoter to drive expression of the H2B-GFP marker protein has 
confirmed that esophageal turn-over in the adult mouse does not exceed 7-10 days. 
Notably, no quiescent LRCs were detected, possibly suggesting the cycling nature of 
the resident stem cells of the mouse esophagus. Future studies should be directed 
to the identification of esophageal stem cell-specific genes and their promoters to 
allow lineage tracing and the introduction of specific gene mutations to assess their 
potential as cell of origin of esophageal cancer.  
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MATERIALS AND METHODS
Transgenic mice
The ED-L2-rtTA2-M2 construct was generated as follows. The rtTA2-M2 sequence, 
was PCR-amplified from the pUHrT62-1 vector 10 (gift from W. Hillen, Erlangen) 
using the cloning forward (5’-ATTCTCGAGGCCGCCACCATGTCTAGACTG-3’) and 
the cloning reverse (5’-TAGACGCGTTTATCCTGGGAGCATGTCAAGG-3’) primers 
(Figure 1A). The PCR product was then subcloned downstream of the ED-L2 
promoter 8(ED-L2 vector kind gift from Joanna B. Wilson, Glasgow) by digesting both 
PCR product and vector with the restriction enzymes XhoI and MluI, and ligating both 
fragments. The final vector was sequence verified using the sequencing primers 
5’-CTTTTCGGCCTGGAACTAATC-3’ and 5’-CTGTCCAGCATCTCGATTG-3’ 
(Figure 1A). The  2.1 kb expression cassette was cut out of the plasmid backbone 
by BamHI and ClaI digest, gel-purified and prepared for injection into fertilized 
C57BL6/J oocytes.  Founders were identified by PCR amplification of tail DNA using 
transgene specific genotyping primers (5’-CAAGACTTTCTGCGGAACAAC-3’ and 5’- 
GTGTCTCTCTTTCCTCTTTTG-3’, Figure 1A). Transgenic ED-L2-rtTA2-M2 animals 
were bred with tetO-HIST1H2BJ/GFP (H2BGFP) animals 11 (kindly provided by E. 
Fuchs, New York). Transgene expression was induced in compound heterozygous 
animals and their littermates by replacing normal drinking water with 5% sucrose 
water containing 2 mg/ml doxycycline (Sigma, D9891, Figure 1B). Dox-treated 
water was changed every 2 days. After 7 days of doxycycline treatment, mice were 
sacrificed and tissues were analysed for H2B-GFP-expression. 
The same pulse scheme was also applied to the compound hnRNPA2B1-CBX3-
rtTA2S-M2//tetO-H2B-GFP mice. After one week, pulsed mice were withdrawn 
doxycycline from the drinking water and sacrificed at 0, 5, 7 and 10 days (chase).
Cryosectioning 
The esophagus was removed, cut open and washed in PBS. Next, sections of 
~10 cm were spread out flat on paper and fixed in 4% PFA for 60 min and washed in 
PBS for 30 min. Swiss-rolls were placed in KP-CryoBlock (Klinipath, Duiven, NL) and 
frozen on dry ice. Five μm sections were cut and placed on SuperFrost Plus slides. 
The sections were stained with DAPI and analysed by fluorescence microscopy. 
Immunohistochemistry 
Tissues were fixed in 4% PFA and embedded in paraffin. Four μm sections were 
mounted on slides and stained by HE for routine histology. Immunohistochemistry 
was performed according to standard procedures using the following antibodies: 
GFP (1:800, A11222, Invitrogen), CK4 (1:100, ab11215, Abcam), CK13 (1:100, 
ab16112, Abcam), CK14 (1:10000, PRB-155B, Covance) and Ki67 (1:50, M7249, 
DAKO). Signal detection was performed using Rabbit EnVision+ System-HRP 
(K4011, Dako) for GFP. CK4 and CK13 were detected using Goat-anti-Mouse-HRP, 
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CK14 using Goat-anti-Rabbit-HRP. 
Immunofluorescence
GFP (1:50, A11222, Invitrogen), Ki67 (1:50, M7249, Dako), CK4 (1:100, BD 
Pharmingen) ab11215, Abcam), CK13 (1:100, ab16112, Abcam) and CK14 (1:1000, 
PRB-155B, Covance) were employed for Immunofluorescence analysis. Ki67 was 
detected using rabbit-anti-rat-A594 (Invitrogen), CK4 and CK13 were detected using 
goat-anti-mouse-A594 (Invitrogen) and goat-anti-rabbit-A488 (Invitrogen) was used 
for signal detection of GFP.
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ABSTRACT
Adult stem cell niches are often characterized by a dichotomy of cycling and 
quiescent stem cells. However, the intestinal tract seems to represent a notable 
exception as quiescent stem cells have not been unequivocally identified yet. Here, 
we report the isolation and characterization of small intestinal label-retaining cells 
(LRCs) persisting in the lower third of the crypt of Lieberkühn for up to 100 days. 
LRCs do not express markers of cell proliferation and of enterocyte, Goblet or 
enteroendocrine differentiation. However, they do show expression of both Paneth-
like markers and the stem cell marker Msi1. Notably, sorted LRCs are able to form 
self-renewing crypt-villus organoids encompassing the main lineages of the adult 
upper intestinal tract, possibly in cooperation with cycling Lgr5+ stem cells. Following 
radiation-induced tissue injury, LRCs switch from a resting to a proliferating state 
and in the process activate Bmi1 expression while silencing Paneth-specific genes. 
Our results suggest that, during homeostasis, LRCs play an essential but supportive 
role as niche cells of Lgr5+ stem cells. However, in situations of tissue injury, LRCs 
become active and underlie the regenerative response by acquiring stem cell 
characteristics.
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INTRODUCTION
The dichotomy of cycling and quiescent stem cells is thought to meet the demands 
of two distinct settings, namely daily turnover and regeneration upon tissue insults1,2. 
Accordingly, stem cell niches such as skin 3-6, stomach 7,8, and bone marrow 9,10 
have been shown to encompass both quiescent and cycling populations. Whereas 
cycling stem cells maintain daily homeostasis, their quiescent equivalents have been 
postulated to play a rate-limiting role in tissue regeneration upon injury 10. 
The epithelial lining of the upper gastro-intestinal tract is characterized by a unique 
tissue architecture consisting of villi and crypts. The intestinal crypt of Lieberkühn is a 
highly dynamic niche with stem cells residing in its lower third, a position from where 
they give rise to a population of fast-cycling transit-amplifying (TA) cells. TA cells 
undergo a limited number of cell divisions and eventually differentiate into the four 
specialized cell types of the small intestine, namely absorptive, enteroendocrine, 
Goblet, and Paneth cells. Based on clonal analysis and knock-in experiments, it was 
shown that the crypt base columnar cells (CBCs), located in the lower third of the crypt 
and earmarked by Lgr5 expression, represent actively cycling stem cells capable of 
giving rise to all differentiated cell types of the intestinal epithelium 11-14. Recently, it 
was also shown that Paneth cells, apart from their well-known bactericidal function, 
are in close physical association with Lgr5+ stem cells to which they provide essential 
niche signals 15. However, targeted ablation of Lgr5+ CBCs demonstrated that these 
cells are in fact dispensable 16,17. Accordingly, upon radiation-induced tissue injury, 
Lgr5+ CBCs are lost without affecting the regenerative process 18, thus pointing at the 
existence of additional, possibly quiescent, stem cell types in the intestine capable 
of underlying tissue regeneration following major tissue injury. In fact, Bmi1 was 
previously identified as a marker of slower cycling and distinct intestinal stem cells 
located at position +4 from the base of the crypt in the proximal mouse duodenum 19. 
The location of Bmi1+ cells along the crypt-villus axis is reminiscent of cells with long-
term BrdU label-retaining capacity, an alleged characteristic of quiescent stem cells, 
previously shown to map at the same +4 position 20. Upon irradiation, the +4 cells 
enter the cell cycle and, as such, are thought to underlie the clonogenic regenerative 
response of the crypt 21,22. Yet, these early studies were limited by the lack of specific 
markers to allow isolation and lineage tracing of the +4 cells. Moreover, DNA-labeling 
by BrdU is dependent on cell division and does in itself represent a genotoxic insult 
for quiescent stem cells, thus triggering their cell cycle activation9. More recently, 
expression of the Dcamkl1 (doublecortin and CaM kinase-like-1) and Tert (mouse 
telomerase reverse transcriptase) genes were shown to earmark slow-cycling 
intestinal stem-like cells 23,24. Dcamkl1+ cells survive intermediate (6Gy) though not 
high (12Gy) radiation dosages 23. Combining radiation-induced tissue injury with 
lineage tracing revealed that Tert-expressing slow-cycling intestinal stem cells are 
able to contribute to all differentiated lineages 24. However, at present it is not clear 
whether Tert+ cells initiate the regenerative process or arise from a more quiescent 
cell population.  
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Here, we report the identification and characterization of quiescent, label-retaining 
intestinal cells with Paneth cell characteristics which are located in the lower third of 
the crypt of Lieberkühn and are activated to proliferate following radiation-induced 
tissue injury. While exiting dormancy, label-retaining cells progressively lose their 
Paneth cell identity and acquire gene expression features reminiscent of stem cells.
RESULTS
In vivo identification and isolation of infrequently cycling intestinal cells 
We employed a non-mutagenic and cell cycle independent approach to isolate 
quiescent label-retaining intestinal cells, namely in vivo pulse-chase with the histone 
2B - green fluorescent protein (H2B-GFP) 3,9,10. To this aim, we have adapted the 
method originally developed by the Fuchs laboratory 3 to label and isolate quiescent 
skin cells by breeding our transgenic model expressing the tet repressor–VP16 
cassette under control of the villin promoter (villin-rtTA) 25 with transgenic animals 
carrying the H2B-GFP expression cassette controlled by a tetracycline-responsive 
regulatory element (TRE-H2B-GFP) (Figure 1A). Upon doxycycline administration 
in the drinking water (pulse), compound villin-rtTA/TRE-H2B-GFP animals show 
complete labeling of the intestinal epithelium (Figure 1B-C) 25. Following doxycycline 
withdrawal (chase), expression of H2B-GFP fusion protein is silenced (Figure 1D) 
and, due to the high intestinal turnover rate, labeled cells are progressively cleared 
(Figure 1E-I). Label-retaining cells (LRCs) are retained within the lower third of the 
small intestinal crypt for at least 70 days (Figure 1I). 
LRCs localize at the crypt base and do not express markers of intestinal 
proliferation and of Goblet and enteroendocrine differentiation. 
To investigate the position and frequency of the LRCs in more detail, we first 
employed IHC analysis of cross-sections of chased mice to show that H2B-GFP 
LRCs cluster between positions +1 and +5 from the base of the crypt (Figure 2A,B). 
Next, we visualized the intestines of pulse-chased animals in 3D by means of 
multiphoton microscopy. This approach enabled the identification and localization of 
LRCs within the entire volume of the lower third of the crypt, rather than looking at 
cross-sections (Figure 2C). Intestines were analyzed from doxycycline-treated mice, 
after a medium- (20 or 35 days) and a long-term chase (77 days). In agreement with 
our studies by IF and on histological cross-sections by IHC, we found an average 
of 7.04 ± 2.63 LRCs per crypt after 20 days of chase (data not shown). In mice 
chased for over 70 days, LRCs were still present at an average of approx. 1 per crypt 
(0.875±0.8)(Figure 2D). To determine the relative position of LRCs along the crypt-
villus axis, we measured their distance from the dense irregular layer of connective 
tissue (DICT) located at the crypt base. The collagen in the DICT layer generates a 
strong signal when examined using Second Harmonic Generation (SHG) and thus 
acts as a robust standard to measure the distance of individual LRCs from the base 
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of the crypt. The average position of LRCs was 19.4+/-3.5 mm and 11.3 +/-3.5 mm to 
the DICT at 36 and 77 days of chase, respectively (Figure 2E). As a reference, Lgr5+ 
cells in Lgr5-EGFP-IRES-CreERT2 knock-in mice (here referred to as Lgr5-EGFP)14 
are located at 17.6 mm +/5.02mm from the DICT (peak to peak) (Figure 2E). 
Taken together, the data show that the LRCs are located at the base of the crypt 
at a position largely overlapping with that of Lgr5+ cells. 
Intestinal quiescent stem cells are expected not to express differentiation and 
proliferation markers. Accordingly, we analyzed the newly identified LRCs by FACS at 
different chase times to assess co-expression of H2B-GFP with the enteroendocrine 
differentiation marker synaptophysin (Figure 3A) and with the proliferation marker 
Ki-67 (Figure 3B). As shown in Figure 3A-B, both markers are progressively lost 
from the H2B-GFP+ population within 21 days. The resting (G0) state of LRCs was 
confirmed by the lack of Ki-67 staining in GFP+ cells (Figure 3C). Of note, cycling 
crypt base columnar cells were labeled by Ki-67 staining (Figure 3C, arrowhead). 
Likewise, co-staining with antibodies directed against GFP together with PAS 
(Periodic-Acid-Schiff) staining confirmed that LRCs do not express this Goblet cell-
specific differentiation marker (Figure 3D). 
Figure 1. In vivo identification and isolation of infrequently cycling cells (LRCs) from 
the mouse intestine. (A,D) General strategy. Villin-rtTA and TRE-H2B-GFP transgenic mice 
were bred to generate compound experimental animals. (B-I) Duodenal sections of villin-rtTA/
TRE-H2B-GFP mice before (B,C) and after 2 (E), 4 (F), 7 (G), 10 (H), and 70 (I) days of chase 
shown by epifluorescence (B, E-I; green), DAPI counterstain (E-I; blue) and by immunohisto-
chemistry (IHC, C, brown).
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LRCs co-express Paneth and stem cell markers
Paneth cells are long-lived, terminally differentiated cells and thus potentially 
label-retaining 26,27. The average life span of Paneth cells has been estimated around 
60 days 27. In the duodenum, we were able to detect LRCs for up to 100 days of 
chase (data not shown). These cells were located within the Paneth cell zone of the 
crypt and often (Figure 4A, arrow), though not exclusively (Figure 4A, arrowhead), 
stained positively for the Paneth cell marker lysozyme.
To further clarify the relationship between LRCs and Paneth cells, we applied the 
recently reported CD24hiSSChi FACS gating strategy (Figure 4B) 15. CD24/SSC FACS 
analysis of crypt epithelial cells from compound villin-rtTA/TRE-H2B-GFP animals 
chased for longer than 70 days revealed that LRCs represent about 0.7% of the 
small intestinal crypt cells. The majority of LRCs falls directly into the CD24hiSSChi 
Figure 2. Mapping of Label Retaining Cells along the crypt-villus axis. Mapping of LRCs 
was performed in small intestinal samples stained for GFP by IHC (A, brown) from animals 
chased for 4-6 weeks. (B) Frequency at which LRCs were positioned relative to the bottom of 
the small intestinal crypt (+1). (C-E) Analysis of H2B-GFP retention by means of multiphoton 
microscopy. (C) Representative images of H2B-GFP expression of intestinal crypts at days 
20, 36, and 77 following doxycycline withdrawal on day 0. (D) Histogram based on three di-
mensional analysis showing the number of crypts containing 0, 1, 2, 3, or 4 nuclei at day 77 
following removal from doxycycline. (E) Position and intensity of H2B-GFP retaining nuclei 
relative to the DICT layer at the crypt base and Lgr5.
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gate (75.4%, Figure 4C,D), where lysozyme-positive cells were previously reported 
to cluster 15. In fact, the vast majority, if not all, of the LRCs seem to represent a 
homogeneous cell population as those cells falling outside the CD24hiSSChi gate are 
scattered around it (Figure 4C). Some of the cells located in close proximity to the 
CD24hiSSChi gate fall within the upper edge of the CD24med gate (Figure 4C,D; 3.1% 
CD24med). Of note, only a very small minority of LRCs does not express CD24 and 
clearly falls outside of this cluster (Figure 4D; 5.5% CD24-negative). 
Next, we isolated the different CD24hiSSChi H2B-GFP+ (LRCs) and H2B-GFP- 
(non label-retaining) subpopulations to perform quantitative RT-PCR (qPCR) 
expression analysis of genes known to earmark Paneth cells (Defa1) as well as 
cycling and quiescent stem cells (Bmi1 19, Lgr5 14, Msi1 28, Prox1 29, Tert 24, Dll1 30, 
Lrig1 31). As a control for the qPCR analysis, we employed Lgr5-EGFP knock-in mice 
which express EGFP under the control of the endogenous Lgr5 gene promoter14. 
qPCR analysis of H2B-GFP+CD24hiSSChi cells (LRCs) and their GFP-negative 
counterpart was performed from five villin-rtTA/TRE-H2B-GFP animals chased 
for 64 (2 mice) and 83 days (3 mice), respectively. None of the markers showed 
significant expression differences between samples taken at 64 and 83 days of 
chase (not shown). Consequently, data from all five animals were combined and 
displayed in Figure 4E. High Defa1 expression confirmed the Paneth cell identity 
of H2B-GFP+CD24hiSSChi LRCs. Of note, LRCs within the CD24hiSSChi gate show 
Figure 3. Analysis of proliferation and differentiation markers in LRCs. (A-B) Progressive 
loss of expression of differentiation and proliferation markers in LRCs following doxycycline 
withdrawal. The enteroendocrine differentiation marker synaptophysin (A) and the prolifera-
tion marker Ki-67 (B) were detected by APC-A whereas FITC-A detects H2B-GFP. (C-D) Anal-
ysis of small intestinal sections from villin-rtTA/TRE-H2B-GFP mice chased for 5 weeks. (C) 
LRCs (GFP, green) and cycling cells (ki-67, red), the white arrowhead points to a cycling crypt 
base columnar cell (ki-67, red); (D) LRCs (GFP, arrowhead, brown) and Goblet cell marker 
PAS (arrow, red).
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Figure 4. Characterization of LRCs for Paneth and stem cell markers. (A) Co-staining 
of small intestinal sections from villin-rtTA/TRE-H2B-GFP mice chased for 79 days of LRCs 
(arrow and arrowhead, GFP, green) and Paneth cells (lysozyme; red). Several (arrow) but 
not all (arrowhead) LRCs are positive for the Paneth cell marker lysozyme. Imaginary cell 
boundaries have been drawn (white dotted line).  (B) Representative FACS image of mouse 
small intestinal epithelial crypt cells analyzed for the Paneth cell marker CD24. Paneth cells 
fall commonly within the CD24hiSSChi gate. (C) Representative FACS image of label retaining 
cells (chase 75 days) analyzed for the Paneth cell marker CD24. (D) Composition of LRCs ac-
cording to CD24. (E) Plots of relative gene expression levels (qRT-PCR) of Defa1, Lgr5, Bmi1, 
Msi1, Tert, Dll1, Lrig1, and Prox1. CD24hiSSChi LRCs (dark green) and their H2B-GFP-nega-
tive counterpart (grey) were analyzed by qRT-PCR, displayed are averaged β-actin normal-
ized values (± s.e.m.) and the corresponding p-values obtained by two-sample t-test (* <0.02; 
** < 0.005; *** < 2x10-6). Analysis of Lgr5 was also performed in two populations sorted from 3 
Lgr5-EGFP mice, namely Lgr5+ (blue) cells and Lgr5-CD24hiSSChi (black) cells, to compare the 
Lgr5 expression levels in Lgr5-EGFP cells (blue) with that of CD24hiSSChi LRCs (dark green).
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significantly higher Defa1 expression than their GFP-negative counterpart (p<0.005). 
Expression of Lgr5 was very low in LRCs (when compared with Lgr5+ cells) and did 
not significantly differ between CD24hiSSChi LRCs and H2B-GFP-CD24hiSSChi cells. 
The latter was also true for Bmi1, Tert, Lrig1, and Prox1. Notably, Dll1 expression 
was significantly lower in CD24hiSSChi LRCs compared to H2B-GFP-CD24hiSSChi 
cells (p<0.005). Among the stem cell markers, only Msi1 was significantly higher 
expressed in LRCs (p<0.02). 
Overall, these results indicate that LRCs have a lifespan of up to 100 days 
and show a Paneth-like cell identity as indicated by Defa1 expression and by their 
CD24hiSSChi FACS phenotype. Furthermore, LRCs express relatively high levels of 
the stem cell marker Msi1. 
Intestinal LRCs: stem or niche cells?
The observed Msi1 expression in LRCs indicates that, next to their Paneth cell 
identity, they may be multipotent, i.e. capable of giving rise to the various differentiated 
epithelial lineages of the adult GI tract, even in homeostasis. To test this hypothesis 
we applied previously established culture conditions 32 to generate ex vivo crypt-
villus organoids from LRCs thus assaying their multipotency in comparison with Lgr5+ 
stem cells. To this aim, we employed CD24/SSC FACS to sort H2B-GFP+ and H2B-
GFP- cells from pulsed-chased villin-rtTA/TRE-H2B-GFP animals and, as control, 
Lgr5-GFP+ cells from Lgr5-EGFP mice 14. Figure 5A shows the average percentages 
of organoids formed in five independent experiments, carried out with FACSorted 
Figure 5. Organoid-formation assay. (A) Organoid-forming capacity of sorted populations 
from villin-rtTA/TRE-H2B-GFP mice, chased for 72-78 days. Displayed are average percent-
ages of organoids formed (±s.e.m.) from 5000 FACS-sorted and plated events in 5 independ-
ent experiments as scored 14 days after plating. (B) Representative IF images showing the 
composition of the LRC CD24hiSSChi population (left) and the H2B-GFP- CD24hiSSChi popula-
tion (right). (C) Quantification of the composition of FACS-sorted LRC CD24hiSSChi (left) and 
H2B-GFP- CD24hiSSChi (right) populations by morphology for single cells and aggregates of 
differently sized cells; displayed are percentages.
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Figure S1. Organoid-formation assay in Lgr5-EGFP mice. (A) Organoid-forming capacity 
of sorted populations from Lgr5-EGFP mice. Displayed are average percentages of organoids 
formed (±s.e.m.) from 5000 FACS-sorted and plated events in 5 independent experiments as 
scored 14 days after plating. (B) To assess the presence of doublets among the sorted cells, 
the different subpopulations were examined by confocal microscopy. Representative IF im-
ages showing the composition of all sorted cell populations (left, - 20µm) and their quantifica-
tion by morphology for single cells and aggregates of differently sized cells (right), displayed 
are percentages.
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single cells obtained from small intestinal crypts of pulsed-chased villin-rtTA/TRE-
H2B-GFP animals (chase time 72-78 days). Organoids were obtained from LRCs 
(H2B-GFP+CD24hiSSChi) at higher frequencies (~4 fold, 0.08%) than from H2B-GFP-
CD24med cells (0.02%), i.e. the sorting gate where Lgr5+ cells are known to reside 
(Figure 5A and S4I) 15. Their GFP-negative counterpart (H2B-GFP-CD24hiSSChi) was 
able to form organoids with a frequency (0.06%) comparable to that of LRCs (Figure 
5A). Of note, CD24-negative LRCs, which constitute 5.5% of all LRCs (Figure 4D), 
were not able to give rise to organoids (data not shown). LRCs-derived organoids 
were morphologically indistinguishable from those obtained from GFP-negative 
cells and from whole crypts, and encompassed all differentiated cell types, namely 
enterocytes, Paneth, Goblet, and enteroendocrine cells. Also, Lgr5 expression was 
detected by RT-PCR in the LRC-derived organoids. 
As recently reported, doublets of Lgr5+ (cycling stem cells) and CD24hiSSChi 
(allegedly Paneth) cells have increased organoid-forming capacity when compared 
with single Lgr5+ cells (up to 80 fold) 15. We performed similar control experiments 
by employing Lgr5-EGFP mice and tested the organoid-forming capacity of different 
sub-populations FACSorted according to their Lgr5-GFP staining (here indicative 
of Lgr5 expression) and to the CD24hiSSChi markers (Figure S1A). While Lgr5+ 
single cells showed a very low organoid-forming capacity, Lgr5-GFP+CD24hiSSChi 
doublets (i.e. composed of Lgr5+ and Paneth cells) were significantly (~70 fold) 
more efficient in forming viable organoids. The composition and percentages 
of single cells and aggregates within each population is depicted in Figure S1B. 
Because of their size, these Lgr5+CD24hiSSChi doublets are likely to contaminate the 
CD24hiSSChi sorting gate in the LRC-sorting experiments even when stringent single 
cell selection is applied. Highly stringent gating for single cells was performed in a 
two-step strategy and is explained in detail in Figure S4. To assess the presence 
of doublets among the sorted LRCs, we examined the different subpopulations 
by confocal microscopy (Figure 5B). To this aim, 500 cells were sorted in each 
well of a 6-well plate, imaged by confocal microscopy and counted. Figure 5B 
shows representative images of each H2B-GFP+CD24hiSSChi (left) and H2B-GFP-
CD24hiSSChi population (right). The percentage of single cells and doublets present 
in sorted CD24hiSSChi LRCs (Figure 5C, left, 8.9%) and in H2B-GFP-CD24hiSSChi 
(Figure 5C, right, 11.4%) cells is displayed. In view of the sizeable presence of 
doublets among CD24hiSSChi LRCs, we cannot draw any definitive conclusion on 
the capacity of single LRCs to form organoids. 
Taken together, the presented evidence points to an essential role of Paneth-
like CD24hiSSChi in providing niche support to actively cycling Lgr5+ cells during 
homeostasis, as previously published 15. Whether LRCs also represent bona fide 
stem cells during homeostasis cannot be stated exclusively based on the present 
data, unless, in the future, doublets can effectively be excluded from the LRCs 
enriched samples.
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LRCs respond to radiation-induced tissue injury by entering the cell cycle, and 
acquiring stem-like characteristics and by loosing their Paneth cell identity. 
Quiescent stem cells are thought to play a rate-limiting role in the regenerative 
process following tissue injury as previously shown in other stem cell niches 3,5,6,10. 
In the mouse GI tract, tissue injury can be experimentally simulated by whole-body 
exposure to ionizing radiation leading to complete cell death of crypt cells (crypt 
clearance). Irradiated crypts progressively shrink and eventually disappear within two 
days 33. After a lag in growth following a single 12 Gy radiation dose, new outgrowing 
crypts are thought to result from single clonogenic cells 33. To study the behavior of 
LRCs upon tissue injury, villin-rtTA/TRE-H2B-GFP mice were exposed to a single 
12 Gy dose following a four-week chase period. After an 8-12 hour recovery time, 
animals were injected five times with BrdU at 4-hour intervals to mark proliferating 
cells. Animals were analyzed 28 and 32 hours after irradiation, respectively (Figure 
6A). When compared with non-irradiated controls (Figure 6B), several short ribbons 
of H2B-GFP positive cells were observed in the small intestines of the mice analyzed 
at 32 hours after radiation (Figure 6C,D). This short term lineage tracing indicates the 
proliferative activation of LRCs upon tissue injury, as also suggested by the observed 
diminished H2B-GFP intensity within the ribbons due to the progressive dilution of 
the H2B-GFP signal after each cell division cycle. 
In order to quantify the levels of H2B-GFP at this time point, FACS analysis of 
live epithelial cells was applied 32 hrs after radiation: a distinct population of cells 
with intermediate GFP intensity (GFPmed) when compared with the parental LRCs 
(mainly GFPhi) becomes evident upon irradiation (Figure 6E). To ensure that the 
observed GFP-levels do not result from non-specific, endogenous fluorescence 
or radiation-induced expression of the H2B-GFP transgene, sham-pulsed mice 
were subjected to the same treatment (Figure S2A). Sham-pulsed animals and 
doxycycline-pulsed and chased mice were analyzed at 32 hours after radiation 
(Figure S2A), the same time point when the above-mentioned cell ribbons (Figure 
6C,D) and the GFPmed population (Figure 6E) appeared. GFP-levels of sham-pulsed 
animals, when compared to littermates treated with doxycycline and chased, were 
close to background levels (Figure S2B). The GFPhi population was absent in sham-
pulsed mice and a significantly smaller fraction of GFPmed cells was measured (Figure 
S2B, p<0.001). Hence, irradiation and BrdU-injection by itself does not induce the 
expression of the H2B-GFP transgene. On the contrary, the GFPmed cells detected 
after radiation descend from the population of cells that retained the H2B-GFP-
protein prior to the radiation insult. 
To confirm that the GFPmed population results from cell cycle activation of H2B-
GFP LRCs, BrdU-uptake was compared between GFPmed and GFPhi cells at 28 and 
32 hours after irradiation (Figure 6F). While at 28 hrs after radiation, the proliferation 
rates of GFPmed and GFPhi cells did not differ, at 32 hrs, i.e. the time point when 
clusters of H2B-GFP positive cells were observed (Figure 6C,D), GFPmed cells show 
a clear increase in BrdU-uptake when compared to GFPhi cells (Figure 6F). Hence, 
the GFPmed cells descend from H2B-GFP LRCs, which react to the tissue insult by 
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Figure 6. Proliferative response of LRCs upon radiation-induced tissue injury. (A) Ex-
perimental scheme. (B-D) IF analysis for GFP (green, LRCs) and lysozyme (red, Paneth cells) 
relative to a non-irradiated control animal at four weeks of chase (B) and to two irradiated 
animals that were treated according to the scheme in (A) analyzed at 32 hours after irradia-
tion (C,D). (E) Overlay of representative image of FACS analysis of intestinal epithelial cells 
of non-irradiated animals at four weeks of chase (black) compared to animals at 32 hours 
after whole-body irradiation (red, treated according to the scheme in 6A) for H2B-GFP inten-
sity. Following radiation-induced tissue injury, a new GFPmed population appears (red peak), 
which is almost absent in untreated control animals (black line). (F) BrdU uptake as a measure 
of the LRCs’ proliferative response to tissue injury. The average BrdU levels (±s.d.) measured 
in 2 independent mice are displayed. (G) CyclinD1-expression as a measure of the LRCs’ pro-
liferative response to tissue injury. Displayed is the percentage of CyclinD1-expressing cells 
from all Actb-positive ones as determined by single-cell RT-PCR (±s.d.) and the correspond-
ing p-values obtained by two-sample t-test (* < 0.02). (H) Percentage of GFPhi and GFPmed 
cells expressing Defa1, Bmi1, and Lgr5 as determined by single cell RT-PCR.
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entering the cell cycle thus incorporating BrdU and progressively diluting the GFP-
labeled chromatin. The proliferative response of LRCs to tissue injury was confirmed 
by single-cell RT-PCR (Figure 6G). Only a small proportion of the quiescent cells (i.e. 
LRCs from non-irradiated mice) and of the GFPhi cells following irradiation expressed 
CyclinD1. In contrast, the percentage of CyclinD1-expressing cells in the GFPmed 
population was significantly higher than in the GFPhi cells upon tissue insult (Figure 
6G, p < 0.02).
The presence of short ribbons of H2B-GFP nuclei in each crypt and the decrease 
of H2B-GFP intensity following radiation-induced tissue injury was confirmed and 
quantified by multiphoton microscopy (Figure S3). Here, we examined the number 
and intensity of LRCs after a short-term chase (35 days). Consistent with a stimulation 
of proliferation following tissue injury, there was a significantly increased number of 
H2B-GFP+ cells at 3 and 5 days following gamma irradiation (12 Gy) (Figure S3a) 
with altered position (Figure S3b) and a significantly reduced GFP intensity (Figure 
S3c).    
To further characterize the GFPhi and GFPmed cells arising upon irradiation, single-
cell RT-PCR analysis was carried out for the Defa1, Bmi1 and Lgr5 genes (Figure 
6H). As predicted by the previously reported radio-resistance of Paneth cells 26, the 
Figure S2. 12Gy whole-body irradiation does not induce expression of the H2B-GFP 
transgene. (A) Two sham pulse-chased (top) and two doxycycline pulse-chased (bottom) 
compound heterozygous villin-rtTA/TRE-H2B-GFP mice were subjected to 12 Gy whole-body 
irradiation and five injections of BrdU every four hours, following a twelve hour recovery time 
after radiation. Animals were FACS-analyzed at 32 hours after radiation. (B) Results of the 
FACS analysis of live epithelial cells prepared from the intestines of these animals for GFP 
expression. Displayed are the average GFP-levels measured by FACS (± s.d.) 32 hours after 
radiation. While sham-pulsed control animals show only very low levels of GFP, doxycycline 
pulsed and chased animals display the clear presence of a GFP high and a GFP medium 
population. Doxycycline pulsed and chased animals have significantly more GFP medium 
cells than sham-pulsed mice (** p<0.001).
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GFPhi fraction encompasses a majority of Defa1-expressing cells when compared 
with GFPmed cells. Instead, the GFPmed population is clearly enriched in Bmi1+ cells 
(Figure 6H). Notably, only very few GFPmed cells expressed Lgr5 (Figure 6H), thus 
suggesting that Bmi1+ cells but not crypt base columnar cells are direct descendants 
of LRCs upon radiation-induced tissue injury. Complete regeneration following the 
radiation dosage of 12 Gy is very efficient and is completed within the first four days. 
Overall, these results indicate that, upon radiation-induced tissue injury, dormant 
LRCs exit the G0 phase of the cell cycle and start dividing as part of the physiologic 
regenerative response of the intestinal epithelium. During this process, LRCs loose 
markers of Paneth cell differentiation, acquire Bmi1 expression and therewith a more 
stem-like identity. 
Figure S3. Analysis of H2B-GFP retention following radiation treatment. (A) The number 
of H2B-GFP nuclei per crypt was quantified for control mice, and on days 1, 2, 3, and 5 follow-
ing radiation treatment. Graph shows increased numbers of LRC at days 3 and 5 (Day 3/5 v 
Day 0, ** p value ≤ 0.001. Mann Whitney at least 75 crypts scored per day). (B) Quantification 
of the mean distance between the centers of H2B-GFP nuclei and the local center of the DICT 
layer. Graph shows that following radiation treatment H2B-GFP nuclei are located progres-
sively more closely to the crypt base (Day 5 v Day 0, ** p value ≤ 0.001. Mann Whitney: at 
least 75 crypts scored per day). (C) The intensity of H2B-GFP signal is diluted on day 2 follow-
ing radiation treatment. There is an 8 fold difference in the average intensity of nuclei A and B 
(within the same crypt). There is a 17 fold difference in the average intensity of nuclei B and C 
(within different crypts). Note that in order to visualize nucleus B, image contrast has been set 
so that both nuclei A and C appear saturated. Image field is 140 x 140 µm.
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DISCUSSION
The existence within the crypts of Lieberkühn of dormant cells which become 
activated and proliferate in response to tissue insults is reminiscent of the scenario 
observed in other stem cell niches, e.g. the stomach 7,8 and the bone marrow 9,10,34, 
where, while resident stem cells are responsible for the daily homeostasis, dormant 
stem cells are activated and recruited in the presence of tissue damage 1. In the 
mouse GI tract, depletion of cycling intestinal stem cells has first been achieved 
through the targeted deletion of the Ascl2 gene whose expression largely overlaps 
that of Lgr5 16. As predicted, Lgr5+ stem cells disappeared within 5 days following 
conditional deletion of Ascl2. Notwithstanding the high efficiency of this targeted 
depletion, complete regeneration of the intestinal epithelium was observed between 6 
and 10 days after disappearance of the cycling stem cell population 16. More recently, 
an even more efficient experimental approach aimed at the complete ablation of 
Lgr5-expressing cells showed that these cycling stem cells are dispensable and 
that their loss is compensated by the expansion of the Bmi1+ stem cell pool 17. Upon 
their activation, Bmi-1+ stem cells give rise to Lgr5+ cells together with all other cell 
lineages of the mouse small intestine 17. Hence, Bmi1-expressing stem cells may 
represent a stem cell pool which becomes active in situations of tissue injury 17. 
Tissue injury in the intestine is often due to inflammation and/or dietary mutagens. 
Experimentally, tissue injury can be simulated by whole-body exposure to ionizing 
radiation leading to complete sterilization of the epithelial lining followed by tissue 
regeneration from clonogenic stem cells 33. Irradiation of Lgr5-EGFP mice was shown 
to result in the depletion of Lgr5+ stem cells followed by a proliferative, regenerative 
phase 18. Similarly, Dcamkl1-expressing quiescent stem cells disappear following 
whole-body exposure to a radiation dosage of 12 Gy 23. 
In view of the above observations and of the results presented here, the activation 
and recruitment of quiescent intestinal cells capable of de-differentiation and 
acquisition of a stem-like identity becomes a plausible scenario to account for the 
rapid regenerative process upon loss of Lgr5+ cycling stem cells following radiation-
induced tissue injury. Our results are indicative of an entirely novel functional role 
for infrequently dividing, Paneth-like cells as stem cells upon tissue injury. When 
massive cell death is induced by irradiation, Paneth/LRCs survive because of their 
intrinsic radio-resistance 26 and become activated to proliferate and acquire a stem-
like identity, as shown by Bmi1 expression 17,19 and the simultaneous loss of their 
Paneth cell identity. 
By combining radiation-induced tissue injury with Tert-specific lineage tracing, 
Montgomery et al. showed that Tert earmarks slow-cycling intestinal stem cells 
able to contribute to all intestinal lineages 24. However, it remains unclear, if Tert-
expressing cells are the ones initiating tissue regeneration or are actually daughter 
cells of a more quiescent cell population. The Paneth/LRCs here identified do not 
express Tert during homeostasis.
We propose a scenario where Paneth/LRCs survive tissues insults, enter the 
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cell cycle, and acquire expression of the stem cell marker Bmi1, while progressively 
losing their Paneth cell features. Subsequently, the newly generated Bmi1+ stem 
cells underlie the regenerative response. Future experiments will have to address 
whether Tert-expressing cells descend (directly or through the Bmi1+ cells) from 
Paneth/LRCs following tissue injury or if they represent a distinct population of 
quiescent stem cells. 
Although Paneth cells play an essential role both as integral part of the Lgr5 niche 
and during the regenerative response, their depletion from the intestinal epithelium 
of mice can be tolerated for up to six months 35,36. Sox9, a stem cell marker expressed 
in Lgr5+ CBCs but also in enteroendocrine and Paneth cells 37, is required for Paneth 
cells formation in the mouse small intestine 38. Sox9 depletion results in Paneth cell 
loss, crypt enlargement and an increase in proliferation rates 38. However, these and 
other mice lacking Paneth cells have not been yet fully challenged (e.g. by radiation) 
to assess whether their ablation affect the subsequent regenerative process.
Paneth cells are found in the small intestine yet not in the colon where otherwise 
uncharacterized CD24+ cells are intermingled with Lgr5+ stem cells similar to the 
organization of Paneth and Lgr5+ cells in the upper intestine 15. Notably, Paneth 
cell metaplasia, i.e. the unusual appearance of Paneth cells in the colon, has been 
reported in patients affected by chronic inflammatory bowel diseases such as 
Ulcerative Colitis 39. In view of our results, Paneth cells metaplasia may arise from 
the activation and reprogramming of quiescent cells due to persistent inflammation-
driven tissue insults. From this perspective, Paneth cells are likely to play key roles 
in the maintenance of intestinal homeostasis not only by acting against pathogenic 
microbes but also by providing niche support to cycling stem cells and by themselves 
providing a source of activated stem cells in situations of tissue injury.   
In conclusion, we identified a novel, dormant population of intestinal label-
retaining cells distinct from the recently identified cycling Lgr5- and Bmi1-expressing 
stem cells. These quiescent cells do not express markers of proliferation and have 
morphologic and gene expression features reminiscent of Paneth cells. LRCs 
are likely to mainly play a niche role during homeostasis but in the presence of 
tissue insults, switch from a resting to a proliferative, stem-like state as part of the 
regenerative response of the injured epithelium.  
MATERIALS AND METHODS
Mice
Transgenic Villin-rtTA2-M2 animals 25 were bred with tetO-HIST1H2BJ/GFP 
(H2BGFP) animals 3. Transgene expression was induced in compound heterozygous 
animals and their littermates by replacing normal drinking water with 5% sucrose water 
containing 2 mg/ml doxycycline (Sigma, D9891). Dox-treated water was changed 
every 2 days. After 7 days, doxycycline treatment was stopped and mice received 
regular drinking water again. At defined time-points after doxycycline-withdrawal, 
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mice were sacrificed and tissues were analyzed for H2B-GFP-expression. 
Radiation and BrdU injection
Animals were exposed to 12 Gy of whole-body g-radiation. Mice were injected 
intraperitoneally at 4-hour intervals with 100 µl BrdU solution in PBS at 10mg/ml-1 
(BD Pharmingen). 
Immunofluorescence
GFP (1:50, A11222, Invitrogen), Ki67 (1:50, M7249, Dako), BrdU (1:50, 
BD Pharmingen) and Lysozyme (1:1000, A0099, Dako) were employed for 
Immunofluorescence analysis. Ki67 was detected using rabbit-anti-rat-A594 
(Invitrogen), BrdU was detected using goat-anti-mouse-A594 (Invitrogen) and goat-
anti-rabbit-A488 (Invitrogen) was used for signal detection of GFP.
Immunohistochemistry
Tissues were fixed in 4% PFA and embedded in paraffin. Four µm sections 
were mounted on slides and stained by HE and PAS for routine histology. 
Immunohistochemistry was performed according to standard procedures using the 
following antibodies: GFP (1:800, A11222, Invitrogen), Lysozyme (1:5000, A0099, 
Dako), Synaptophysin (1:750, A0010, Dako), Villin (1:200, 610359, BD Transductoin 
Laboratories) and BrdU (1:250, BD Pharmingen). Signal detection was performed 
using Rabbit EnVision+ System-HRP (K4011, Dako) for GFP, Lysozyme and 
Synaptophysin. Villin and BrdU were detected using Mouse EnVision+ System-HRP 
(K4001, Dako).
Multiphoton Microscopy 
Mice were sacrificed and a ~1 cm section of the intestine was removed at ~5 
cm distance from the stomach. The intestinal section was rinsed twice in PBS and 
placed in a glass-bottomed petri dish (Matek) in a few drops of PBS containing the 
muscle relaxant scopolamine (Sigma) to stop peristalsis and stabilize the sample for 
imaging.  Samples were imaged on a LaVision Biotec TRIM scope using an Olympus 
20x, 0.95 NA water immersion objective on an inverted Nikon Eclipse T2000 stand. 
Samples were illuminated using a Coherent Chameleon II Ultrafast laser at 850 nm. 
GFP fluorescence and collagen SHG were simultaneously detected using 525/50 
and 435/40 nm band-pass filters (respectively).
Images were analysed using Fiji 1.45i (ImageJ) and SigmaPlot. A gaussian curve 
was fit to the axial profile of SHG intensity in order to determine the centroid and 
width of the dense irregular connective tissue (DICT) layer at the base of each crypt. 
The ImageJ macro “3D Objects Counter” was used to determine the intensities and 
axial positions of the GFP-H2B labeled nuclei within a given crypt. Axial position was 
then compared to the SHG centroid of the DICT beneath that crypt.
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Crypt isolation and cell culture
Crypts were isolated and cultured according to the protocol kindly provided 
and previously described by T. Sato, R. Vries, and H. Clevers32. Sorted cells were 
collected in crypt culture medium and embedded in Matrigel containing Jagged-1 
peptide (1 mM; AnaSpec), EGF (10–50 ng/ml; Peprotech), R-spondin 1 (1000 ng/
ml; R&D Biosystems) and Noggin (100 ng/ml; Peprotech). 500 sorted events were 
plated per well of a 48-well plate. Crypt culture medium (250 ml for 48-well plates) 
containing Y-27632 (10 mM) was overlaid. Growth factors were added every other 
day and the entire medium was changed every 4 days. Organoid counting was done 
two weeks after plating and percentages were calculated using the total number of 
sorted events per population.
For passage, organoids were removed from Matrigel and mechanically dissociated 
into single-crypt domains, and then transferred to fresh Matrigel. Organoids were 
passaged every 1–2 weeks. 
Cell preparation for FACS
Small intestinal crypts were isolated as described above. Crypts were spun 
twice at 600 rpm for 2 min. to remove blood cells and other single cells. Clean crypt 
preparations were digested into single cells in TrypLE (Invitrogen) for 30 min. at 
37˚C. The cell suspension was passed through a 40 μm cell strainer, washed by 
doubling the volume using 2% FCS/PBS, and spun down for 5 min. at 1200 rpm 
at 4˚C. All staining steps were performed for 30 min. at 4˚C in the dark. Antibodies: 
synaptophysin (DakoCytomation) and secondary APC-conjugated F(ab’)2 Donkey-
anti-rabbit IgG(H+L) (Jackson); ki-67 (DakoCytomation) and secondary APC-
conjugated goat-anti-rat Ig specific (BD Pharmingen); anti-mouse CD24-APC clone 
M1/69 (BioLegend); APC BrdU Flow Kit (BD Pharmingen); LIVE/DEAD Fixable Dead 
Cell Stain Kit (L10119, Invitrogen). 
FACS
A detailed description of our gating strategy including representative FACS plots 
can be found in Figure S4.
Quantitative PCR
CD24hiSSChi LRCs and their GFP-negative counterpart were sorted from crypt 
preparations of the small intestine of five animals that were chased for 64 (2) and 
83 (3) days respectively. Likewise, Lgr5-positive cells and CD24hiSSChi were sorted 
from three different Lgr5-EGFP animals. Total RNA was isolated using RNeasy Mini 
Kit (Quiagen), converted into cDNAs using High Capacity RNA-to-cDNA kit (Applied 
Biosystems) and employed in a pre-amplification step using the Taqman®PreAmp 
Master Mix (Applied Biosystems) according to manufacturer’s instructions. The 
Linearity of pre-amplification was controlled for all primers. Assays were carried out as 
duplicate reactions using the 7900HT Fast Real Time system (Applied Biosystems). 
Quantitative PCR was performed for the following markers: Actb, Defa1, Lgr5, 
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Bmi1, Msi1, Prox1, Lrig1, Dll1 and Tert using inventoried TaqMan assays (Applied 
Biosystems, see below) according to manufacturer’s instructions. The Actb gene 
was used as house keeping gene.
gene TaqMan Assay
actin, beta (Actb) Mm00607939_s1
defensin, alpha 1 (Defa1) Mm02524428_g1
leucine rich repeat containing G protein coupled receptor (Lgr5) Mm00438890_m1
Bmi1 polycomb ring finger oncogene (Bmi1) Mm03053308_g1
Musashi homolog 1(Drosophila) (Msi1) Mm00485224_m1
prospero-related homeobox 1 (Prox1) Mm00435969_m1
leucine-rich repeats and immunoglobulin-like domains 1 (Lrig1) Mm00456116_m1
delta-like 1 (Drosophila) (Dll1) Mm01279269_m1
telomerase reverse transcriptase (Tert) Mm00436931_m1
Comparison of the marker expression at the two different chase time points (64 days 
and 83 days) did not show any differences. Therefore, data from all five animals was 
analyzed together. Displayed are thus the averages of five animals, the standard 
error of means and the corresponding p-values obtained by two-sample t-test. 
Single cell RT-PCR
Single cells were directly sorted into PCR tubes containing 9-μl aliquots of RT-
PCR lysis buffer and treated as described previously and two-step multiplex nested 
single cell RT-PCR was done as described 40. Multiplex single cell RT-PCR allows 
the detection of multiple genes expressed in one single cell. RNA-quality control 
was achieved by using the housekeeping gene Actb and examining different gene 
products at the same time. Primer sequences are displayed below. 
Single cell RT-PCR of CyclinD1: LRCs were obtained from three pulse chased 
animals; GFPhi and GFPmed cells were obtained from three pulse-chased animals 
and isolated 36 h after irradiation. Single cell RT-PCR was carried out on a total of 3 
x 90 LRCs, 3 x 60 GFPhi and 3 x 120 GFPmed cells. Single cells were only included in 
the analysis if the housekeeping gene Actb was expressed. The average percentage 
of CyclinD1-expressing cells was calculated from the number of Actb-positive cells 
(±s.d.). 
Single cell RT-PCR expression analysis of the Defa1, Bmi1, and Lgr5 genes, 
performed on FACSorted GFPhi and GFPmed cells 36 hrs following radiation, was 
carried out on a total of 2 x 30 GFPhi and 2 x 60 GFPmed cells from each of one 
male and one female mouse. Single cells were included in the charts only when the 
housekeeping gene Actb was expressed. The average percentage of expressing 
cells was calculated from the number of Actb-positive ones. 
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RNA-isolation and RT-PCR
RNA was isolated from organoid cultures using TRIzol Reagent (Invitrogen) and 
cDNA was synthesized using RevertAid H Minus First Strand cDNA Synthesis Kit 
(Fermentas) following the manufacturer’s instructions. RT-PCR was done using 
primers Lgr5_F1 (acctcagtatgaacaacatc) and Lgr5_R1 (ggagtccatcaaagcatttc). 
gene primer sequence
Actb_F1 atatcgctgcgctggtcgtc
Actb_R1_R2 ccggagtccatcacaatgcc
Actb_F2 tggtgggaatgggtcagaag
CyclinD1_F1 gcgtaccctgacaccaatc
CyclinD1_R1 gcttgttctcatccgcctc
CyclinD1_F2 catgcggaaaatcgtggcc
CyclinD1_R2 ggccggatagagttgtcag
Defa1_F1 cctactctttgcccttgtcc
Defa1_R1 ctcatgctcgtcttgttctc
Defa1_F2 agagactaaaactgaggagc
Defa1_R2 caggttccattcatgcgttc
Bmi1 _F1 tgcatcgaacaaccagaatc
Bmi1_ R1 atcattcacctcttccttag
Bmi1 _F2 cactaccataatagaatgtc
Bmi1_ R2 aatctcttcttctcttcatc
Lgr5_F1 acctcagtatgaacaacatc
Lgr5_R1 ggagtccatcaaagcatttc
Lgr5_F2 ttacgtcttgctggaaatgc
Lgr5_R2 gagcattgtcatctagccac
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Figure S4. Methods. Description of the gates applied for the definition of singlets, dou-
blets, higher level aggregates. A preliminary gate (not shown) was applied on FSC-A vs 
SSC-A to discriminate cells from debris and big aggregates, followed by a gate to discriminate 
live and dead cells with hoechst 33258 (not shown). (A) A gate in FSC-H vs FSC-W was ap-
plied to divide singlets and doublets from higher level aggregates, and was refined by a similar 
gate in SSC-H vs. SSC-W (not shown). (B-D) The population of singlets + doublets was further 
analyzed for the pattern of expression of GFP (H2B-GFP LRCs and Lgr5-GFP) and CD24. 
(E-F) The selected populations were divided in singlets and doublets with a further gate on 
FSC-A vs SSC-A. The following populations were obtained: (G) CD24hiSSChi LRCs and GFP-
CD24hiSSChi single cells, (I) Lgr5-GFPhi singlets, (J) doublets of Lgr5-GFPhi with CD24hiSSChi 
Paneth cells (GFP+CD24hiSSChi). This strategy, based on the fine tuning of the single cell 
gates on the specific populations of interest, allowed to obtain a higher percentage of single 
cells, together with a good recovery during sorting, if compared with a general initial stringent 
gate on FSC-H vs FSC-W (indicated by the dashed line in plot A).
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ABSTRACT
Colorectal cancer (CRC) is one of the most common cancer types in the western 
world. Amongst the risk factors for this disease is a family history of CRC as well 
as chronic inflammatory conditions such as Crohn’s disease and ulcerative colitis, 
commonly known as inflammatory bowel disease (IBD). Here, we describe a mouse 
model, Apc1638N/+/villin-KRASV12G, predisposed to develop multiple small intestinal 
adenocarcinomas. Upon dextran sodium sulfate (DSS) administration through the 
drinking water, a chemical that induces an IBD-like phenotype in the colorectum, 
Apc1638N/+/villin-KRASV12G mice develop multifocal adenomas and adenocarcinomas. 
The resulting tumors are characterized by the presence of metaplastic Paneth cells, 
a typical feature of inflammation-related colorectal adenocarcinomas. Therewith, we 
have established a valuable pre-clinical model system for comparing genetic and 
inflammatory bowel cancer. Furthermore, this model will serve as a great tool to 
test anti-inflammatory drugs for the prevention of colorectal cancer and investigating 
their mechanisms of action.
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INTRODUCTION
Colorectal cancer represents the worldwide third and second most common 
cancer type among men (10%) and women (9.4%), respectively 1. It accounts for 8% 
of all cancer deaths and is therewith the fourth most common cause of death from 
cancer in the world 1. Generally, colorectal cancer is more frequent in developed 
countries, which reflects the impact of dietary habits on the development of the 
disease. Next to environmental influences, colorectal cancer can also be caused by 
genetic traits such as Lynch syndrome (HNPCC, hereditary nonpolyposis colorectal 
cancer) and FAP (familial adenomatous polyposis). FAP patients develop a high 
multiplicity of polyps in the colorectum, some of which progress towards colorectal 
cancer with time. FAP is caused by germline mutations of the APC tumor suppressor 
gene, leading to the constitutive activation of the canonical Wnt/b-catenin signaling 
pathway. More importantly, 80% of sporadic colorectal cancers are characterized 
by an early functional inactivation of APC, pointing to the key role played by this 
pathway in colorectal carcinogenesis at large 2. 
Mouse models carrying targeted mutations in the homologous mouse Apc gene, 
e.g. ApcMin/+ and Apc1638N/+, serve as unique in vivo tools to study the mechanisms and 
evolution of colorectal cancer 3-5. However, these animals develop multiple polyps 
throughout the small intestinal tract whereas colonic tumors are rarely observed. 
Nevertheless, morphologically abnormal structures called aberrant crypt foci (ACF) 
were observed in the colonic mucosa of 7-months old Apc1638N/+ mice 6. These minute 
lesions represent a pre-cancerous state although in the mouse model they rarely 
progress into adenomas and cancer. The villin-KRASV12G mouse model develops an 
average of 2.4 intestinal tumors from age 9 months onward, 7% of which are located 
in the colon 7. In our laboratory, an improved mouse model for intestinal cancer 
was established by combining the targeted Apc1638N mutation with the transgenic 
villin-KRASV12G allele 8. Apc1638N/+/villin-KRASV12G animals develop on the average 
10 fold more small intestinal tumors than Apc1638N/+ animals, the majority of which 
present as adenocarcinomas 8. We could also detect disseminated tumor cells in the 
liver of these animals, which indicates that the intestinal tumors have the ability to 
metastasize to distant organ sites 8. However, although the villin promoter driving the 
expression of the oncogenic version of KRAS is also active in the large intestine, we 
could not observe any colorectal tumors in Apc1638N/+/villin-KRASV12G animals. 
Next to the genetic predisposition, colorectal cancer risk is also increased in 
patients with inflammatory bowel disease (IBD) such as Crohn’s disease (CD) and 
Ulcerative Colitis (UC). The duration and severity of the inflammation in IBD patients 
correlate with the cumulative probability of colorectal cancer development9. Colitis 
can be triggered and modeled in mice by administering dextran sodium sulfate 
(DSS), a non-genotoxic sulfated polysaccharide, through the drinking water10. 
Chronic treatment with DSS induces a colitis-like phenotype with inflammation, 
crypt distortion, epithelial cell erosion and dysplasia 10. Upon DSS administration to 
ApcMin/+ animals, multifocal colon tumors are initiated and their progression towards 
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malignancy is accelerated through the DSS-induced chronic inflammation 11. 
In the present study, we evaluated the effect of DSS-induced inflammation 
on intestinal tumourigenesis in the Apc1638N/+/villin-KRASV12G mouse model. We 
observed that, following DSS-induced chronic inflammation, tumor formation is 
highly enhanced in the colorectum. Furthermore, we performed the histological 
characterization of the resulting tumors and show that Paneth cell metaplasia, i.e. 
the abnormal appearance of Paneth cells in the colon, is a common feature of these 
inflammation-induced tumors.
RESULTS
DSS-induced colorectal tumors in Apc1638N/+/villin-KRASV12G mice
Apc1638N/+/villin-KRASV12G, Apc1638N/+, villin-KRASV12G, and wild type mice entered 
the study at an average age of seven to eight weeks and were treated with 2 cycles 
of DSS (Figure 1A) or left untreated. DSS, when given in multiple cycles, induces a 
chronic inflammation of the coecum and the colorectum 10. A small decrease in body 
weight could be observed following the second cycle of DSS after which all animals 
recovered and could be analyzed ten weeks after the onset of DSS treatment 
(data not shown). At the time of analysis, only villin-KRASV12G male mice showed 
a significant decrease in body weight between DSS-treated and untreated animals 
(p<0.001, data not shown). 
Gross morphologic analysis of the small intestine, coecum and colorectum of DSS-
treated and untreated mice revealed striking differences in their distal bowel tumor 
phenotype. While untreated control animals (Figure 1B-C, Table 1) only occasionally 
presented with colorectal tumors, DSS treatment triggered multifocal tumors in the 
large intestine of Apc-mutant animals (Figure 1B-C, Table 2). DSS is known to induce 
inflammation mainly in the coecum and colon-rectum, i.e. the anatomical sites where 
most tumors were observed (Figure 1B-C, Table 2). No significant difference was 
observed in tumor multiplicity between wild type and villin-KRASV12G transgenic 
genotype duo-
denum
jejunum ileum coecum proximal 
colon
distal 
colon
rectum
wild type 0 0 0 0 0 0 0
villin-KRASV12G 0 0.08 ± 
0.08
0.08 ± 
0.08
0 0.08 ± 
0.08
0 0
Apc1638N/+ 0.78 ± 
0.22
0.44 ± 
0.24
0 0 0 0 0
Apc1638N/+/
villin-KRASV12G
5.63 ± 
1.48
3.63 ± 
0.82
0 0 0.13 ± 
0.13
0 0.25 ± 
0.16
Table 1. Tumors multiplicity in untreated control mice (± s.e.m.)
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Figure 1. DSS-induced colorectal tumors in Apc1638N/+/villin-KRASV12G animals. (A) Treat-
ment scheme. Animals were subjected to two 4-day cycles of DSS water. (B-C) Average tumor 
multiplicity (± s.e.m.) in coecum, colon and rectum of DSS-treated mice (black bars) com-
pared to untreated controls (grey bars), shown for Apc1638N/+ (B) and Apc1638N/+/villin-KRASV12G 
animals (C). Significance was calculated employing two-tailed t-test. P-Values are displayed (* 
p < 0.05; ** p < 0.01; *** p < 0.001). (D) Average tumor multiplicity (± s.e.m.) in coecum, colon 
and rectum of DSS-treated mice, shown for wild type (grey bars), villin-KRASV12G (blue bars), 
Apc1638N/+ (red bars) and Apc1638N/+/villin-KRASV12G animals (green bars). Significance was cal-
culated employing two-tailed t-test. P-Values are displayed (* p < 0.05; ** p < 0.01; *** p < 
0.001). (E) Example of DSS-induced colonic tumors (arrows) in an Apc1638N/+/villin-KRASV12G 
mouse  (macroscopic picture and HE, 4x). (F) Example of rectal cluster of smaller tumors 
(boxed) in an Apc1638N/+/villin-KRASV12G mouse (macroscopic picture and HE, 4x).
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animals (Figure 1D). Among these animals tumor incidence was highest in the 
rectum (1.1 tumors ± 0.29 s.e.m. and ± 0.36 s.e.m. in wild type and villin-KRASV12G, 
respectively) (Table 2). Tumor multiplicity was significantly increased in Apc1638N/+ 
and Apc1638N/+/villin-KRASV12G animals especially in the coecum and rectum where, 
irrespective of the KRAS genotype, mice carrying the Apc1638N allele developed 
on average 3-4 tumors (Figure 1D). However, in the proximal (1.50 ± 0.45 vs. 0.46 
± 0.14) and especially in the distal colon Apc1638N/+/villin-KRASV12G mice showed a 
significantly higher tumor multiplicity than in Apc1638N/+ (4.33 ± 0.74 vs. 1.54 ± 0.42; 
p<0.05 and p<0.01, respectively) (Figure 1D and Table 2). Possibly, differential 
expression of the KRAS oncogene in these segments of the distal bowel is likely 
to affect tumor onset upon DSS-induced inflammation. Notably, DSS treatment did 
not significantly affect tumor multiplicities throughout the small intestine (Table 1-2), 
which is in agreement with the inflammatory nature of the mechanisms underlying 
tumor formation in the cecum and colon-rectum. 
The colorectal tumors we observed were of either flat (Figure 1E, arrows) or 
polyp-like morphology. Clusters of smaller rectal tumors were frequently observed 
in these animals (Figure 1F, box). Analysis of tumor size, determined by measuring 
the tumor diameter, revealed that DSS-treated Apc1638N/+/villin-KRASV12G animals 
had significantly larger lesions in the distal colon and rectum than Apc1638N/+ mice 
(p<0.001, data not shown). Pathological evaluation of routine histology revealed 
that colorectal tumors were either adenomas or adenocarcinomas, with the latter 
showing invasion into the submucosa. 
Apc LOH in DSS-induced colorectal tumors
The spontaneously developing aberrant crypt foci (ACF) previously observed 
in Apc1638N/+ animals were shown to retain wild type Apc protein expression which 
suggests that heterozygous Apc loss (i.e. before LOH of the wild type allele occurs) 
might suffice to initiate these precancerous lesions 6. However, full-blown colorectal 
tumors arising in ApcMin/+ animals upon DSS treatment showed Apc LOH 11. 
genotype duo-
denum
jejunum ileum coecum proximal 
colon
distal 
colon
rectum
wild type 0.08 ± 
0.08
0 0 0.17 ± 
0.11
0 0.33 ± 
0.26
1.08 ± 
0.29
villin-KRASV12G 0.05 ± 
0.05
0 0 0.50 ± 
0.15
0.05 ± 
0.05
0.20 ± 
0.12
1.10 ± 
0.36
Apc1638N/+ 0.77 ± 
0.28
0.54 ± 
0.14
0.23 ± 
0.23
3.08 ± 
0.57
0.46 ± 
0.14
1.54 ± 
0.42
3.62 ± 
0.68
Apc1638N/+/
villin-KRASV12G
6.75 ± 
0.76
5.25 ± 
0.86
0.58 ± 
0.36
3.58 ± 
0.71
1.50 ± 
0.45
4.33 ± 
0.74
3.17 ± 
0.53
Table 2. Tumor multiplicity in DSS treated mice (± s.e.m.)
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To determine whether Apc LOH is also involved in the development of colorectal 
tumors in DSS-treated Apc1638N/+/villin-KRASV12G animals, we performed LOH analysis 
on isolated colorectal tumor material. Six out of 16 tumors (37%) showed loss of the 
wild type Apc allele, suggesting that apart from LOH, additional  2nd-hit mechanisms 
are possibly responsible for colorectal tumor formation in the DSS treated animals. 
To determine, if activation of Wnt signalling pathway is present in these tumors, we 
performed immunohistochemistry for ß-catenin (Figure 3). In total, 31 tumors and 
hyperplastic areas were scored for the presence of cytoplasmic or nuclear ß-catenin. 
While all tumors displayed clear cytoplasmic accumulation of ß-catenin, 10 out of 31 
tumors showed clear nuclear ß-catenin accumulation. 
Therefore we can conclude, that Wnt signalling pathway is activated within these 
tumors and another second hit mechanism than loss of the second Apc wildtype 
allele must be responsible for the formation of these tumors.
Colorectal tumors contain metaplastic Paneth cells
An interesting morphologic observation in inflammatory bowel disease is 
the appearance of Paneth cells in the colonic mucosa. While Paneth cells form 
an essential part of the small intestinal stem cell niche 12, they are normally not 
present in the mucosa of the colon. To check whether DSS-induced inflammation 
of the colorectum is also accompanied by Paneth cell metaplasia, we performed a 
thorough immunohistochemical characterization of the resulting tumors (Figure 2). 
All tumors were stained for the goblet cell marker PAS and for the enteroendocrine 
cell marker synaptophysin (Figure 2). In general, tumors appeared to be moderately 
differentiated and encompassed both goblet and the enteroendocrine cells (Figure 
2). Furthermore, we evaluated the presence of Paneth cells within the tumors and 
of Paneth cell metaplasia in the surrounding normal epithelium by lysozyme staining 
(Figure 2). Larger tumors from Apc1638N/+ and Apc1638N/+/villin-KRASV12G mice showed 
Figure 3. Activation of Wnt signalling pathway in DSS-induced colonic tumors. Activa-
tion of Wnt signalling as shown by employing IHC for ß-catenin. Accumulation of ß-catenin 
is observed in the cytoplasm and in some tumors also in the nucleus. Images were taken at 
20x (A) and 40x (B) magnification. 
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several lysozyme-positive cells, often clustered together (Figure 2). However, Paneth 
cell metaplasia was never observed outside of tumor lesions, within the normal-
appearing colonic mucosa. Notably, single isolated Paneth cells were observed in 
smaller rectal tumors (Figure 2, lowest panel). 
Figure 2. Immunohistochemical characterization of DSS-induced colorectal tumors. 
Colorectal tumors were stained for HE, periodic acid-Schiff (PAS), and the enteroendocrine 
cell marker synaptophysin (20x magnification). Metaplastic Paneth cells were detected by 
lysozyme staining. Tumors of every genotype (wild type, villin-KRASV12G, Apc1638N/+, and 
Apc1638N/+/villin-KRASV12G) are displayed. The lowest panel shows a typical rectal lesion from 
an Apc1638N/+ animal.
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DISCUSSION
In the current study, we describe the effect of dextran sodium sulfate (DSS) 
treatment on the tumor phenotype of the Apc1638N/+/villin-KRASV12G mouse model. 
While untreated Apc1638N/+ and Apc1638N/+/villin-KRASV12G animals only developed 
tumors in the small intestine as previously described 8, DSS-treated animals of both 
genotypes presented with adenomas and adenocarcinomas in the coecum and 
colon-rectum, in addition to the upper GI lesions whose multiplicity was apparently 
not affected by DSS. LOH of the wild type Apc allele is observed in the majority 
of intestinal Apc-mutant tumors in mouse and man. However, only 6 out of 16 
colorectal lesions induced by DSS treatment showed clear Apc LOH, implying that 
other 2nd hit mechanisms such as point mutations and/or epigenetic inactivation or 
even oncogenic mutations at other genes (e.g. ß-catenin) are likely to be involved 
in the development of these tumors 13. Notably, both, coecum and colorectal tumors 
contained next to goblet and enteroendocrine lineages also metaplastic Paneth cells. 
DSS is a non-genotoxic sulfated polysaccharide that chemically disrupts the 
natural barrier-function of the colorectal epithelium, causing crypt alteration, tissue 
ulceration and infiltration of neutrophils 14. The chronic inflammatory process is 
accompanied by constant tissue repair and elevated levels of mutagens such as 
reactive oxygen species (ROS) 15, both of which make cells highly susceptible to 
acquire somatic mutations. In this manner, DSS-induced chronic inflammation of 
the coecum and colorectum sustains the development of colorectal tumors. ACF, 
i.e. focalized clusters of aberrant crypts, which appear larger than normal crypts and 
with a thicker epithelial layer, have previously been described in Apc1638N/+ as well as 
in villin-KRASV12G mice 6,7. It is likely that the tumors reported here in the distal bowel 
of Apc1638N/+ and Apc1638N/+/villin-KRASV12G result from the progression of ACF to more 
dysplastic lesions and frank adenoma. 
DSS-induced chronic inflammation in mice serves as a useful model to study the 
pathogenesis of colorectal cancer in IBD patients. Crohn’s disease and ulcerative 
colitis together account for 1.4 million IBD patients in the US and 2.2 million patients 
in Europe 16. Patients with IBD are at increased risk of developing colorectal cancer 
and the mortality in those patients is higher than among sporadic cancer cases 17. 
IBD is characterized by a persistent inflammation of the colonic tissue, which is 
accompanied by tissue ulceration, loss of crypt architecture, infiltration of immune 
cells and constant tissue repair. A frequent and notable feature of chronic inflammation 
of the colon is represented by Paneth cell metaplasia 18,19. Paneth cells are terminally 
differentiated cells that form an essential part of the stem cell niche of the mouse 
small intestine 12, but are normally absent in the colorectum. Recently, we isolated and 
characterized quiescent Paneth-like cells in the mouse small intestine, which function 
as niche cells during tissue homeostasis but are activated to cycle following heavy 
radiation-induced tissue injury 20. Consequently the Paneth-like cells start dividing, 
de-differentiate and acquire expression of the intestinal stem cell marker Bmi1 20. 
Quiescent Paneth-like cells are thus able to act as stem cells once tissue injury is 
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induced and are likely to initiate the regenerative response of the epithelium20. The 
appearance of metaplastic Paneth cells in very early inflammation-induced colonic 
tumor lesions as shown in Figure 2 suggests a functional relevance of Paneth cells 
in the regenerative response to inflammation-induced tissue damage and in tumor 
development. Paneth cell metaplasia can also be observed in inflammation-related 
colorectal cancers in men 21. We suggest a model where quiescent stem cells of the 
colon are closely related to the quiescent Paneth-like cells of the small intestine. 
We hypothesize that chronic inflammation in the colon activates these quiescent 
resident stem cells, which increase their turnover rate to facilitate tissue repair 22. 
Because of their increased division rate, quiescent stem cells are more susceptible 
to acquire (epi)genetic alterations caused by the persistent mutagenic inflammatory 
environment, which result in tumor development22. Therefore, in this hypothetical 
scenario, quiescent colonic stem cells represent the cell of origin of inflammation-
related colorectal cancer (see also 22).    
MATERIALS AND METHODS
Animals
Male and female C57BL6/J wild type, villin-KRASV12G, Apc1638N/+ and Apc1638N/+/villin-
KRASV12G mice were bread and housed under standard IVC conditions. Experimental 
mice were administered 4% (w/v) DSS (MW 36,000-50,000; MP Biomedicals, 
Netherlands) in drinking water for four days, starting at approximately seven to eight 
weeks of age. This first cycle of DSS treatment was followed by 17 days of normal 
drinking water. In the pilot study, a second cycle of four days of DSS treatment did 
not increase mortality (data not shown), as previously described for ApcMin/+ mice 23. 
Therefore, a second four-day cycle of 4% DSS was added. To monitor the health 
status of the animals during and after DSS-treatment, body weight was measured 
three times per week. All experimental animals were analyzed seven weeks after 
completing the second cycle of DSS treatment, i.e. at an age of approximately four 
months. Animals of the control group did not receive any treatment, were housed 
under the same conditions, and analyzed at four months of age. 
Pathologic examination
At the time of analysis, the small intestine, coecum and colorectum were excised, 
rinsed in PBS and cut-open. The small intestine was subdivided into duodenum, 
jejunum and ileum. The colorectum was sub-divided into a proximal, middle and 
distal segment. Location and size of tumors were reported for small intestine, 
coecum and colorectum. ACF were stained as previously described 24. Tissues were 
fixed overnight in 4% PFA, and processed by standard procedures and embedded 
in paraffin. 
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Immunohistochemistry and Histology
Four µm sections were mounted on slides and stained by hematoxylin and eosin 
(HE) and periodic acid-Schiff (PAS) for routine histology. Immunohistochemistry 
was performed according to standard procedures using the following antibodies: 
Lysozyme (1:5000, A0099, Dako) and Synaptophysin (1:750, A0010, Dako). Signal 
detection was performed using Rabbit EnVision+ System-HRP (K4011, Dako) for 
Lysozyme and Synaptophysin. 
 
DNA isolation
Tumor tissue was macro-dissected from one 10 µm section of paraffin-embedded 
tissue and kept in a total volume of 100 µl Cell Lysis Solution (A7933, Promega) 
containing 5% Chelex (143-2832, BioRad) and Proteinase K (1.25 mg/ml) for over 
night at 60°C. Samples were spun down and 1 µl of DNA was used per PCR reaction. 
LOH analysis
PCR was performed using GoTaq (M830C, Promega) under standard conditions 
with an annealing temperature of 55°C and 28 cycles employing the following 
primers: ApcC2 (5’- GGAAAAGTTTATAGGTGTCCCTTCT-3’) together with FAM-
labelled ApcA3 (5’-FAM- CTAGCCCAGACTGCTTCAAAAT-3’) for detecting the wild 
type allele and Neo3 (5’- CACTTCATTCTCAGTATTGTTTTG-3’) together with FAM-
labelled ApcA3 (5’-FAM- CTAGCCCAGACTGCTTCAAAAT-3’) for detecting the 
mutant allele. The amplified PCR-product of the wild type allele has a length of 177 
bp, while amplified PCR product of the mutant allele has a length of 187 bp. Mutant 
and wild type alleles were amplified in separate PCRs and mixed in a 1:1 ratio for 
analysis. The quantities of the two different PCR products were measured on ABI 
3100 (Applied Biosystems) and analyzed employing Soft Genetics Gene Marker V 
1.70 software. 
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ABSTRACT
Mouse models carrying targeted mutations in the endogenous Apc gene develop 
multiple intestinal adenomas in addition to a broad spectrum of extra-intestinal 
manifestations. Here, we report the high incidence of multifocal stomach tumours 
in the Apc1638N/+ mouse model. As expected, the majority of the stomach tumours 
here analyzed show loss of the wild type Apc allele and, accordingly, b-catenin 
accumulation in the cytosol and nucleus. 
The newly characterized gastric tumours are of the intestinal type and of rather 
heterogeneous cellular composition with differentiated cell lineages occurring 
in different tracts of the digestive system including Paneth cell and squamous 
epithelium. Notably, the Apc1638N/+ gastric tumours encompass a subpopulation of 
cells expressing a recombinant villin promoter previously shown to mark quiescent 
stem cells in the mouse stomach. We also report that the endogenous villin gene is 
expressed in the normal epithelium lining the mouse stomach and in particular in the 
isthmus and the lower third of the glands where cycling and more quiescent stem 
cells are known to reside. Hence, Apc1638N/+ develop mixed-lineage stomach tumours 
which will serve as in vivo tool for cell-of-origin and cancer stem cells studies in 
gastric cancer. 
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INTRODUCTION
Notwithstanding the worldwide decline in its prevalence due to dietary changes 
(i.e. lowering of salt intake and the availability of fresh fruits and vegetables throughout 
the year), stomach cancer still represents the 4th most common type of cancer with 
an incidence of 7.8% throughout the general population, and the second leading 
cause of cancer-related death with a mortality of 9.7%. Also, Helicobacter pylori 
infection plays an important aetiological role as it results in chronic gastritis and 
intestinal metaplasia, an important precursor lesion of tumours of the stomach 1,2.
According to the Laurén histological classification, human gastric tumours can 
be subdivided into those of the intestinal and the diffuse type 3. Intestinal gastric 
cancers form recognizable glands and range from well- to moderately- differentiated 
tumours 2. They usually arise in association with long-lasting H. pylori infections 
and on a background of intestinal metaplasia. It has been proposed that the initial 
inflammatory lesion predisposes and progresses through a series of stages to 
intestinal metaplasia and gastric carcinoma 4. Diffuse gastric cancer consists of 
dispersed or poorly cohesive cells diffusely infiltrating the gastric wall with little or no 
gland formation. 
Although the majority of gastric carcinomas are sporadic, genetic susceptibility 
accounts for approx. 10% of the cases 5, mainly in the setting of hereditary, autosomal 
dominant conditions such as Lynch syndrome (HNPCC; due to germline mutations 
in mismatch repair genes) 6 and familial adenomatous polyposis (FAP; due to APC 
mutations) 7 for the intestinal type, and hereditary diffuse gastric carcinoma (HDGC; 
due to E-cadherin (CDH1) mutations) 8,9 for the diffuse type. 
FAP, an autosomal dominant hereditary condition mainly characterized by 
adenomatous polyps distributed throughout the distal colon, is caused by germline 
nonsense mutations in the APC tumour suppressor gene 10-12. Apart from the colonic 
polyposis, FAP patients have been shown to be predisposed to a broad spectrum 
of extra-colonic manifestations among which a common precursor of gastric cancer, 
namely fundic gland polyps 13, i.e. hyperplastic lesions with limited malignant potential. 
However, FAP patients have been reported with fundic gland polyps developing into 
dysplasia and carcinoma 14.
In order to model FAP and colon cancer in general, several Apc-mutant mice 
have been generated and characterized for their tumour phenotype 15. Notably, these 
mouse models mainly develop multiple adenomas in the upper intestinal tract with very 
few, if any, in the distal bowel. Also, the observed high multiplicity of small intestinal 
adenomas affects the general fitness and viability of most Apc-mutant models which 
precludes their natural development into malignant lesions 15. However, in addition to 
their intestinal phenotype, Apc-mutant mice have been reported to develop tumours 
in other organs reminiscent of the extra-colonic manifestations observed in FAP like 
gastric adenomas and desmoid disease in the ApcMin/+ and Apc1638N/+ models 16-18. 
Apc1638N/+ represents a unique preclinical model for attenuated forms of FAP as it 
develops only few (4-5) upper intestinal adenomas arising with delayed onset (6-9 
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months), thus allowing for a longer life span in these animals 19. Accordingly, intestinal 
Apc1638N/+ adenomas appear to evolve into adenocarcinomas in mice older than one 
year of age 17,19. Furthermore, Apc1638N/+ mice present with stomach tumours, the 
multiplicity of which can be modulated in a genetic background heterozygous for a 
targeted E-cadherin (Cdh1) null allele 18. 
The stem cell niche of the epithelium lining the stomach encompasses both 
cycling and quiescent stem cells mainly localized in the antrum on the lesser 
curvature, a common site for gastric tumours in man 20. Whereas the cycling Lgr5+ 
stem cells are thought to be responsible for daily tissue turnover 21, their quiescent 
counterpart seems to become active upon tissue injury possibly underlying the 
regenerative response 22. Tissue-specific stem cells are thought to represent the cell 
of origin of epithelial cancer, as recently and elegantly shown for mouse intestinal 
adenomas arising upon loss of Apc function in Lgr5+ cycling stem cells23. Throughout 
the digestive tract, a scenario can be envisaged with cycling stem cells representing 
the cell of origin in the majority of sporadic cancers, whereas their more quiescent 
equivalents are likely to play an analogous role in cancers arising in individuals 
affected by chronic inflammatory conditions such as H. pylori-driven gastritis, Crohn’s 
disease and ulcerative colitis 24. In the mouse stomach, indeed both cycling 21 and 
more quiescent 22 stem cells have been identified which are likely to play rate-limiting 
roles in gastric cancer onset and growth 20.
Here, we thoroughly characterized stomach tumours arising in aged Apc1638N/+ 
animals. Notably, the heterogeneous and mixed-lineage composition of these 
stomach lesions encompassing intestinal (Paneth cell) and squamous metaplasia 
together with gastric cell types and clusters of quiescent stem-like cells make them 
an interesting model to study cell of origin and cancer stem cells in Wnt-driven gastric 
tumorigenesis. 
RESULTS
Apc1638N/+ animals develop stomach tumours with late onset
To study the prevalence of stomach tumours in the Apc1638N/+ mouse model, we 
first analysed a group of animals of mixed genetic background (C57BL6/J and CD1) 
at a mean age of 519 days (n=8) (Table 1). These mice were found to carry an 
average of 5.6 (±0.6 s.e.m.) tumours of variable size mainly located in the distal part 
of the stomach. Younger Apc1638N/+ animals (220 days) on the same mixed genetic 
background revealed a comparable number of gastric tumours though smaller in 
size (Table 1).
To exclude that the observed gastric tumour phenotype is related to the specific 
genetic background of these animals, 10 inbred C57BL6/J Apc1638N/+ animals (age 
248 days) and 14 wild type controls (age 257 days) were analysed for the presence of 
stomach tumours. While none of the control animals showed tumours in the stomach, 
an average of 3.2 (±0.8 s.e.m.) tumours were observed in animals of the Apc1638N/+ 
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genotype. Hence, in agreement with previous reports in the same and other Apc-
mutant mice 16,18, Apc1638N/+ animals develop stomach tumours with a delayed onset 
though similar multiplicities as the previously described small intestinal lesions 15,19. 
Multiple polypoid lesions focally expanding into the duodenal mucosa were also found 
in the stomach of Apc1638N/+ mice just proximal to the gastroduodenal junction. These 
were sessile and characterized by suprabasal proliferation of dysplastic epithelial cells 
with an intestinal phenotype including undifferentiated cells as well as goblet cells, 
enterocyte-like cells, endocrine (synaptophysin positive), and Paneth cells. Often, 
the basal part of the gastric glands was still intact. The polarity of the neoplastic cells 
was usually maintained, except in focal areas, where nuclear pleomorphism was 
more marked and cribriform architecture occurred. Mitotic activity was significant, as 
also shown by Ki-67 with a growth fraction of up to 30% of the lesional epithelial cells 
(data not shown). The latter were interpreted as invasive into the lamina propria. 
These lesions were diagnosed as tubular adenomas of intestinal type, mostly of low 
grade dysplasia but focally high grade up to intramucosal carcinoma.
Genetic 
background
Genotype No. studied Mean age No. of tu-
mors
Tumor size 
(mm3)
C57BL6/J // 
CD1
Apc1638N/+ 8 519 days 5.6 ± 0.6 14.2 ± 6.7
C57BL6/J // 
CD1
Apc1638N/+ 12 220 days 3.3 ± 0.8 5 ± 0.8
C57BL6/J Apc1638N/+ 10 248 days 3.2 ± 0.8 8 ± 1.1
C57BL6/J wild type 14 257 days 0 0
Table 1. Stomach tumour incidence in Apc1638N/+ mice
Figure 1. Representative results of Apc loss of heterozygosity (LOH) (A) and ß-catenin 
IHC analysis (B-C) of Apc1638N/+ stomach tumours (20x and 60x magnification, respectively).
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LOH of the wild type Apc allele earmarks the vast majority of Apc1638N/+ gastric 
tumours
As previously shown for all Apc-mutant mouse models 15 and in hereditary and 
sporadic colon cancer patients 25, loss or mutation of the wild type Apc/APC allele 
represents the rate-limiting event for tumour formation. Accordingly, ApcMin/+ mice 
develop multiple adenomas in the stomach, which are characterized by loss of 
heterozygosity of the wild type Apc allele and activated Wnt signalling 16. 
To determine whether Apc LOH is also involved in the development of gastric tumours 
in Apc1638N/+ animals, we performed LOH analysis on macrodissected gastric tumours 
by semi-quantitative PCR. Ten out of 18 tumours (56%) showed unequivocal loss of 
the wild type Apc allele (Figure 1A). These percentages are similar to those observed 
during previous LOH studies of intestinal tumours from Apc1638N/+ mice on a mixed 
genetic background (64%) 26. Accordingly, immunohistochemical (IHC) analysis 
revealed that the majority of the Apc1638N/+ stomach tumours show heterogeneous 
patterns of b-catenin cytosolic and nuclear accumulation (12 out of 17; Figure 1B-C), 
similar to what is observed in Apc-mutant intestinal tumours in man and mouse 27. 
Apc1638N/+ stomach tumours are of the intestinal-type with multiple gastric cell 
lineages and areas of Paneth cell and squamous metaplasia.
To characterize the nature of the Apc1638N/+ stomach tumours, we performed 
histological and IHC analysis in inbred C57BL6/J background (Figure 2). 
In the normal stomach epithelium, 2 different mucus producing cells are present, 
namely surface pit and mucus neck cells. The pit cells produce insoluble mucus, 
which can be histochemically stained by the periodic acid Schiff (PAS) method. 
In wild type animals, the luminal part of the gastric epithelium is covered by this 
dense mucus (Supplementary Figure 1C-D). All Apc1638N/+ tumours analysed showed 
positive staining for PAS (Figure 2D-F). However, the percentage of PAS-producing 
cells varied among tumours and mucus-producing cells were heterogeneously 
distributed within different tumour areas. 
Mucus neck cells specifically express trefoil factor 2 (TFF2) in their mucin granules. 
These cells secrete soluble mucus thought to play a role in the regulation of gastric 
acid secretion. In wild type pyloric epithelium, mucus neck cells reside in the base 
of the pyloric units (Supplementary Figure 1E-F) and secrete the TFF2 containing 
mucus into the gastric ducts. However, it has been shown that, in gastric cancer, 
cytoplasmic TFF expression is a marker of tumour metastasis and its presence is 
associated with poor prognosis 28. TFF2 was heterogeneously expressed in Apc1638N/+ 
tumours both in the cytoplasm as well as in the membrane of cells (Figure 2G-I). 
To analyse enteroendocrine differentiation within Apc1638N/+ gastric tumours, 
we employed synaptophysin as a generic lineage-specific marker. In wild type 
animals, these cells are present in the glands of the normal pyloric antrum as a 
scattered population in the basal region of the units (Supplementary Figure 1G-
H). Enteroendocrine cells were present in all tumours in varying numbers and 
densities (Figure 2J-L), sometimes scattered and in some cases in clusters. To 
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Figure 2. Histopathological analysis of Apc1638N/+ stomach tumours. Two stomach tumours 
located in the pyloric antrum (left panel, 10x magnification) and in the pylorus (middle, 10x 
and right panel, 40x) were characterized by HE (A-C), PAS (D-F), TFF2 (G-I), synaptophysin 
(J-L), gastrin (M-O), lysozyme (P-R), the proliferation marker ki-67 (S-U) and the intestinal 
enterocyte differentiation marker villin (V-X). The right panel depicts a higher magnification 
(40x) of the middle panel.
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assess the nature of the enteroendocrine cells found in the tumours, gastrin and 
somatostatin staining was also performed. These hormones are secreted by G- 
and D-cells respectively, the two main enteroendocrine cell types in the epithelium 
of the pyloric antrum (Supplementary Figure 1I-J and K-L, respectively). Both cell 
types were extremely rare within the stomach tumours, indicating that the majority of 
enteroendocrine cells in Apc1638N/+ gastric tumours do not belong to the G- or D-cell 
type (Figure 2M-O, gastrin; somatostatin not shown). 
Lysozyme staining was employed to assess the presence of Paneth cell differentiation. 
Paneth cells normally reside in the lower third of crypts throughout the small intestine 
and are part of the innate response to infectious agents. According to the Laurén 
classification of gastric tumours, intestinal differentiation in gastric cancer labels 
tumours of the intestinal type 3. In wild type pyloric mucosa, only rare and weakly 
stained lysozyme-positive cells were observed (Supplementary Figure 1M and 1N, 
Supplementary Figure 1. Expression pattern of differentiation markers in the stomach 
of wildtype animals. (A,B) HE. (C,D) Histochemistry for PAS marking pit cells. Immunochis-
tochemistry was performed for TFF2 (E,F, mucous neck cells), synaptophysin (G,H, enteroen-
docrine cells), gastrin (I,J G-cells), somatostatin (K,L D-cells), lysozyme (M,N, Paneth cells) 
and the proliferation marker ki67 (O,P). In wild type pyloric mucosa, only rare and weakly 
stained lysozyme-positive cells were observed likely to represent cross-reacting stromal mac-
rophages (N, arrow).
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arrow), likely to represent cross-reacting stromal macrophages. In contrast, in approx. 
95% (22/23) of the Apc1638N/+ animals analyzed, we found tumours that harbour cells 
with strong cytoplasmatic lysozyme staining (Figure 2P-R). Notably, tumours of the 
pyloric sphincter, i.e. located in the most distal part of the stomach and extending in 
part to the proximal intestine, invariably contained lysozyme positive cells (data not 
shown). 
Next, we analysed cell proliferation in Apc1638N/+ tumours by Ki-67 IHC. Within the 
normal pyloric glands, proliferating cells were found only in the basal side of the 
glands (Supplementary Figure 1O-P). In tumours, proliferating cells were generally 
concentrated towards the luminal side (Figure 1S-U). 
Histological evaluation of Apc1638N/+ stomach tumours from very aged animals 
on a mixed C57BL6/J - CD1 genetic background (Table 1, 1st row, mean age 519 
days) showed squamous differentiation in small regions in approximately 50% of the 
lesions (Figure 3). IHC analysis with a number of markers specific for squamous cell 
lineages was carried out. CK-14 broadly marks squamous epithelia from different 
tissues whereas p63 is generally expressed in the basal layer of squamous epithelia. 
Both markers were expressed in the area of squamous differentiation in Apc1638N/+ 
tumours (Figure 3A-B). CK-6 marks squamous epithelium of the hair follicle type 
and was found to be expressed in a more patchy fashion within the squamous areas 
(Figure 3C). To confirm the loss of glandular epithelium in the squamous regions, 
IHC analysis of Troma-1 was performed. Troma1 is a marker of glandular epithelium 
and its absence could be confirmed in areas of squamous differentiation (Figure 3D). 
Overall, the data indicate that the stomach tumours found in Apc1638N/+ mice 
encompass multiple gastric- and intestinal-specific cell lineages with distinct Paneth 
cell and squamous differentiation.
Figure 3. Stomach tumours from Apc1638N/+ animals encompass areas of squamous dif-
ferentiation. IHC analysis with the squamous cell markers CK14 (A, 10x magnification) and 
CK6 (C, 10x), as well as with the basal cell marker p63 (B, 20x) confirm the presence of areas 
of squamous metaplasia within the stomach tumours. (D) IHC analysis of Troma-1 expres-
sion, a marker for glandular epithelium, was found to be negative in the squamous tumour 
areas (D, 10x).
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Apc1638N/+ stomach tumours encompass a population of quiescent, stem-like 
cells
Recently, the intestine-specific 12.4 kb villin promoter was found to be active in a 
rare subpopulation of gastric cells with multilineage potential 22. These stem-like cells 
are located in the antrum of the murine stomach, are quiescent, and become active 
and enter the cell cycle in situations of inflammatory challenge 22. Previously, our 
laboratory developed the villin-rtTA/TRE-H2B-GFP mouse model where the same 
12.4 villin promoter is employed to label epithelial cells in the intestinal tract in an 
doxycycline-inducible fashion 29. Accordingly, by administrating doxycycline in the 
drinking water of villin-rtTA/TRE-H2B-GFP mice, we are able to detect the quiescent 
stem cell in the stomach epithelium (Supplementary Figure 2G-H) 22,29. To determine 
whether these stem-like cells are also present in Apc1638N/+ stomach tumours, we bred 
Apc1638N/+ animals in the villin-rtTA/TRE-H2B-GFP background. Triple heterozygous 
mice were then aged and administered doxycycline-containing water for one week 
to induce H2B-GFP expression from the 12.4 kb villin promoter in the Apc-driven 
stomach tumours 29. Following doxycycline induction, animals were sacrificed and 
tumours analysed for the presence of GFP-expressing cells. GFP-positive nuclei 
were mainly scattered throughout the tumours as single, isolated positive cells with 
only few clusters (Figure 4A-B). Next, we used consecutive sections to characterize 
these alleged stem-like tumour cells for the expression of additional markers. 
Consecutive slides stained for GFP (Figure 4C) and villin (Figure 4D) reveal that the 
Supplementary Figure 2. Expression pattern of villin and the 12.4 kb Villin promoter in 
the duodenum and stomach of wildtype animals. IHC for villin in the duodenum (A,B,C) 
and the stomach (D,E,F). (G,H) IHC for GFP in stomach of VillinrtTA/H2B-GFP animals follow-
ing 7 days of doxycycline pulse showing expression of the 12.4 kb Villin promoter.
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Figure 4. GFP IHC analysis of stomach tumours from compound, doxycycline-treated 
Apc1638N/+/villin-rtTA/TRE-H2B-GFP mice. Consecutive tissue sections (C-D, E-G, H-I and 
J-K) were employed to determine expression of differentiation and proliferation markers by 
the GFP-positive cells. The following markers were employed: GFP (A,B,C,F,H,J); villin (D); 
ki67 (E); GFP and PAS (F); synaptophysin (G); TFF2 (I); lysozyme (K). Images were taken at 
40x magnification.
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12.4kb villin promoter expressing cells form a subpopulation of the gastric tumour 
cells, which express the mature villin protein. Consecutive slides stained for GFP 
(Figure 4F) and the proliferation marker Ki-67 (Figure 4E) confirmed that the 12.4 
kb villin-promoter expressing cells are not cycling. Double staining of GFP and PAS 
showed that the majority of H2B-GFP-positive tumour cells are mucus-secreting 
(Figure 4F). Also, tumour cells expressing the enteroendocrine differentiation marker 
synaptophysin did not overlap with the GFP-positive cells (Figure 4F-G). Evaluation 
of consecutively stained tissue sections (Figure 4H (GFP) and Figure 4I (TFF2)) 
showed that some H2B-GFP-positive tumour cells expresses trefoil factor 2.
Finally, lysozyme (Figure 4K), a marker of Paneth cell differentiation, was not 
expressed in H2B-GFP-expressing cells (Figure 4J). 
Taken together, the above results indicate that a subpopulation of tumour cells 
within Apc1638N/+ gastric tumours express the H2B-GFP marker from the 12.4 kb villin 
promoter, previously shown to identify a quiescent stem cell type in the stomach 
epithelium 22. These cells do not proliferate and do not express enteroendocrine 
differentiation markers. However, they partially produce mucin, as shown by PAS 
staining. Moreover, they are TFF2 positive, reported to represent a marker of tumour 
metastasis and poor prognosis 28
DISCUSSION
Patients affected by familial adenomatous polyposis (FAP), a hereditary 
predisposition to multiple colorectal polyps caused by germline mutations in the 
APC tumour suppressor gene, often develop extra-colonic manifestations including, 
among others, desmoids and tumours of the upper gastro-intestinal tract. Likewise, 
mouse models for FAP carrying targeted mutations at the endogenous Apc gene, 
develop a similar broad spectrum of extra-colonic tumour types and, somewhat 
paradoxically, very few, if any, colonic adenomas 15. 
Fundic polyps of the stomach are hyperplastic lesions with limited malignant 
potential 13 which are found in up to 50% of FAP patients 30,31. However, although 
FAP patients have been reported with fundic gland polyps developing into dysplasia 
and carcinoma 14, in general no excess risk for gastric cancer has been shown in 
FAP 7,32 with the only exception of Korean and Japanese polyposis patients (7- and 
3-fold increased risk, respectively), i.e. in geographic regions where gastric cancer 
is more common than in the West 33,34. 
Apc1638N/+ mice represent a valid model of attenuated FAP, as they develop a limited 
number of small intestinal adenomas which allow an extended life span when 
compared with more severe Apc-mutant models where the high adenoma multiplicity 
causes early morbidity and mortality 15. Accordingly, Apc1638N/+ mice develop extra-
intestinal manifestations such as desmoids, cutaneous cysts, and gastric tumours, 
which becomes apparent at later stages when compared with intestinal adenomas17,18. 
Here, we performed a thorough genetic and histological analysis of gastric tumours 
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arising in Apc1638N/+ and found that they are composed of mixed stomach- and 
intestine-specific cell lineages with squamous differentiation. Notably, the presence 
of this broad spectrum of differentiated cell types reflects different segments of the 
digestive tract: the oesophagus and forestomach represented by squamous cells 
(p63+, CK6+, CK14+); the stomach with pit (PAS+) and mucus neck cells (TFF2+); and 
the intestine with Paneth and enteroendocrine cells (lysozyme- and synaptophysin-
expressing, respectively). The observed heterogeneity of cellular types is likely to 
result from the known effects of constitutive activation of the Wnt signalling pathway 
on the self-renewal and differentiation capacity of gastro-intestinal stem cells 35. Also, 
it has been previously shown that, in the intestine, Apc mutations are capable of 
triggering adenoma formation only if they occur at the stem cell level, i.e. in Lgr5+ crypt 
base columnar cells, and not in more committed progenitor cells 23. In view of the fact 
that Lgr5+ stem cells have been identified also in the stomach 21, it is plausible that 
they also represent the cells of origin of the stomach tumours observed in Apc1638N/+. 
Here, Wnt activation will likely interfere with the normal differentiation program and 
give rise to Paneth cells and squamous cells in addition to the stomach-specific cell 
lineages.
Apart from the above mentioned Lgr5+ cycling stem cells, a quiescent stem cell type 
has been identified in a region included between the lower isthmus and the base of 
the glands. These quiescent SCs are mainly found on the lesser curvature of the 
antrum (only few in the corpus) and are earmarked by b-galactosidase expression 
driven by the 12.4 kb villin promoter 20,22. These cells are activated by inflammatory 
stimuli and can replenish entire gastric glands. By taking advantage of a transgenic 
mouse model developed in our laboratory in which the H2B-GFP marker protein is 
driven by the same 12.4 kb villin promoter 29, we have identified similar quiescent 
cells within Apc1638N/+  stomach tumours where they are scattered as single, isolated 
cells (Figure 4). These cells appear to be non-proliferating and to express mucin 
and TFF2, markers of mucus neck cells and, as expected by their 12.4 kb promoter 
activity, also villin. The latter can be interpreted as part of the intestinal character of the 
Apc1638N/+ stomach tumours. However, further villin IHC analysis of the normal gastric 
epithelium of the mouse revealed expression both at the luminal side (brush border) 
but also in the lower third of the glandular units overlapping both the isthmus and 
the lower gland where the quiescent stem cells are known to reside (Supplementary 
Figure 2D-H). This is also reminiscent of the expression pattern in the small intestine 
where villin was shown to be expressed not only in mature enterocytes but also in 
the lower third of the crypt where stem cells are localized (Supplementary Figure 
2A-C) 29,36,37.  Within Apc1638N/+ stomach tumours, these quiescent, stem-like cells also 
appear to be located within clusters of villin-expressing cells (Figure 4C-D) although 
only few of the villin-expressing tumour cells seems to co-express the H2B-GFP 
marker protein under the transcriptional control of the 12.4 kb villin promoter. At 
present, although the presence of these cells in Apc1638N/+ stomach tumours is of 
potential interest, it is not clear whereas they play any role in tumour maintenance, 
progression and invasion. Lineage tracing experiments with inducible Cre transgenic 
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mice under the control of the 12.4 kb villin promoter will help elucidating their alleged 
role as cancer stem cells and/or as cells of origin of these gastric tumours.
   
MATERIALS AND METHODS
Animals
Phenotypic analysis was performed in animals of both mixed (C57BL6/J and CD1) 
and inbred (C57BL6/J) genetic background as shown in Table 1. All animals were 
fed ad libitum and housed in SPF facilities. All animal experiments were performed 
according to institutional and national regulations. To check for the presence of 
villin-expressing cells within stomach tumours, Apc1638N/+ animals were bred with 
compound heterozygous villin-rtTA/TRE-H2B-GFP animals 29. Apc1638N/+/villin-rtTA/
TRE-H2B-GFP offspring were of mixed (C57BL6/J, FVB/N, CD1) genetic background 
and analysed at a median age of 385 days. One week before analysis, transgene 
expression was induced in compound animals by replacing normal drinking water 
with 5% sucrose water containing 2 mg/ml doxycycline (Sigma, D9891). Doxycycline-
containing water was changed every 2 days.
DNA isolation
Tumor tissue was macro-dissected from one 10 µm section of paraffin-embedded 
tissue and kept in a total volume of 100 µl Cell Lysis Solution (A7933, Promega) 
containing 5% Chelex (143-2832, BioRad) and Proteinase K (1.25 mg/ml) for over 
night at 60°C. Samples were spun down and 1 µl of DNA was used per PCR reaction. 
LOH analysis
PCR was performed using GoTaq (M830C, Promega) under standard conditions 
with an annealing temperature of 55°C and 28 cycles employing the following 
primers: ApcC2 (5’- GGAAAAGTTTATAGGTGTCCCTTCT-3’) together with FAM-
labeled ApcA3 (5’-FAM- CTAGCCCAGACTGCTTCAAAAT-3’) for detecting the 
wildtype allele and Neo3 (5’- CACTTCATTCTCAGTATTGTTTTG-3’) together with 
FAM-labeled ApcA3 (5’-FAM- CTAGCCCAGACTGCTTCAAAAT-3’) for detecting the 
mutant allele. The amplified PCR-product of the wildtype allele has a length of 177 
bp, while amplified PCR product of the mutant allele has a length of 187 bp. Mutant 
and wildtype alleles were amplified in separate PCRs and mixed in a 1:1 ratio for 
analysis. The quantities of the two different PCR products were measured on ABI 
3100 (Applied Biosystems) and analyzed employing Soft Genetics Gene Marker V 
1.70 software. 
Immunohistochemical Analysis
Mouse tissues were fixed in 4% paraformaldehyde (PFA) overnight, washed once 
in PBS and transferred to 70% ethanol (EtOH). Fixed tissues were embedded 
perpendicular to the mucosal surface in paraffin; 4 µm sections were cut and 
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mounted on a glass slide. Routine histology was performed for haematoxylin and 
eosin (H&E) staining. Otherwise, dried sections were deparaffinised in xylene 2x for 
5 min., rehydrated 1x in 100%, 1x 70% and 1x in 50% ethanol for at least 1 min and 
washed in PBS + 0.05% Tween. With the exception for PAS staining (see below), 
an antigen-retrieval step was performed according to the optimized protocol for each 
antibody. For lysozyme, Troma-1 and CK-6, staining slides were incubated for 5 min 
(CK-6 for 10 min) in 0.1% pronase solution at 37°C. For TFF2, GFP, synaptophysin 
and gastrin staining heat retrieval was performed for 10 min. in citrate solution (pH 
6). For Ki-67, CK-14, p63 and somatostatin staining heat retrieval was performed for 
10 min. in Tris-EDTA solution (pH 8). Endogenous peroxidase was inactivated by a 
10 min. incubation step in 1.5% H2O2/PBS solution in PBS. A 30 min. pre-incubation 
step in 5% non-fat dry milk in PBS was followed by overnight incubation at 4°C with 
the primary antibody. Sections were stained with the Envision HRP-ChemMate kit 
(DAKO). For Ki-67 and Troma-1 an incubation step with a secondary goat anti-rat 
antibody (HRP labeled) was needed. For PAS staining slides were prepared using 
the periodic acid-Schiff staining system (DAKO). 
The following dilutions were employed for the primary antibodies: lysozyme 1:10000 
(DAKO), CK-6 1:5000 (Covance Eurogentec), TFF2 1:1500 (ProteinTech Group), 
GFP 1:600 (Invitrogen), synaptophysin 1:750 (DAKO), gastrin 1:750 (Novus 
Biologicals), somatostatin 1:200 (Abnova), Ki-67 1:200 (DAKO), CK-14 1:10000 
(Covance Eurogentec), villin 1:1000 (generous gift from Monique Arpin and Sylvie 
Robine, Paris), p63 1:1500 (DAKO) and Troma-1 1:100 (Developmental Studies 
Hybridoma Bank). The villin polyclonal antibody here employed was raised against 
human villin as previously described 37.
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ABSTRACT
According to the cancer stem cell model, tumors are heterogeneous and are 
characterized by a hierarchical structure reminiscent of that of normal tissues with 
stem cells co-existing next to transit amplifying and fully differentiated cell types. Adult 
stem cell niches, such as the hematopoietic stem cell niche or the intestinal crypt, 
are often characterized by a dichotomy of cycling and quiescent stem cells. Recent 
studies on ovarian cancer and some leukemias indicate that this dichotomy of cycling 
versus quiescent stem-like cells may also be present within malignancies. Here, 
we describe the isolation and characterization of a quiescent, label-retaining cells 
(LRCs) in intestinal adenocarcinomas from Apc1638N/+/villin-KRASV12G mice, These 
tumor LRCs are undifferentiated epithelial cells, earmarked by low expression levels 
of epithelial to mesenchymal transition (EMT) genes such as Slug, Snail, Twist1 and 
Zeb1. The quiescent state of tumor LRCs seems to be maintained by high expression 
levels of the cell cycle inhibitor p21. Notably, the majority of tumor LRCs falls within 
the CD24hiCD29+ subpopulation of tumor cells previously shown to be enriched in 
cancer stem cells (CSCs). Nevertheless, tumor LRCs did not have tumor-initiating 
properties when injected subcutaneously into NOD-SCID mice. Given their quiescent 
nature, it is plausible that the tumor LRCs require specific niche signals in order to 
be activated, enter the cell cycle and recapitulate tumorigenesis. Alternatively, they 
may represent the niche of cycling CSCs, analogous to the previously reported role 
of Paneth-like, label-retaining cells in supporting Lgr5+ stem cells in the normal crypt. 
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INTRODUCTION
Colorectal cancer is the third most common cancer in men (10%) and the second 
most common type of cancer in women (9.4%) worldwide 1. It accounts for 8% of 
all cancer deaths and is therewith the fourth most common cause of death from 
cancer in the world 1. Generally, colorectal cancer is more frequent in industrialized 
countries, which reflects the impact of dietary habits on the development of the 
disease. Next to environmental factors, colorectal cancer can also be caused by 
genetic traits such as Lynch syndrome (HNPCC, hereditary nonpolyposis colorectal 
cancer) and FAP (familial adenomatous polyposis). FAP patients develop a high 
multiplicity of polyps in the colorectum, some of which progress towards colorectal 
cancer with time. FAP is caused by a genetic mutation of the APC-gene, leading to 
the transcriptional activation of Wnt signaling pathway. 80% of all colorectal cancers 
display an early functional inactivation of APC, pointing to an important role of this 
pathway during colorectal carcinogenesis 2. 
Mouse models carrying germline mutations of the homologous mouse Apc 
gene, e.g. ApcMin/+ and Apc1638N/+, serve as essential tools towards the elucidation 
of the cellular and molecular mechanisms underlying intestinal cancer onset 
and progression towards malignancy 3-5. These animals develop multiple polyps 
throughout the small intestinal tract, although they rarely present with colonic tumors 
in sharp contrast with the FAP phenotype. Previously, we published a novel mouse 
model obtained by breeding Apc1638N/+ mice with a transgenic model expressing an 
oncogenic KRAS allele, namely Apc1638N/+/ villin-KRASV12G 6. These animals develop 
10 times more small intestinal tumors than Apc1638N/+ mice, and an accelerated 
adenoma – carcinomas progression 6. Moreover, disseminated tumor cells were 
detected in the liver of these animals, thus indicating the metastatic potential of the 
primary intestinal cancers in these compound animals 6.
According to the cancer stem cell model, tumors are heterogeneous and share 
the hierarchical structure of normal tissues, with stem-like cells co-existing next to 
transit amplifying and fully differentiated cell types. Following this parallel between 
normal and cancer stem cell niches, it is plausible to think that the dichotomy of 
cycling and quiescent stem cells observed in many normal tissues also characterizes 
epithelial malignancies. While cycling stem cells are believed to be responsible for 
normal tissue turnover, their quiescent counterpart is only activated upon tissue 
injury and responsible for tissue repair (reviewed in 7). Quiescent cancer stem 
cells have already been isolated from ovarian 8,9 and pancreas adenocarcinomas 
10, melanoma11, breast cancer 12, hepatocellular carcinoma 13, and acute myeloid 
leukemia (AML) 14. 
Here, we describe the isolation and characterization of a quiescent, label-
retaining population of intestinal tumor cells from Apc1638N/+/villin-KRASV12G intestinal 
adenocarcinomas. 
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RESULTS
Identification of intestinal label-retaining tumor cells (tumor LRCs)
We employed the method originally developed by Elaine Fuchs’ laboratory to 
isolate quiescent skin cells 15. We bred a transgenic model encompassing the tet 
repressor-VP16 cassette driven by the ubiquitously expressed hnRNPA2B1 promoter 
(hnRNPrtTA) 16 with transgenic animals carrying the H2B-GFP expression cassette 
controlled by a tetracycline-responsive regulatory element 15 (Figure 1A). Compound 
Figure 1. Isolation of tumor label-retaining cells (tumor LRCs) from hnRNPrtTA/H2B-
GFP/Apc1638N/+/villin-KRASG12V adenocarcinomas. (A-B) In the presence of doxycycline 
(pulse), H2B-GFP expression is driven by the ubiquitous hnRNPrtTA-promoter. (B) IHC analy-
sis of GFP expression (brown) showing a patchy distribution of positive nuclei following doxy-
cycline pulse. (C) After doxycycline withdrawal (chase), H2B-GFP expression is interrupted. 
(D) Only few, slow-cycling tumor label-retaining cells retain nuclear H2B-GFP, as shown by 
IHC analysis of GFP expression (brown) following a chase period of 14 days. (E) Experimen-
tal scheme: Single tumors were isolated, digested into a single cell suspension and injected 
subcutaneously into NOD-SCID animals. Recipient mice were constantly pulsed until tumor 
became palpable. Doxycycline was then withdrawn, and mice chased for two weeks.
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transgenic animals were then bred with our Apc1638N/+/villin-KRASV12G mouse model for 
intestinal tumourigenesis 6. Animals with the four-genotype combination hnRNPrtTA/
H2B-GFP/Apc1638N/+/villin-KRASG12V developed multiple small intestinal tumors at an 
age of four to six months. These tumors encompass all differentiated cell lineages 
but are in general less differentiated than the adjacent normal tissue. 
Upon doxycycline administration in the drinking water (pulse), compound animals 
showed nuclear H2B-GFP labeling of the normal intestinal epithelium, stroma and 
tumor cells, as expected. However, the H2B-GFP labeling was patchy within the 
intestinal tumors (Figure 1B). Following doxycycline withdrawal (chase), expression 
of the H2B-GFP fusion protein is silenced (Figure 1C) and, due to the high cell 
turnover rate, labeled cells are progressively cleared. Only few infrequently dividing, 
label-retaining cells (tumor LRCs) are retained within these tumors for up to 2-3 
weeks (Figure 1D). Tumor LRCs were more frequently located close to the stromal 
compartment and were often clustered together. 
Since tumors represent clonal outgrowths, ideally each should be analyzed 
separately. However, this approach did not yield sufficient cell numbers for analysis 
and sorting by FACS. Hence, an additional transplantation step was added to the 
procedure, as shown in Figure 1E. Tumors were isolated from the mouse small 
intestine, digested into single cell suspensions and injected subcutaneously in 
distinct sites of the flanks of NOD-SCID recipient animals. Following transplantation, 
recipient mice were constantly pulsed by administering doxycycline in their drinking 
water. Once tumors became palpable, doxycycline treatment was stopped; recipients 
were then chased (i.e. no dox) for 12 to 14 days and analyzed. 
Immunohistochemical characterization of tumor LRCs
Subcutaneously grown tumors showed a similar differentiation pattern as the 
primary tumors (Figure 2). Tumor LRCs were of epithelial as well as stromal origin. 
While stromal tumor LRCs were evenly distributed throughout the tumor, epithelial 
tumor LRCs appear to be distributed in clusters. Immunohistochemistry (IHC) on 
consecutive tumor sections was employed to characterize the population of tumor 
LRCs for the expression of the goblet cell marker PAS, the Paneth cell marker 
lysozyme, and the marker of enteroendocrine cells synaptophysin. As shown in 
Figure 2, the majority of tumor LRCs appears to be negative for the above markers. 
Only very few tumor LRCs stained positive for the goblet cell marker PAS (Figure 2D, 
arrow and 2F, arrow), the Paneth cell marker lysozyme (Figure 2F, arrowhead), and 
the enteroendocrine cell marker synaptophysin (Figure 2E, arrow). 
Overall, these data indicate that tumor LRCs do not express markers of intestinal 
differentiation and are distributed in clusters within the tumors. 
Characterization of tumor LRCs for the cell surface markers CD24/CD29
Recently, we have identified a subpopulation from Apc1638N/+/villin-KRASV12G 
intestinal tumors earmarked by expression of the CD24hiCD29+ surface antigen 
markers and enriched in cancer stem cells (CSCs) 17. To assess whether tumor 
124
Chapter 6
Figure 2. Characterization of tumor LRCs by IHC. IHC analysis was performed on con-
secutive sections of pulsed/chased tumors grown subcutaneously. (A-F) IHC analysis of GFP 
(tumor LRCs, brown, far left and right column), the goblet cell marker PAS (red, far left), the 
Paneth cell marker lysozyme (brown, left), and the enteroendocrine cell marker synaptophy-
sin (brown, right). Most tumor LRCs (GFP, brown) apear not to express these markers of in-
testinal differentiation. Only few, isolated tumor LRCs appear to express PAS (D and F, arrow), 
lysozyme (F, arrowhead) or synaptophysin (E, arrow).
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Figure 3. FACS analysis of subcutaneously grown tumors. (A) Gating strategy applied 
to obtain single live epithelial cells. Gating for cells and cell clusters was implemented by 
employing side scatter area (SSC-A) and forward scatter area (FSC-A) (far left). Hoechst 
exclusion served as a criterion for live cells (left). Single cells were obtained using a two-step 
strategy on SSC-H (height) and SSC-W (width) for cell granulosity (right), and on FSC-H and 
FSC-W for cell size (far right). (B,D) Single live epithelial cells from subcutaneously grown 
tumors following 7 days of doxycycline pulse were analyzed by FACS for the expression of 
CD24 and CD29 (B, left) and for GFP (B, middle). H2B-GFP labeled tumor cells (B, right) 
were subsequently analyzed for the expression of CD24 and CD29 (B, right). (C,E) Single 
live epithelial cells of subcutaneously grown tumors were FACS-analyzed following 14 days of 
chase for the expression of CD24 and CD29 (C, left) and for GFP (C, middle). H2B-GFP tumor 
label-retaining cells (C, right) were subsequently analyzed for the expression of CD24 and 
CD29. (D-E) Quantification of the analysis performed in B and C. Displayed are the fractions 
each subpopulation (GFP+ and CD24hiCD29+) forms within a population (Lin- and GFP+) in 
percent following doxycycline-pulse (D) and 14 days of chase (E). The tumor LRC-population 
is significantly enriched in CD24hiCD29+ cells (E, *** p<10e-9).
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LRCs represent a subpopulation of these CSCs, we compared by CD24/CD29 FACS 
analysis H2B-GFP labeled tumor cells after doxycycline pulse with tumor LRCs 
sorted after a chase period of 14 days. Tumor cell suspensions were depleted of 
blood lineage cells that are positive for CD31, CD45 and Ter-119 (Lin-). FACS single 
cell gating was applied according to standard procedures using cell granulosity (side 
scatter, SSC) and cell size (forward scatter, FSC) as shown in Figure 3A. Single 
live epithelial cells were analyzed following doxycycline pulse (Figure 3B and 3D) 
and after 14 days of chase (Figure 3C and 3E). At both time points, live epithelial 
cells show the same distribution as bulk tumor cells when analyzed for CD24 and 
CD29 expression (Figure 3B-C, left). Although not all epithelial cells are GFP-labeled 
during pulse (Figure 3B, middle), the H2B-GFP cell population harbors the same 
CD24 and CD29 distribution at pulse (Figure 3B, right) as the total population of 
tumor epithelial cells (Figure 3B, left). Therewith we can conclude that labeling 
with the ubiquitously expressed hnRNPrtTA promoter occurs in an unbiased way 
for the cell surface markers CD24 and CD29 (for quantification see Figure 3D). All 
samples analyzed after 14 days of chase showed on average a 4.6 fold enrichment 
in CD24hiCD29+ cells in the tumor LRC population when compared to the Lin- bulk 
of tumor cells (Figure 3E, 68.4% versus 15.0%, p<10e-9). Hence, we can conclude 
that the majority of tumor LRCs forms a subgroup of the previously characterized 
CSC-enriched CD24hiCD29+ cell population. 
Expression of proliferation, stem and cancer stem cell markers in tumor LRCs
Subsequently, we characterized these tumor LRCs by means of quantitative PCR 
for the expression of markers of proliferation and stemness (Figure 4). To this aim, 
bulk tumor cells (Lin-, Figure 4, grey), GFP+CD24hiCD29+ tumor LRCs (Figure 4, 
green) and their GFP-CD24hiCD29+ counterpart (Figure 4, red) were isolated form 
five subcutaneously grown tumors after a two weeks chase. All expression levels 
were normalized to the housekeeping gene b-Actin. In Figure 4, the average ratios 
(±s.e.m.) of the relative gene expression levels of tumor LRCs (GFP+CD24hiCD29+, 
green) compared to either bulk tumor cells (Lin-, Figure 4, left panel, grey) or to their 
GFP-CD24hiCD29+ counterpart (Figure 4, right panel, red) are shown. Tumor LRCs 
retained nuclear H2B-GFP over a period of two weeks and are thus expected to 
express only low levels of proliferation markers. As shown in figure 4, tumor LRCs 
express levels of the cell cycle gene CyclinD1 that are comparable to the total 
population of epithelial cells. However, tumor LRCs are characterized by significantly 
higher expression levels of the cell cycle inhibitor Cdkn1 (Figure 4A), even when 
compared to their GFP-CD24hiCD29+ counterpart (p<0.05). Cell cycle progression is 
thus possibly inhibited through Cdkn1 expression among tumor LRCs. 
In human ovarian cancer, a subpopulation of CD24 expressing cells is characterized 
by a lower proliferation rate but higher tumorgenicity than the total population of 
tumor cells 9. These cells expressed significantly higher levels of stemness genes 
such as Bmi1 and Oct3/4. Our previous study also supports the fact that high CD24 
expression levels enrich for cancer stem cells 17. As tumor LRCs fall within this 
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previously described CD24hiCD29+ population, they display characteristically high 
RNA levels of Cd24a when compared to the total population of epithelial cells (Figure 
4B, left, p<0.05). 
In the small intestine, various markers for tissue stem cells have been described. 
High Lgr5 expression levels mark a population of frequently cycling stem cells 18. 
Evidence suggests that these cells are the cells of origin of intestinal adenomas in 
Apc-driven tumorigenesis 19. Tumor LRCs express significantly higher levels of Lgr5 
than the Lin- cell population (Figure 4B, left, p<0.05). However, expression levels of 
the Lgr5 gene are comparable between GFP+CD24hiCD29+ and GFP-CD24hiCD29+ 
cells (Figure 4B, right). Thus, high levels of Lgr5 are mainly characteristic for the 
CD24hiCD29+ population, in agreement with our previous observations 17. 
Moreover, CD24hiCD29+ cells have increased levels of Wnt signaling 17. Axin2 
is a Wnt target gene and serves as a reliable readout for Wnt signaling activity. 
Tumor LRCs display significantly higher levels of the Wnt target Axin2 than the total 
population of tumor epithelial cells (Figure 4C, left, p<0.05). Again, Axin2 levels of 
tumor LRCs were comparable to those of their GFP-CD24hiCD29+ counterpart (Figure 
4C, right), confirming that high Wnt signaling activity is a general characteristic of 
CD24hiCD29+ tumor cells, i.e. undistinguishable between quiescent and cycling 
CSCs 17. Recent reports have shown that an intestinal stem cell signature is able to 
Figure 4. Characterization of tumor LRCs by qRT-PCR. Quantitative RT-PCR was per-
formed on CD24hiCD29+ tumor LRCs (green), epithelial Lin- tumor cells (grey), and GFP-
CD24hiCD29+ tumor cells (red). Displayed are average ratios (± s.e.m.) of CD24hiCD29+ 
tumor LRCs vs. epithelial Lin- tumor cells (left panel), and average ratios (± s.e.m.) of 
CD24hiCD29+ tumor LRCs compared to GFP-CD24hiCD29+ tumor cells (right panel). RT-
PCR analysis was carried out for the following genes: the cell cycle promoter and inhibitor 
Ccnd1 and Cdkn1, respectively (A); the Cd24a and the stem cell marker Lgr5 (B); for the Wnt 
target gene Axin2 (C); a panel of stem cell markers including Bmi1, Msi1, Tert, Prom1 (C); the 
EMT markers Twist1, Slug, Snail and Zeb1 (D); and for EphB2 and Jarid1B (E). Significance 
was calculated employing two-sample t-test, significant p-values are displayed (* p<0.05; ** 
p<0.01; *** p<0.001).
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identify colorectal CSCs 20. Various stem cell markers have been described for the 
mouse small intestine, namely Bmi1 21, Msi1 22, Tert 23, Dckl1 24 and Porminin1 25. To 
determine whether tumor LRCs recapitulate the expression pattern of normal stem 
cells, we tested Lin-, GFP+CD24hiCD29+ and GFP-CD24hiCD29+ tumor cells by RT-
qPCR (Figure 4C). However, most stem cell markers were expressed at similar levels 
in tumor LRCs when compared to the total population of epithelial tumor cells (Figure 
4C, data for Dckl1 not shown). The only marker significantly upregulated in tumor 
LRCs when compared to the bulk tumor cells was Prominin1 (CD133; Figure 4C, 
left, p<0.05). This difference was not observed when tumor LRCs were compared to 
their GFP-CD24hiCD29+ counterpart (Figure 4C, right). In the mouse small intestine, 
expression of Prominin1 largely overlaps with that of Lgr5 in crypt base columnar 
cells 25. Likewise, constitutive Wnt signaling activation in Prominin1-expressing cells 
leads to massive dysplasia. In the resulting lesions, Prominin1 expression is retained 
in 7% of all tumor cells 25. Since both, Lgr5 and Prominin1 are upregulated in the 
tumor LRC population and their GFP-CD24hiCD29+ counterpart (Figure 4B and 4C), 
it appears that these markers are expressed across the CSCs. Additional embryonic 
stem cell markers, namely Oct3/4, Sox2 and Nanog, were tested and found to be 
expressed at very low levels or absent in the population of tumor LRCs (data not 
shown). 
Slow cycling stem-like cells isolated from pancreas adenocarcinoma cells lines 
were previously shown to display a fibroblast-like morphology reminiscent of epithelial 
to mesenchymal transition (EMT) 10. Therefore, we tested the expression of four 
EMT genes, namely Twist1, Slug, Snail and Zeb1. Notably, tumor LRCs displayed 
significantly lower levels of the EMT markers than the bulk tumor population (Figure 
4D, left, p<0.001). Significantly lower expression levels could be detected for Twist1 
and Snail when tumor LRCs were compared to their GFP-CD24hiCD29+ counterpart 
(Figure 4D, right, p<0.001). These results point to the fact that in our experimental 
setting, tumor LRCs did not arise through EMT. 
Additionally, tumor LRCs were tested for the expression of Jarid1b and EphB2 
(Figure 4E). Jarid1b is an H3K4 methylase highly expressed in slow cycling 
melanoma cells. Jarid1b knockdown leads to tumor exhaustion 11. However, the 
expression level of Jarid1b did not significantly differ between the bulk and LRC 
tumor cell populations (Figure 4E). EphB2 has recently been described as a marker 
highly expressed in normal and cancer colon stem cells cells 20. EphB2 expression 
levels did not significantly differ between bulk tumor cells, CD24hiCD29+ tumor LRCs 
and their GFP-CD24hiCD29+ counterpart (Figure 4E). 
Taken together, our data suggests that tumor LRCs are a quiescent tumor 
population whose low proliferative activity is controlled by high levels of the cell 
cycle inhibitor Cdkn1. Tumor LRCs, as well as their GFP-CD24hiCD29+ counterpart 
express high levels of Lgr5 and Prominin1 when compared to the bulk of the tumor. 
Furthermore, tumor LRCs display strikingly low levels of the EMT genes Twist1, 
Slug, Snail and Zeb1.
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Tumorigenic potential of tumor LRCs
In order to assess the tumorigenic potential of tumor LRCs, we sorted by FACS 
the entire GFP+ tumor cell population (tumor LRCs), their GFP- counterpart as well 
as CD24hiCD29+ and bulk (Lin-) tumor cells, following a chasing period of two weeks. 
All populations were injected subcutaneously into NOD-SCID animals (Table 1). 
Tumor formation was assessed after a maximum grafting time of six months and 
tumors were scored upon histological confirmation. Bulk tumor cells (Lin-), employed 
as positive control and injected at high multiplicities (250.000 cells), formed tumors 
in 10 out of 12 injections (Table 1). The CD24hiCD29+ tumor cell population was 
previously shown to be enriched in tumor propagating and self-renewing CSCs 17. 
Accordingly, these cells formed tumors in 4 out of 5 cases upon injection of 5000 
cells (Table 1). However, the total population of GFP+-label retaining tumor cells (i.e. 
not further selected for their relative CD24/CD29 expression) was not able to form 
subcutaneous tumors. Notably, their GFP-negative counterpart was able to form 
tumors in 4 out of 21 cases when injected at a multiplicity of 5000 cells (Table1). 
Next, we compared the tumor forming capacity of the GFP+CD24hiCD29+ population 
with their GFP-CD24hiCD29+ counterpart by subcutaneous injections at different cell 
multiplicities into NOD-SCID mice (Table 2). As expected, CD24hiCD29+ tumor cells 
were able to initiate tumor growth in 8 out of 15 injections (1500 transplanted cells) 
(Table 2), whereas total tumor cells depleted of CD24hiCD29+ cells (not CD24hiCD29+) 
were only able to give rise to tumors when injected at high multiplicities (2 out of 6 
with 5000 transplanted cells) (Table 2). GFP-CD24hiCD29+ cells displayed tumor-
initiating frequencies similar to those of whole CD24hiCD29+ cells (Table 2; 16 out 
of 31 with 1500 transplanted cells). Nonetheless, the GFP+CD24hiCD29+ population 
of tumor LRCs was generally unable to initiate subcutaneous tumors as no growths 
were observed upon injection of 1500 (6 injections) and 1000 (2 injections) cells 
(Table 2). Only in a single case (out of four injections) we observed a tumor upon 
injections of 500 GFP+CD24hiCD29+ cells (Table 2). 
cell number cells injected growth / injected
250.000 Lin- 10/12
5.000 CD24hiCD29+ 4/5
5.000 GFP- 4/21
5.000 GFP+ 0/9
3.500 GFP+ 0/3
2.000 GFP+ 0/1
Table 1. Subcutaneously grown tumors from sorted cell populations. Total epithelial cells 
(Lin-), CD24hiCD29+ tumor cells, tumor label retaining cells (GFP+) and the total GFP- epithelial 
population (depleted of tumor LRCs) were sorted by FACS following a two-week chase period. 
Populations were injected subcutaneously into NOD-SCID mice in different multiplicities. Tu-
mor growth was scored following a waiting time of up to six months.
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DISCUSSION
In this study, we identified a quiescent population of intestinal tumor cells within 
adenocarcinomas from Apc1638N/+/villin-KRASV12G animals. These tumor label-
retaining cells (LRCs) do not express markers of intestinal differentiation, are 
distributed in cell clusters in the tumor and are localized within the cancer stem cell 
enriched CD24hiCD29+ FACS gate. Most likely, the quiescent state of tumor LRCs 
is kept through the expression of high levels of the cell cycle inhibitor Cdkn1 (p21). 
The cyclin-dependent kinase p21 is necessary for quiescence and maintenance 
of the normal hematopoietic stem cell pool and other tissues 26-28. In fibroblasts, 
p21 controls the entry into quiescence and the maintenance of the quiescent state, 
allowing damaged cells to activate DNA-damage like responses 29. 
Tumor LRCs are characterized by the expression of the CD24hiCD29+ cell surface 
markers, previously established to enrich for cancer stem cells in adenocarcinomas 
from Apc1638N/+/villin-KRASV12G mice 17. Cancer stem cells, as normal stem cells, 
possess the ability to self-renew and differentiate 30. To date, cancer stemness can 
only be operationally defined by the ability of the putative cell population to give 
rise to tumors harboring the same features as the primary tumor when injected 
subcutaneously at low cell multiplicities into recipient animals. In order to test their 
cell number population growth / injected
100.000 Lin- 1/1
50.000 not CD24hiCD29+ 2/2
5.000 not CD24hiCD29+ 2/6
1.500 not CD24hiCD29+ 0/6
1.500 CD24hiCD29+ 8/15
10.000 GFP- CD24hiCD29+ 3/3
5.000 GFP- CD24hiCD29+ 13/27
1.500 GFP- CD24hiCD29+ 16/31
500 GFP- CD24hiCD29+ 1/6
1.500 GFP+ CD24hiCD29+ 0/6
1.000 GFP+ CD24hiCD29+ 0/2
500 GFP+ CD24hiCD29+ 1/4
Table 2. Subcutaneously grown tumors from cell populations sorted according to 
CD24hiCD29+. Total epithelial cells (Lin-), epithelial cells depleted of CD24hiCD29+ tumor 
cells (not CD24hiCD29+), CD24hiCD29+ tumor cells, CD24hiCD29+ tumor label retaining cells 
(GFP+ CD24hiCD29+), and their GFP-negative counterpart (GFP- CD24hiCD29+) were sorted 
by FACS following a two-week chase period. Populations were injected subcutaneously into 
NOD-SCID mice in different multiplicities. Tumor growth was scored following a waiting time 
of up to six months.
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tumor-propagating ability, tumor LRCs were subcutaneously injected into NOD-
SCID animals but were unable to give rise to tumors. These negative results can find 
different, hypothetical explanations. First, LRCs have intrinsic quiescent features 
which they retain in transplantation assays in the absence of stress signals 31. During 
quiescence cells do not enter the cell cycle unless changes in their microenvironment 
activate them to resume cell growth 32. Such microenvironmental changes may 
include, among others, chemo- or radiotherapy-induced cellular stress 32. Hence, it 
is possible that quiescent tumor LRCs require specific niche signals in order to be 
activated and give rise to tumors. Future experiments should address this possibility 
by irradiating donor animals before isolating tumor LRCs or by irradiating recipient 
NOD-SCID mice before transplanting tumor cells. Irradiation of the donor animals 
after transplantation should lead to the activation of tumor LRCs and therewith mimic 
the situation in the clinic where dormant cancer stem cells can be activated to cycle 
and give rise to metastatic outgrowth following radio- or chemotherapy. However, 
this approach might impair the general transplantation efficiency by damaging the 
genetic material of these tumor cells. In contrary, irradiating the recipient NOD-SCID 
mice before transplantation does not affect the fitness of tumor cells and has been 
described as a very efficient method to suppress the immune reactivity against 
transplanted tumor cells, prepare the soil (niche) and therewith increase the tumor 
take 33. Therewith, irradiation of recipients prior to subcutaneous transplantation of 
sorted tumor cell populations should be the method of choice for future experiments.
This scenario is also in agreement with recent studies from our and other 
laboratories on the dichotomy of cycling and quiescent stem cells in the normal 
intestinal crypt. Here, crypt base columnar cells (CBCs), located in the lower third of 
the crypt and earmarked by Lgr5 expression, represent actively cycling stem cells 
capable of giving rise to all differentiated cell types of the intestinal epithelium18,34-36. 
Subsequently, it was also shown that Paneth cells, apart from their well-known 
bactericidal function, are in close physical association with Lgr5+ stem cells to 
which they provide essential niche signals 37. More recently, expression of the Bmi1, 
Dcamkl1 (doublecortin and CaM kinase-like-1) and Tert (mouse telomerase reverse 
transcriptase) genes were shown to earmark more slow-cycling intestinal stem-like 
cells 23,38. In our laboratory, we have identified and characterized quiescent, label-
retaining intestinal cells with Paneth cell characteristics which are located in the lower 
third of the crypt of Lieberkühn and are activated to proliferate following radiation-
induced tissue injury. While exiting dormancy, label-retaining cells progressively lose 
their Paneth cell identity and acquire gene expression features reminiscent of stem 
cells 39. By drawing a parallel between the normal and cancer stem cell niche, it 
is plausible to think that quiescent, label-retaining (possibly reminiscent of Paneth 
cells) tumor cells play a dual role in cancer: in the primary tumor, they provide the 
niche for more cycling CSCs to fuel tumor growth and invasion. Moreover, when 
disseminated to distant organ sites, in the presence of stimulatory stress signals 
(e.g. chemo- and cytochines, and/or other inflammatory cues) they can re-enter the 
cell cycle and underlie metastasis formation. 
132
Chapter 6
Although cancer treatments have become more efficient and successful over the 
last decades, metastases occurring after a period of tumor dormancy still represent 
the main cause of morbidity and mortality among individual cancer patients. Tumor 
dormancy is a widely used term to describe the state in which tumor cells exist for 
long periods of time following treatment or surgical removal of the primary tumor. 
From their dormant state, quiescent cancer cells can subsequently switch to a 
state of active cycling and underlie tumor relapse. The quiescent feature of tumor 
label-retaining cells makes it difficult to study their behavior in vivo. Nevertheless, 
understanding the biology of quiescent tumor cells and the molecular and cellular 
mechanisms underlying both dormancy maintenance and the stimuli which trigger 
cell cycle activation and ultimately result in metastatic growth will be crucial for the 
future development of targeted therapies.
MATERIALS AND METHODS
Animals
Transgenic hnRNPA2B1-rtTA mice 16 were bred with tetO-HIST1H2BJ/GFP 
(H2BGFP) animals 15. Compound heterozygous hnRNPrtTA/H2B-GFP mice were 
then bred with Apc1638N/+/villin-KRASV12G mice 6. All mouse lines were kept on an 
inbred C57BL6/J genetic background, except for H2B-GFP, which was on a CD1 
genetic background. 
Transgene expression was induced in compound hnRNPrtTA/H2B-GFP/Apc1638N/+/
villin-KRASV12G animals and their littermates by replacing normal drinking water 
with 5% sucrose water containing 2 mg/ml doxycycline (Sigma, D9891). Dox-
treated water was changed every 2 days. After 7 days, doxycycline treatment was 
stopped and mice received regular drinking water again. At defined time-points after 
doxycycline withdrawal, mice were sacrificed and tissues were analyzed for H2B-
GFP expression. 
NOD-SCID mice were subcutaneously injected with cell suspension derived 
from single tumors isolated from compound hnRNPrtTA/H2B-GFP/Apc1638N/+/villin-
KRASV12G animals. Recipient animals received doxycycline water following the 
injection until a tumor mass became palpable. Only then, doxycycline treatment was 
stopped and animals received normal drinking water. 
Immunohistochemistry (IHC) and Histology
Four µm sections were mounted on slides and stained by HE and PAS for routine 
histology. IHC was performed according to standard procedures using the following 
antibodies: GFP (1:800, A11222, Invitrogen), Lysozyme (1:5000, A0099, Dako) and 
Synaptophysin (1:750, A0010, Dako). Signal detection was performed using Rabbit 
EnVision+ System-HRP (K4011, Dako) for GFP, Lysozyme and Synaptophysin. 
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Single cell digestion
The small intestine was dissected, cut-open and washed in PBS. Tumors were 
isolated and chopped into small pieces using a razor blade. Tissue pieces were 
left at 37°C in digest medium (RPMI + p/s, 10%FCS, 5 ng/ml EGF, 0.03 ng/ml 
Hydrocortisone, 1x Insulin/Transferrin, 4 mg/ml Collagenase, 0.1 mg/ml Dispase, 50 
μg/ml DNAse) for 1.5 hrs until ~90% of the specimen was reduced to single cells. 
The cell suspension was passed through a 40μm cell strainer, washed by doubling 
the volume using 2% FCS/PBS, and spun down for 8 min at 1200 rpm at 4°C. Tumor 
cell preparation was resuspended in 100ml 50% Matrigel (BD Pharmingen) and 
injected subcutaneously into NOD-SCID mice.
Cell preparation for FACS 
To exclude non-epithelial cells from analysis, 1x106 cells were stained for 30 min 
in 100 μl of lineage staining solution consisting of 2% FCS/PBS, Biotin anti-mouse 
CD31 (1:100), Biotin anti-mouse CD45 (1:200) and Biotin anti-mouse TER-119 
(1:100) (all from BD Pharmingen) at 4°C. To deplete blood cells Dynabeads Biotin 
Binder (Invitrogen) was applied following the manufacturer’s instructions. Following 
depletion of lineage cells, the cell suspension was stained for CD24-APC (Biolegend, 
1:250) and CD29-PE (Abcam, 1:25) for 30 min at 4°C. Cells were then washed and 
re-suspended in 0.2 μg/ml Hoechst 33258 (Invitrogen) in 2%FCS/PBS in order to 
facilitate discrimination of live from dead cells. Fluorescent activated cell sorting was 
performed using a BD FACSAria.
Quantitative PCR
Five subcutaneously grown hnRNPrtTA/H2B-GFP/Apc1638N/+/villin-KRASV12G 
tumors were chased for ten to thirteen days and used for this sorting experiment. 
FACS-sorted were CD24hiCD29+ tumor LRCs (GFP+CD24hiCD29+), their GFP-
negative counterpart (GFP-CD24hiCD29+), and a total pool of live epithelial cells for 
each tumor. Total RNA was isolated using RNeasy Mini Kit (Quiagen), converted into 
cDNAs using High Capacity RNA-to-cDNA kit (Applied Biosystems) and employed in 
a pre-amplification step using the Taqman®PreAmp Master Mix (Applied Biosystems) 
according to manufacturer’s instructions. The Linearity of pre-amplification was 
controlled for all primers. Assays were carried out as duplicate reactions using 
the 7900HT Fast Real Time system (Applied Biosystems). Quantitative PCR was 
performed for the following markers: Actb, Axin2, Ccnd1, Lgr5, Sox2, Twist1, Oct3/4, 
Bmi1, Defa1, Tert, Dclk1, Prom1, Slug, Snail, Zeb1, Jarid1b, EphB2, Cd24a, Cdkn1a 
and Nanog using inventoried TaqMan assays (Applied Biosystems, see below) 
according to manufacturer’s instructions. The Actb gene was used as house keeping 
gene. For preparation of the graphs, ratios were built between the expression level 
of the gene of interest in tumor LRCs (GFP+CD24hiCD29+) and the bulk tumor cell 
population (Lin-) or to the their GFP-negative counterpart (GFP-CD24hiCD29+), 
respectively. Significance was calculated employing a two-tailed t-test. 
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gene assay number
Actb Mm00607939_s1
Axin2 Mm00443610_m1
Ccnd1 Mm00432359_m1
Lgr5 Mm00438890_m1
Sox2 Mm03053810_s1
Twist1 Mm00442036_m1
Pou5f1 (Oct3/4) Mm03053917_g1
mmu-Bmi1 Mm03053308_g1
mmu-Defa1 Mm02524428_g1
mmu-Msi1 Mm00485224_m1
mmu-Tert Mm01352136_m1
Dclk1 (mmu-Dcamkl1) Mm01545303_m1
Prom1 (mmu-Prom1) Mm00477115_m1
Slug (mmu-Snai2) Mm00441531_m1
Snail (mmu-Snai1) Mm00441533_g1
Zeb1 (mmu-Zeb1) Mm00495564_m1
Jarid1b (mmu-Kdm5b) Mm03053411_s1
EphB2 (mmu-EphB2) Mm01181017_m1
Cd24a (mmu-Cd24a) Mm00782538_sH
Cdkn1a (mmu-p21) Mm00432448_m1
Nanog (mmu-Nanog) Mm02019550_s1
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Adult mammalian organs such as the hematopoietic system, the skin and the 
gastrointestinal tract are amongst the fastest self-renewing tissues in our body. To 
ensure the functionality of these organs, a constant supply of fresh cell material 
is needed. This cell supply is fueled by a population of tissue stem cells, which 
give rise to transit amplifying progenitors that subsequently differentiate into the 
functional cell types of the respective tissue (Figure 1A). After exerting their function, 
terminally differentiated cells undergo programmed cell death (apoptosis). Tissue 
homeostasis is maintained through a delicate balance of (stem-) cell self-renewal, 
cell proliferation, cell differentiation and programmed cell death. 
The stem cell compartment of such high turnover tissues is characterized by 
a dichotomy of stem cell states1. Whereas fast cycling stem cells are responsible 
for fueling daily tissue turnover, their more quiescent counterpart is only activated 
upon tissue injury and responsible for repair2. The hematopoietic stem cell niche, 
for example, harbors a silent stem cell reservoir3-5 capable of temporarily exiting its 
dormant state to self-renew in response to bone marrow injury. Such a switch from 
quiescence to self-renewal can also be triggered through IFN-gamma in response 
to chronic infection6. Even in tissues characterized by lower turnover rates such as 
the urinary bladder, a similar scenario takes places. Upon tissue injury, the Shh-
expressing basal cell population shifts from quiescence to proliferation and expands7. 
Increased Shh levels in turn activate stromal Wnt signaling which stimulates the 
proliferation of urothelial and stromal cells to facilitate repair7. 
In this PhD thesis, I studied quiescent (label-retaining) normal and tumor cells 
in the gastrointestinal tract and the influence of inflammation on tumorigenesis. For 
detailed background information on the intestinal stem cell niche, quiescence, chronic 
inflammation and tumor cell quiescence, the reader is referred to the Introduction. 
Characterization of LRCs during homeostasis and tissue injury
The main focus of this thesis lies in the characterization of a quiescent cell population 
in the mouse small intestine (Chapter 1 and 3). For this aim, we developed a mouse 
model, which expresses a doxycycline-inducible H2B-GFP fusion protein in all cells of 
the epithelial lining of the small and large intestine (Chapter 1). Subsequently, these 
mice were utilized to perform pulse-chase studies and therewith mark quiescent 
(label-retaining) cells within the mouse small intestine. The results of this work are 
described in Chapter 3. We identified a novel, dormant population of intestinal label 
retaining cells (LRCs), distinct from the recently identified cycling Lgr5- and quiescent 
Bmi1-expressing stem cells8-10, which persist at the base of the intestinal crypt for up 
to 100 days. LRCs show high expression levels of the stem cell marker Msi111. LRCs 
do not express markers of proliferation and have morphologic and gene expression 
features reminiscent of (im)mature Paneth cells. Most importantly, Paneth/LRCs 
are capable of generating or supporting the generation of crypt-villus structures 
encompassing all intestinal epithelial lineages when an in vitro culturing system is 
employed12,13. The role of Paneth/LRCs during homeostasis is thus the creation of 
a niche support for faster cycling Lrg5 crypt base columnar cells (CBCs) (Chapter 
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3 and ref. 13). Homeostasis within the intestinal stem cell niche is tightly regulated 
and extremely important for proper stem cell function, as outlined in the Appendix14. 
For example, loss of Lgr4, a factor, which is expressed in crypt base columnar cells, 
transit amplifying cells and rare Paneth cells leads to a 50% decrease of epithelial 
proliferation and an 80% reduction of Paneth cell differentiation14,15 (Appendix). 
Absence of terminally differentiated Paneth cells subsequently disturbs the intestinal 
stem cell niche in such a way that small intestinal crypts isolated from these Lgr4 
knockout mice are not able to form budding organoids in vitro14,15 (Appendix). This 
phenomenon can be explained by the fact that Paneth cells provide essential niche 
signals to CBCs, amongst others through secretion of EGF, Wnt3a and Dll413 but 
possibly also through cell-to-cell contact. In the absence of the close association 
of CBCs with Paneth cells, organoid formation in vitro is impaired (Appendix). The 
situation however is more complex in vivo, as mice with a specific deletion of the 
Paneth cell lineage do not shown any morbidity or intestinal phenotype16,17. The lack 
of a Paneth cell niche must thus be compensated in vivo through other niche cells, 
such as stromal myofibroblast and / or their secreted factors (e.g. hepatocyte growth 
factor)18. 
The intestinal stem cell compartment is extremely complex. Based on clonal 
analysis and knock-in experiments, it was shown that crypt base columnar cells 
(CBCs), located in the lower third of the crypt and earmarked by Lgr5 expression, 
represent actively cycling stem cells capable of giving rise to all differentiated cell 
types of the intestinal epithelium8,19-21. Moreover, Bmi1 has been identified as a 
marker of a distinct, slower cycling intestinal stem cell located at position +4 from 
the base of the crypt in the proximal mouse duodenum9,10. Surprisingly, targeted 
ablation of Lgr5+ crypt base columnar cells was shown not to affect the normal 
intestinal tissue architecture10,22. On the contrary, loss of Lgr5-expressing cells can 
be compensated by an expansion of the Bmi1+ stem cell pool, able to give rise to 
Lgr5 cells and all other cell lineages of the mouse small intestine (Figure 1B)10. Thus, 
Bmi1-expressing stem cells may represent a reserve stem cell pool in situations of 
tissue injury10. Strikingly, in Chapter 3 of this thesis we show that upon radiation-
induced tissue insult, LRCs switch from a resting to a proliferative state as part of 
the regenerative response of the injured epithelium, de-differentiate and acquire 
expression of the stem cell marker Bmi1 (Figure 1C). Our results are indicative of an 
entirely novel functional role for infrequently dividing, Paneth-like cells as stem cells 
upon tissue injury. When massive cell death is induced by irradiation, Paneth/LRCs 
survive because of their intrinsic radio-resistance23, and are activated to proliferate, 
down-regulate Paneth cell specific genes, and express Bmi1, previously shown to 
earmark intestinal stem cells9,10. Newly formed Bmi1 expressing stem cells can in 
turn regenerate the Lgr5 cycling stem cell pool10 and subsequently all intestinal cell 
lineages (Figure 1C). 
By combining radiation-induced tissue injury with Tert-specific lineage tracing 
it was shown that Tert-expressing slow-cycling intestinal stem cells are able to 
contribute to all cell lineages at the peak of the regenerative response (4 days)24. 
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Figure 1. Tissue hierarchy in the mouse small intestine. (A) Traditional model of tissue 
hierarchy. (B) Dichotomy of the intestinal stem cell niche. (C) Dynamics within the intestinal 
stem cell niche following heavy tissue injury. SC stem cell, TA transit amplifying cell, LRCs 
label retaining cells.
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However, it is not clear if Tert-expressing cells are initiating tissue regeneration or 
are actually daughter cells of a more quiescent cell population. Future experiments 
should clarify the relative position of Tert-expressing slow cycling stem cells in our 
model (Figure 1C), and whether they directly descend from Paneth/LRCs following 
tissue injury, or are generated from Bmi1+ daughter cells. 
I suggest that label-retaining, Paneth-like cells play a double role as they both 
can provide the nurture for stem cells during homeostasis13 and function as a stem 
cell for the regenerative response (Chapter 3). However, this model is challenged 
by the fact that depletion of Paneth cells from the mouse intestinal epithelium can 
be tolerated for up to six months16,17. The Sox9 gene is required for the formation of 
Paneth cells in the mouse small intestine and its depletion results in Paneth cell loss, 
crypt enlargement and increased proliferation25. However, intestine-specific Sox9 
knockout does not impair the differentiation of any other intestinal cell lineages25. 
Does this mean that Paneth/LRCs are as dispensable as Lgr5+ crypt base columnar 
cells are? In an Ah-Cre inducible mouse model of Sox9-knockout, the number of 
Paneth cells decreased from four weeks after Cre-induction onwards and Paneth 
cells were almost absent after 7 to 8 weeks13. However, so-called wild type escaper 
crypts containing normal Paneth cells were able to replace the Sox9-knockout crypts 
by crypt fission within a period of less than two weeks13. We suggest that escaper 
Paneth/LRCs might initiate this extremely efficient regenerative response. 
The remaining question to be answered is what happens to intestinal integrity 
upon tissue injury induced in mice lacking Paneth cells? Future experiments should 
determine the effect of high dosages of radiation on tissue-integrity in intestine-
specific Sox9-knockout mice16 or in mice expressing an attenuated diphteria toxin 
under control of the cryptidin-2 promoter17. It will be interesting to see if tissue 
integrity can be maintained and which (stem) cell population is responsible for the 
regenerative response following the tissue injury in the absence of Paneth/LRCs. 
Overall, it is now evident that the intestinal stem cell niche is much more complex 
than initially suspected, and that stem cells, but also more differentiated cells such as 
Paneth cells, have the intrinsic ability to de-differentiate and exert stem cell functions. 
This flexibility serves as a means to secure tissue integrity, especially in situations 
of extreme tissue injury and stress. Future experiments should determine the 
mechanisms that underlie this flexibility and unravel the role of the microenvironment 
in this process.
Strikingly, metaplastic Paneth cells are a common histological feature in the 
colon of inflammatory bowel disease (IBD) patients26,27. Accordingly, we observe the 
appearance of Paneth cells in very early tumor lesions in the colon of mice which 
have been treated with DSS, an agent that, when administered in the drinking water, 
causes inflammation of the large bowel, reminiscent of IBD in man (Chapter 4). 
These data are confirmed by the observation that the Paneth cell surface marker 
CD24 is upregulated in inflammatory bowel disease28. It is thus very likely that 
Paneth-like cells also play a functional role in those tissue repair processes in the 
colon triggered by the DSS-induced inflammatory injury. In inflammatory bowel 
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disease, factors secreted by infiltrating immune cells stimulate the proliferation of 
tumor-initiating cells within the intestinal epithelium29. We hypothesize a scenario 
in which chronic inflammation causes the activation of a quiescent (Paneth-like) 
stem cell population to increase their turnover rate in order to sustain tissue repair. 
Because of the increased division rate and the constant exposure to mutagenic 
inflammatory substances, these cells are more likely to acquire somatic mutations. 
Alterations in quiescent stem cells can thus be the cause of malignant transformation 
in inflammation-related tumors (Introduction).  
Quiescent cells in cancer
The same hierarchical organization characteristic of normal tissues can also 
be found in tumors, where (cancer) stem-like cells give rise to progenitors, which 
then differentiate into the various cell lineages found in tumors (Introduction). As in 
normal high-turnover tissues, a dichotomy of fast cycling versus quiescent cancer 
stem cells seems to exist within the cancer stem cell population (for more details, 
see Introduction). One feature of a quiescent cancer stem cell subpopulation is its 
low division rate. Quiescent cancer stem cells have been identified in hematological 
cancers. Since most chemotherapeutic approaches target proliferative cells, tumor 
cell dormancy represents a crucial mechanism for resistance to anti-proliferative 
chemotherapy. In BCR-ABL CML, the CD34+ subpopulation contains quiescent cells 
that are resistant to imatinib30. In AML, chemotherapy-resistant, quiescent AML stem 
cells engraft in the bone marrow endosteal region31. Interestingly, induction of cell 
cycle in these cells results in an increased sensitivity to chemotherapy32. 
One method of identifying quiescent tumor cells is by employing label retention 
studies. Quiescent and thus label-retaining tumor-initiating cells have for example 
been identified in human glioblastoma33. In Chapter 6 we describe the isolation and 
characterization of a quiescent label-retaining cell population in tumors isolated from 
gastrointestinal adenocarcinomas of Apc1638N/+/villin-KRASV12G animals. The majority 
of these cells cluster in the cancer stem cell enriched CD24hiCD29+ subpopulation34. 
Recently, Pece et al. showed that the gene signature of normal quiescent PKH26 
label-retaining mammary stem cells correlates with cancer stem cell behavior in 
breast cancer35. It is thus possible that the gene expression signature of quiescent 
cancer stem cells is very similar to that of (quiescent) normal stem cells.  Accordingly 
we tested the expression levels of various stem and cancer stem cell markers in 
the population of CD24hiCD29+ label-retaining tumor cells. As shown in Chapter 
6, none of the stem cell markers we tested were significantly higher expressed in 
CD24hiCD29+ label-retaining tumor cells when compared to their CD24hiCD29+ non-
label-retaining counterpart. Since the quiescent label-retaining tumor cell population 
is only a small subpopulation of the CD24hiCD29+ cancer stem cells and an even 
smaller subpopulation of the whole population of tumor cells, their contribution to the 
overall tumor as well as cancer stem cell signature is minute. Therefore it is feasible 
that (cancer) stem cell markers are not specifically expressed in this small cell 
population. The cyclin-dependent kinase p21 (Cdkn1) is necessary for quiescence 
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and maintenance of the normal hematopoietic stem cell pool and other tissues36-38. 
In fibroblasts, p21 controls the entry into quiescence and the maintenance of the 
quiescent state, allowing damaged cells to activate DNA-damage like responses39. 
CD24hiCD29+ label-retaining tumor cells (Chapter 6) express high levels of the cell 
cycle inhibitor p21. Thus, p21 also seems to be involved in maintaining tumor cells 
in their quiescent state. 
Cancer stem cells, as normal stem cells, possess the ability to self-renew and 
differentiate40. To date, cancer stemness can only be operationally defined by the 
ability of the putative cell population to give rise to tumors harboring the same features 
as the primary tumor when subcutaneously injected into animals. However, this 
approach has limitations as the transplantation-efficiency is very much dependent 
on the functionality of the immune system of the recipient animals. Strikingly, 25% of 
advanced human melanoma cells were capable of initiating tumors when a specific 
strain of immunodeficient recipients was used41. Thus, the transplantation of any 
stem cell can only reveal the potential of the stem cell under the particular assay 
conditions but cannot reveal the actual fate of the transplanted cell in its original tissue 
or tumor41. As described in Chapter 6, we isolated tumor LRCs and injected different 
multiplicities of these cells in parallel to various control populations subcutaneously 
into immunocompromised NOD-SCID animals. While controls reliably gave rise to 
subcutaneous tumors, tumor LRCs were very poor initiators of tumor formation. We 
therefore have to conclude that tumor LRCs are a population of long-lived cells that 
does not possess tumor-initiating potential. Similarly to Paneth cells in the normal 
stem cell niche, it is imaginable that these tumor LRCs have a supportive role and 
function as niche cells for cycling cancer stem cells. The poor tumor-initiating abilities 
of tumor LRCs can however also be due to their quiescence feature. To date, it is 
in fact unknown whether dormant CSCs can actually be detected by the currently 
performed xenograft assays42. During quiescence cells remain nonproductive 
until changes in their microenvironment activate them to resume cell growth43. 
Such microenvironmental changes can be, for example, chemo- or radiotherapy-
induced cellular stress43. Similar mechanisms underlie the activation of quiescent 
disseminated tumor cells (DTCs), which was modeled in MMTV-Neu transgenic 
mice44. MMTV-Neu transgenic mice harbor DTCs in their bone marrow, but never 
develop bone metastases44. However, following irradiation-induced tissue injury, the 
bone marrow of these mice is remodeled and DTCs start proliferating44. Hence, it 
is possible that quiescent tumor LRCs require specific niche signals in order to be 
activated and grow out into tumors. In future experiments, recipient animals should 
be subject to irradiation before quiescent tumor LRCs are transplanted. This change 
of microenvironment might facilitate the outgrowth of tumor LRCs in the xenograft 
model. One alternative method to determine cancer stemness of tumor LRCs would 
involve the use of orthotopic transplantation models45. Transplanting cells into a 
microenvironment which mirrors their own might improve their tumor forming ability. 
In summary, the preliminary results presented in Chapter 6 point to the existence of 
quiescent label-retaining tumor cells in adenocarcinomas of Apc1638N/+/villin-KRASV12G 
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animals, which form a subpopulation of the cancer stem cell enriched CD24hiCD29+ 
population of tumor cells. Our evidence suggests that quiescence in tumor LRCs is 
maintained through high expression levels of the cell cycle inhibitor Cdkn1. However, 
their functional role as a niche or in tumor dormancy and metastases has still to be 
determined in future experiments. 
Overall, the results presented in my PhD thesis underline the importance of 
the stem cell niche and emphasize the regenerative potential of quiescent label-
retaining cells in the normal intestine. Furthermore, evidence points to the existence 
of a quiescent cancer cell population in intestinal adenocarcinomas whose functional 
role remains to be deciphered.
The impact of recent advances in stem cell research on the medical practice
The results presented in my PhD thesis help to grasp the complexity and flexibility 
of stem cells and their niche. During the 4.5 years of my PhD, major advances in 
deciphering the complexity of the intestinal stem cell niche have been made: In 
2007, the first year of my PhD, Barker et al. isolated and characterized a cycling but 
long-lived stem cell population in the mouse small intestine, the Lgr5+ crypt base 
columnar cells8. Only one year later (2008), Bmi1 was shown to mark a more slowly 
cycling stem cell population in the anterior mouse small intestine9. Two years after 
the isolation of Lgr5+ crypt base columnar cells (2009), it was shown, that depletion 
of this cell population can be very efficiently compensated in short time22. These 
results were confirmed by a second study (2010) in which exposure of mice to high 
dosages of gamma-irradiation resulted in depletion of Lgr5+ crypt base columnar 
cells which was followed by efficient tissue repair46. The most direct evidence for the 
existence of a backup stem cell pool which is responsible for tissue regeneration 
following loss of Lgr5+ crypt base columnar cells was recently published by Tian et 
al. (2011)10. The authors convincingly showed that depletion of Lgr5+ cells can be 
efficiently compensated by activation of slow cycling Bmi1-expressing stem cells 
which subsequently initiate tissue regeneration and in that process can give rise to a 
new pool of Lgr5+ crypt base columnar cells10. Our study on label-retaining quiescent 
Paneth-like cells in the small intestine adds another twist to the story. In Chapter 3 
of this thesis we show that upon radiation-induced heavy tissue injury label-retaining 
Paneth-like cells are able to start dividing and to initiate the regenerative response. 
Future experiments will have to determine the dynamics between all those stem cell 
populations. 
Moreover, considerable advances have been made in the area of stem cell in 
vitro culture: In 2009, Sato et al. described a method by which they are able to grow 
mouse intestinal organoids in a 3-dimensional structure in vitro12. Strikingly, single 
sorted Lgr5+ crypt base columnar cells were able to give rise to these organoid 
structures in vitro. In 2011, Paneth cells were identified to be essential for creating 
niche support for crypt base columnar cells by secreting various growth factors and 
therewith, enhancing Lgr5+ cells’ clonogenicity in vitro13. Also in 2011, the protocol 
to differentiate human pluripotent stem cells into intestinal tissue in vitro has been 
147
Discussion
published47. Especially the latest successes showing the possibility to isolate and 
expand human colon stem cells in vitro (2011)48 and to establish long-term cultures 
of human intestinal organoids, which can be differentiated into all cell types of the 
intestine (2011)49, promise new advances in regenerative medicine. A scenario can 
be pictured where healthy material is biopsied from a specific donor and propagated 
in vitro48,50. This material in turn can be transplanted into a matching patient suffering 
from severe intestinal conditions such as inflammatory bowel disease. Within that 
framework, ZonMW granted the RITS (Regenerating Intestinal Tissue by Stem 
Cells) project, a collaboration between the Wilhelmina Childrens Hospital Utrecht 
and the Hubrecht Institute, in which researchers aim to transplant cultured human 
intestinal organoids to children with Microvillus Inclusion Disease, a hereditary 
intestinal enteropathy in which children have insufficient functional intestinal surface 
epithelium to support life51. For the future, it also becomes imaginable that patients 
donate a biopsy of their own intestinal tissue before they undergo high-dosage 
radiation therapy, which then will be expanded in vitro and re-transplanted after the 
procedure, to prevent intestinal radiation syndrome. The most recent advances in 
stem cell research are thus very likely to have an ultimate impact on medical practice 
in the near future.   
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The nature vs. nurture debate concerns the relative contribution to an individual’s 
true identity of its nature (i.e. its genetic make-up) compared to its nurture, defined 
as the totality of external, environmental factors. A similar type of debate is currently 
ongoing among developmental and stem cell biologists: is the intrinsic nature (i.e. 
its epi/genetic make-up) of a stem cell what makes it self-renew and differentiate 
according to the physiological needs of a given tissue, or is it its directly surrounding 
environment (nurture) that regulates stemness? Irrespective of the relative weight of 
each contribution, there is little doubt that both cell autonomous and environmental 
factors play crucial roles in the maintenance of homeostasis in self-renewing tissues 
like the skin, mammary gland, blood and intestine. In an article published in this 
issue of EMBO Reports 1, the Lgr4 gene is shown to play a rate-limiting role in 
establishing the stem cell niche of the proximal intestinal tract. 
The epithelial lining of the proximal intestine is characterized by a unique tissue 
architecture consisting of villi and crypts. The intestinal crypt of Lieberkühn is a highly 
dynamic niche with stem cells residing in its lower third, a position from where they 
give rise to a population of fast-cycling transit-amplifying (TA) cells. TA cells undergo 
a limited number of cell divisions and eventually differentiate into the four specialized 
cell types of the small intestine, namely absorptive, enteroendocrine, Goblet, and 
Paneth cells. Notably, Paneth cells (PCs) are the only terminally differentiated cell 
type of the proximal intestinal tract that 1. move downwards along the crypt-villus 
axis, and 2. retain canonical Wnt signalling activity upon differentiation 2. 
Based on clonal analysis and knock-in experiments, it was shown that the crypt 
base columnar cells (CBCs), located in the lower third of the crypt and earmarked 
by Lgr5 expression, represent actively cycling stem cells capable of giving rise to 
all differentiated cell types of the intestinal epithelium 3. More recently, it has also 
been shown that PCs, apart from their well-known bactericidal function, are in close 
physical association with Lgr5+ stem cells to which they provide essential niche 
signals such as EGF, Wnt3a and Dll4 4. This is of importance also in view of another 
observation showing that single Lgr5+ stem cells, when cultured ex vivo, can generate 
crypt-villus organoids without a (mesenchymal) niche 5. As a matter of fact, the latter 
is only partly true as these organoids are cultured in matrigel and in the presence of 
specific growth factors likely to be released by the niche in vivo. 
Lgr5, together with Lgr4 and Lgr6, belong to the family of leucine-rich repeat-
containing G-protein-coupled seven-transmembrane receptors. Lately, both Lgr5 
and Lgr6 have received considerable attention from the stem cell community: Lgr5 
is a downstream Wnt target gene and a marker of cycling stem cells in the intestinal 
tract and in the hair follicle, whereas Lgr6 expression marks adult stem cells in the 
skin 6. However, whether they merely represent stem cell markers or also exert a 
functional role in stemness is to date unknown. 
Mustata et al. report on the functional role of yet another member of the Lgr family, 
Lgr4, by studying the effects of a targeted loss of function mutation (Lgr4KO) on the 
development and differentiation of the mouse small intestine both in and ex vivo 1. 
Endogenous Lgr4 expression is detected in TA cells above the Paneth cell zone, in 
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CBCs, and in rare PCs. Loss of Lgr4 function results in a reduction in crypt depth due 
to a 50% decrease in epithelial cell proliferation and, somewhat surprisingly, in an 
80% reduction in Paneth cell differentiation. Strikingly, these phenotypic features are 
apparently antagonistic to those of Lgr5KO mice where premature PC development 
was observed 7. Accordingly, loss of Lgr4 function partially rescues the perinatal 
lethality of Lgr5KO mice pointing at the non-redundancy of their individual functions. 
To further dissect the role of Lgr4 on crypt development, the ex vivo ‘minigut’ 
culture system 5 was employed: in contrast to crypts from wild type mice which give 
rise to self-renewing structures encompassing all the differentiated cell lineages 
of the adult gut, organoids derived from age-matched Lgr4KO animals are initially 
present as hollow spheres, mainly composed of stem and TA cells, which eventually 
disaggregate within 2-3 days and die within a week in culture. In agreement with 
their apparently opposite and non-redundant functions, crypt cultures from Lgr5KO 
mice survive long term culture and develop into differentiated organoids comparable 
to those of normal mice. Notably, whereas loss of Lgr4 function partially rescues the 
lethality of Lgr5KO mice in vivo, the same is not true ex vivo: compound homozygous 
Lgr4/5KO crypts give rise to hollow spheres which collapse and die as observed in 
Lgr4 KO organoids. Hence, under these experimental conditions, i.e. in the absence 
of a mesenchymal niche, the Lgr4 defect is dominant over the Lgr5 one. 
Analysis of Paneth cell differentiation markers and of Wnt targets, including Lgr5, 
confirmed their down-regulation in Lgr4KO organoids, thus suggesting a role for Lgr4 
in Wnt signalling. Notably, LiCl treatment partially rescues the ex vivo phenotype of 
Lgr4KO crypts, though the same is not true for other Wnt signalling agonists such 
as Wnt3a and Gsk3b inhibitors. Based on these observations, the authors conclude 
that Lgr4 is likely to play a permissive, rather than a direct and active role in Wnt 
signaling. 
In view of this and other studies, a revisitation of the cell autonomous and niche-
independent features of the Lgr5+ cycling stem cell (CBCs) in the intestinal crypt 
seems necessary (Figure 1). First, the capacity of CBCs to recapitulate ex vivo the 
complexity of the crypt-villus unit is largely dependent on Paneth cells 4. When sorted 
as single cells, CBCs perform very poorly in organoid formation, whereas doublets 
of CBCs and Paneth cells show an extremely high clonogenicity 4,5. However, rather 
than exclusively through the secretion of niche signals in the form of Wnt ligands, 
the nature of the interdependency between Paneth cells and CBCs seems to entail 
additional mechanisms. As shown by Mustata et al., loss of Lgr4 function causes 
Paneth cell differentiation blockade in the presence of wild type levels of Wnt3a 
and Wnt11, a defect that can be rescued by LiCl though not by the Wnt3a ligand 
and by Gsk3b inhibitors. This indicates that additional factors secreted by epithelial 
and possibly mesenchymal cells, e.g. stromal myofibroblasts 8, and the physical 
association of Paneth with Lgr5+ cells must underlie their ‘partnership’ in preserving 
homeostasis within such a highly dynamic tissue. Hence, Paneth cells apparently 
constitute an essential component of the intestinal stem cell niche in the upper 
intestinal tract. 
156
Appendix
As it always is the case, good science leads to new questions. Which cell type 
provides this niche function in the colon where PCs are not present? Of note, it has 
been shown that in the colon Lgr5+ cells are intermingled with yet uncharacterized 
CD24+ cells 4, a cell surface antigen known to enrich for Paneth cells in the upper 
intestinal tract. As CD24 expression does not earmark CBCs but rather their flanking 
cells, these observations could again reflect the supportive, niche role of PC and 
CD24+ cells in the upper and distal intestinal tract, respectively. This may also hold 
true for colon cancer where Paneth cells are often present possibly to provide 
niche support for cancer stem cells. Alternatively, premature (in the colon) and/
or fully differentiated (in the upper intestine) PCs may encompass a dual function 
by providing on one hand physical and paracrine support for cycling stem cells in 
homeostasis and, on the other hand, by representing the hitherto elusive quiescent 
stem cells which underlie tissue regeneration upon tissue insults. Whatever the truth, 
the intestinal scene is now set to further dissect the complexity of the nature-nurture 
interaction between intestinal (cancer) stem cells and their niche. 
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Figure 1. Schematic illustration of the intestinal stem-cell compartment in the upper 
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Adult mammalian organs such as the blood system and the gastrointestinal 
tract are amongst the fastest self-renewing tissues in our body. To ensure the 
functionality of these organs, a constant supply of fresh cell material is needed. This 
cell supply is fueled by a population of tissue stem cells which give rise to transit 
amplifying progenitors that subsequently differentiate into the functional cell types 
of the respective tissue. The stem cell compartment of such high turnover tissues 
characteristically contains stem cells in two different states. Whereas fast cycling 
stem cells are responsible for fueling daily tissue turnover, their more slowly cycling 
quiescent counterpart is only activated upon tissue injury and responsible for repair. 
Within this thesis, we studied the presence and functional role of quiescent cells in 
the gastrointestinal tract of mice during homeostasis, following tissue injury and in 
cancer. 
In Chapters 1 and 2 we describe the generation of tightly regulated doxycycline-
inducible models for studying mouse intestinal and esophageal biology, respectively. 
The mouse model developed in Chapter 1 was employed in Chapter 3 to isolate and 
characterize quiescent cells within the intestinal epithelium, so-called label-retaining 
cells. These quiescent cells persist in the base of the intestinal crypt for a period of 
up to 100 days and have morphologic and gene-expression features reminiscent 
of a terminally differentiated cell type of the small intestinal crypt, so-called Paneth 
cells. 
During homeostasis, quiescent label-retaining cells form an essential part of the stem 
cell niche. Notably, following radiation-induced tissue injury, label-retaining cells are 
activated to proliferate, de-differentiate and acquire the expression of the intestinal 
stem cell marker Bmi1. We thus postulate that, through their intrinsic resistance to 
radiation, quiescent Paneth-like label-retaining cells serve as a back-up stem cell 
pool in situations of heavy tissue injury. 
In Chapter 4 we induce colonic inflammation in tumor-prone Apc1638N/+/villin-
KRASG12V animals and observe the presence of Paneth-like cells in early tumor 
lesions. We hypothesize that these cells derive from a quiescent Paneth-like stem 
cell population that is also present in the colon and activated to cycle by inflammation-
induced tissue injury. 
In Chapters 5 and 6 we describe the identificatioin of quiescent cells from gastric 
(Chapter 5) and small intestinal (Chapter 6) tumors. In Chapter 5, we thoroughly 
characterize stomach tumors of the intestinal type from aged Apc1638N/+ animals and 
composed of mixed stomach- and intestine-specific cell lineages with squamous 
differentiation. Interestingly, a rare quiescent population of tumor cells is shown to 
be present within those tumors. However, at present it is not clear whereas these 
quiescent tumor cells play any role in tumor maintenance, progression and invasion. 
The results presented in Chapter 6 point to the existence of quiescent label-
retaining tumor cells in Apc1638N/+/villin-KRASV12G adenocarcinomas. These quiescent 
tumor cells form a subpopulation of the fraction enriched in cancer stem cells. Our 
results suggest that in these tumor cells quiescence is maintained through high 
expression levels of the cell cycle inhibitor Cdkn1. However, their functional role as 
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a niche or in tumor dormancy and metastases has still to be determined in future 
experiments.
Finally, the Discussion chapter summarizes the main findings of this thesis and 
gives directions for future research. Overall, the results of this PhD thesis point to 
a surprising new function of quiescent terminally differentiated Paneth-like cells as 
back-up stem cell pool upon tissue injury. The role of quiescent tumor cells remains 
yet to be determined in future experiments……….silent waters run deep!
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Samenvatting
Organen van zoogdieren, zoals het maag-darmkanaal en het bloed, zijn één 
van de snelst zelf vernieuwende weefsels in ons lichaam. Om de werking van deze 
organen te verzekeren, is een constante aanmaak van nieuw celmateriaal nodig. De 
levering van deze cellen wordt verzorgd door een populatie van weefselstamcellen, 
die aanleiding geven tot een populatie van snel delende cellen. Deze cellen 
differentiëren vervolgens tot de functionele celtypes van het respectieve weefsel. 
Het stamcelcompartiment van zulke snel vernieuwende weefsels bevat meestal 
stamcellen in twee verschillende stadia. Snel delende stamcellen verzorgen de 
dagelijkse celvernieuwing, terwijl hun langzaam delende (stille) broers alleen maar in 
situaties van weefselschade geactiveerd worden. Deze laatste zijn verantwoordelijk 
voor de reparatie van de schade. Binnen dit proefschrift hebben wij de aanwezigheid 
en functie van stille cellen in het maag-darmkanaal van muizen tijdens homeostase, 
na weefselschade en in tumoren bekeken. 
Hoofdstukken 1 en 2 beschrijven de generatie van strak gereguleerde en middels 
doxycycline induceerbare muismodellen voor het bestuderen van de biologie van het 
maag-darmkanaal en de slokdarm. Het in hoofdstuk 1 gegenereerde muismodel 
wordt in hoofdstuk 3 gebruikt om stille (langzaam delende) cellen in het epitheel 
van de darm te karakteriseren. Deze cellen worden ook labelbehoudende cellen 
genoemd (LRC) en behouden hun label in de basis van de crypten van de darm voor 
een periode tot 100 dagen. Ze lijken morfologisch en qua genexpressie erg op een 
terminaal gedifferentieerd celtype van de dunne darm, de zogenoemde Paneth-cellen. 
Tijdens homeostase maken stille cellen een essentieel deel van de stamcelniche uit. 
Vooral als reactie op weefselschade geïnduceerd door straling worden stille cellen 
geactiveerd, vervolgens vermenigvuldigen ze zich, de-differentiëren en brengen 
de stamcelmarker Bmi1 tot expressie. Daarom vooronderstellen wij dat stille, op 
Paneth-cellen lijkende cellen, door hun intrinsieke weerstand tegen bestraling, 
vooral in situaties van sterke weefselschade als back-up stamcelpopulatie dienen.
In hoofdstuk 4 induceren wij ontsteking van de dikke darm in Apc1638N/+/villin-
KRASG12V muizen. Deze muizen zijn gevoelig voor de ontwikkeling van tumoren 
van de dunne darm. De ontsteking in de dikke darm veroorzaakt echter ook 
tumoren in de dikke darm, welke al in een vroeg stadium gekenmerkt zijn door de 
aanwezigheid van op Paneth-cellen lijkende cellen. Wij veronderstellen dat deze 
cellen afkomstig zijn van een stille en op Paneth-cellen lijkende cel populatie die in 
de dikke darm aanwezig is en die door ontsteking geïnduceerde weefselschade ter 
vermenigvuldiging geactiveerd wordt. 
In hoofdstukken 5 en 6 beschrijven wij de identificatie van stille cellen in tumoren 
van de maag (hoofdstuk 5) en de dunne darm (hoofdstuk 6). In hoofdstuk 5 
karakteriseren wij maagtumoren van oude Apc1638N/+ muizen. Deze tumoren zijn van 
het intestinale type, bestaan uit verschillende maag en darm specifieke celtypes en 
bevatten cellen met squameuze differentiatie. Opmerkelijk genoeg vonden wij dat 
deze tumoren een zeldzame populatie stille tumorcellen bevatten. Maar het is nog 
onduidelijk of deze stille tumorcellen een rol spelen in tumoronderhoud, -progressie 
of tumorinvasie. De resultaten in hoofdstuk 6 wijzen op het bestaan van een stille, 
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labelbehoudende cel populatie in dunne darmtumoren van Apc1638N/+/villin-KRASV12G 
muizen. Deze stille cellen maken deel uit van een celpopulatie, die verrijkt is in 
kanker stamcellen. Vanwege de expressie van de celcyclus remmer Cdkn1 hebben 
deze cellen een tragere celdeling. Maar de functie van deze stille tumorcellen als 
niche en bij de vorming van uitzaaiingen moet nog worden bepaald. 
Tenslotte werden de bevindingen van de verschillende hoofdstukken 
samengebracht in de discussie. De resultaten van dit proefschrift wijzen op 
een verassende nieuwe functie van stille, op Paneth-cel lijkende, terminaal 
gedifferentieerde cellen als back-up stam cel populatie na weefsel schade. De 
functie van stille tumorcellen moet in de toekomst nog verder bepaald worden… 
want stille wateren hebben diepe gronden.  
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Zusammenfassung
Blut und Magen-Darm-Trakt gehören zu den Säugetierorganen, die sich am 
schnellsten erneuern. Um die Funktionalität dieser Organe sicher zu stellen, wird 
ständig neues Zellmaterial benötigt. Diese Zellen stammen von Gewebsstammzellen 
ab, deren hochproliferative Tochterzellen zu allen funktionellen Zelltypen des 
Gewebes differenzieren können. Die Stammzellnische dieser hochproliferativen 
Gewebe besteht aus Stammzellen, die sich in zwei verschiedenen Stadien befinden. 
Während sich schnell teilende Stammzellen die tägliche Gewebserneuerung 
unterhalten, werden deren langsam teilende Schwesterzellen nur aktiviert, wenn 
das Gewebe beschädigt wurde. Sie sind daraufhin für die Gewebsregeneration 
zuständig. In dieser Doktorarbeit haben wir die Anwesenheit und funktionelle 
Rolle von sich langsam teilenden Zellen im Magen-Darm-Trakt von Mäusen unter 
Homöostase, nach Gewebsbeschädigung und in Tumoren studiert. 
In Kapitel 1 und 2 beschreiben wir die Entwicklung von genau regulierbaren 
und mittels Doxycyclin induzierbaren Mausmodellen, die benutzt werden können, 
um die Biologie der Speiseröhre und des Magen-Darm-Traktes zu studieren. Das 
Mausmodell, das in Kapitel 1 entwickelt wurde, haben wir in Kapitel 3 benutzt, 
um langsam teilende Zellen im Epithel des Magen-Darm-Traktes zu untersuchen. 
Diese Zellen sind für einen Zeitraum von bis zu 100 Tagen nachweisbar und sind 
morphologisch einem ausdifferenzierte Zelltyp des Magen-Darm-Traktes sehr 
ähnlich, den sogenannten Panethzellen. Während Homöostase formen diese 
Zellen einen essenziellen Teil der Stammzellnische. Erstaunlicherweise werden 
diese Zellen nach durch Bestrahlung induziertem Epithelschaden zur Teilung 
aktiviert, dedifferenzieren und exprimieren plötzlich den Stammzellmarker Bmi1. 
Darum postulieren wir, dass Paneth-ähnliche langsame teilende Zellen durch ihre 
intrinsische Resistenz gegenüber Strahlung nach starkem Gewebsschaden als eine 
Ersatzstammzellpopulation fungieren. 
In Kapitel 4 induzieren wir eine Entzündung im Dickdarm von tumoranfälligen 
Apc1638N/+/villin-KRASG12V-Mäusen. Wir beobachten, dass frühe Gewebsver-
änderungen schon Panethzellen enthalten. Darum stellen wir die Hypothese auf, 
dass es auch im Dickdarm sich langsam teilende Stammzellen gibt, die Panethzellen 
ähneln und die durch Entzündung zur Teilung aktiviert werden. 
In Kapitel 5 und 6 beschreiben wir die Identifizierung von sich langsam 
teilenden Zellen in Magen- (Kapitel 5) und Darmtumoren (Kapitel 6). In Kapitel 5 
charakterisieren wir Magentumore, die in alten Apc1638N/+-Mäusen vorkommen und 
vom intestinalen Typ sind. Diese Tumore enthalten Zelltypen, die charakteristisch 
sind für Magen und Darm, aber auch Plattenepithel. Interessanterweise konnten 
wir auch eine selten vorkommende Population von sich langsam teilenden Zellen in 
diesen Tumoren nachweisen. Allerdings ist im Moment noch unklar, ob diese Zellen in 
Prozessen wie Tumorprogression oder Tumorinvasion eine funktionelle Rolle spielen. 
Die Resultate aus Kapitel 6 weisen daraufhin, dass Adenokarzinome des Magen-
Darm Traktes von Apc1638N/+/villin-KRASG12V-Mäusen auch eine Tumorzellpopulation 
enthalten, die sich langsam teilt. Diese Tumorzellen machen Teil einer Gruppe von 
Zellen aus die angereichert ist in Krebsstammzellen. Unsere Resultate zeigen, dass 
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diese Zellen sich aufgrund der Expression des Zellzyklushemmers Cdkn1 wenig 
teilen. Allerdings ist die Funktion dieser Zellen als Nische oder bei der Ausbildung 
von Tumormetastasen noch unklar.  
Schlussendlich fasst das letzte Kapitel die hauptsächlichen Erkenntnisse 
zusammen und gibt Vorschläge für mögliche zukünftige Projekte. Alles in 
allem weisen die Erkenntnisse dieser Doktorarbeit darauf hin, dass langsam 
teilende, ausdifferenzierte Paneth-ähnliche Zellen als Ersatzstammzellen nach 
Gewebsschaden fungieren. Die Aufgabe sich langsam teilender Tumorzellen muss 
in zukünftigen Experimenten noch festgestellt werden ... denn stille Wasser sind tief!
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